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Chapter 1: Introduction
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1.1 Background 
 
In the Western world, approximately one third of all disease-related mortality is 
directly or indirectly related to atherosclerosis. Intense research over several decades 
has identified several risk factors in relation to the progression of the disease. Most if 
not all risk factors have in common that they act systemically, while it is a well-
known fact that atherosclerosis manifests itself at certain predilection sites, like side 
branches and curvatures 1-4. Consequently, an as yet unexplained factor must be 
involved in the process. 
Wall shear stress or shear stress is defined as the tractive force per unit area applied 
by the flowing blood on the endothelium. Several studies provided evidence for a 
role of this haemodynamic force as the factor linking atherosclerotic plaque 
formation to these predilection sites. This force is transmitted from sensors located at 
the cell membrane to the cell nucleus, affecting the gene expression, cellular 
metabolism, and cellular morphology 5,6. 
In most studies, association of shear stress with atherosclerosis has been limited to 
investigations in vitro or in post mortem human material. Our group has developed a 
novel method based on angiography, Intra Vascular Ultrasound (IVUS), and 
Computational Fluid Dynamics (CFD), to calculate shear stress in vivo. Using this 
method, we could show that in curved atherosclerotic coronary arteries of living 
humans, plaque is located predominantly in the inner curvature where local shear 
stress is low 7-13. In several other studies, it could also be shown that low shear stress 
regions were coupled to in stent restenosis and vascular remodeling after balloon 
angioplasty 9,11-13. In addition, a more recent study indicated that local increase of 
shear stress (by instrumentation of an intra-vascular device) in the stented areas 
reduced in stent restenosis, independent of other confounding factors, such as injury 
and inflammation 14. 
Although these results clearly indicate an important modulating role of shear stress in 
plaque progression, the precise relation between changes in the shear stress field and 
the underlying mechanism in atherosclerosis is currently unknown. This thesis will 
discuss some of the profound effects of shear stress on the biology of the vascular 
wall related to the development of atherosclerosis. The studies described in this thesis 
are all performed using a newly in-house developed device that can induce alterations 
in shear stress in vivo, thereby providing an opportunity to examine the effects of 
shear stress in a cause-effective manner. The development and the validation of this 
device will be further discussed in the next chapters. In this first chapter, a short 
outline of the process of atherosclerosis is given, followed by an overview of the 
different conditions of the shear stress that relates this haemodynamic force to this 
disease. Two (related) mechanisms for coupling shear stress to the occurrence of 
predilection sites in atherosclerosis are also presented. We will discuss the effect of 
different shear stress conditions on the expression of genes that influence vascular 
biology, and the effect of different shear stress parameters on triggering inflammation 
during the development of athersclerosis. The definition of the problem, the 
  
 11
hypothesis, the aims of the research and the outline of this thesis, are also described 
in this chapter. 
 
1.2 Atherosclerosis 
Atherosclerosis is a degenerative disease of large and medium sized arteries, 
characterized by lipid accumulation and collagen deposition. It is known as a major 
cause of ischaemia (e.g. myocardial infarction), leading to the high morbidity and 
mortality rate in cardiovascular disease. The exact initiator is unclear, but a number 
of risk factors  (e.g. age, smoking, high levels of plasma cholesterol, diabetes 
mellitus, and hypertension) and inflammation are strongly associated to the initiation 
of atherosclerosis. It is conceivable that all these factors contribute to the onset and 
the progression of the disease, mutually amplifying the effects via triggering of the 
immune response. However, as stated previously, these systemic risk factors cannot 
explain the locality of the onset of the disease. It is also known that atherogenesis 
(i.e. development of atherosclerosis) starts at the level of the endothelial cells (ECs). 
Damage or stimulation of the endothelium by components induced by risk factors, 
such as nicotine by smoking, activates the ECs to express pro-inflammatory 
molecules, attracting leukocytes (mainly monocytes) into the area between the 
endothelium and internal elastic lamina (i.e. intima). The permeability of the 
endothelium is also affected, resulting in the increased influx of macro-molecules 
including low density lipoproteins (LDL) that will become trapped in the vessel wall 
as they bind to the extra cellular matrix. Oxidation of these bound LDL particles 
(oxLDL) by superoxides, hydroxyl radicals or peroxynitrites provide yet another 
stimulus to boost the already on-going inflammatory response of the endothelial 
cells. The oxLDL is scavenged by macrophages via scavenger receptors such as 
CD36 and Scavenger Receptor A (SRA), activating them to become lipid-laden cells 
(foam cells). Following the by the American Heart Association (AHA) provided 
histological classifications of atherosclerotic lesions 15, this initial pathology can be 
classified as Type I (initial) lesions, consisting mainly of isolated macrophages and 
foam cells located in the intima. As the lesion further progresses into Type II (fatty 
streaks) and Type III (intermediate) lesions, multiple layers of macrophages and 
foam cells are formed, and continuing lipid accumulation in the vessel wall result in 
the accumulation of lipid droplets outside the cells, eventually leading to the 
formation of a lipid core. The lipid core is an extensive accumulation of extracellular 
lipid localized in the intima that characterizes Type IV (atheroma) lesions. In type II 
lesions, vascular smooth muscle cells (VSMCs) also start to migrate into the intima 
in response to chemoattractants secreted by activated macrophages and ECs. In 
addition, proliferation of these VSMCs due to stimulation by secreted growth factors 
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and cytokines (e.g. tumor growth factor-β ( TGF-β), interleukin 1 (IL1), and tumor 
necrosis factor α ( TNF-α) ) contributes to the progression of the disease. The Type 
IV is the first lesion considered advanced by histological criteria, whereas the term 
early lesions is also used for Type I and II lesions.  
As atherosclerosis continues to develop, disarrangement of intimal structure by the 
lipid core is followed by thickening of the intima, caused by increased formation of 
fibrous connective tissue layers that consists of VSMCs and collagen. This 
contributes to the progression of the plaques into Type V lesions. Three subtypes of 
Type V lesions can be distinguished: Type Va (fibroatheroma) lesions are 
characterized by the presence of these fibrous layers, also called the fibrous cap, 
covering to one or more lipid cores. Type Vb (calcific) lesions show extended 
calcification in the intima, and Type Vc (fibrotic) lesions are characterized by fibrous 
tissue layers without or with only minimal lipid (no core) and minimal or no calcium 
accumulation. Later adjustments to the AHA classification classify Type Vb and 
Type Vc as possible later phases of Type IV-VI lesions as a result of plaque 
stabilization due to regression of the lipid component. Therefore, Type Vb is also 
listed after the update as type VII and Type Vc as Type VIII lesions 16.   
In addition to Type IV, Type V lesions are also considered advanced lesions. Type 
IV and type V lesions in which disruptions of the lesion surface, haemorrhage, or 
thrombotic deposition have occurred are classified as Type VI or complicated 
lesions. Different subtypes of Type VI lesions can also be distinguished: Type VIa 
are characterized by disruption of the plaque surface, Type VIb by the occurrence of 
hemorrhage, and type VIc by thrombosis. Type VIabc indicates the presence of all 
three of these features. From all these lesion types, mainly Type V and VI lesions are 
clinically relevant: Type VI lesions often obstruct the vessel lumen (i.e. lumen 
stenosis), causing ischaemia in the down stream tissues as a result of the diminished 
blood flow. This could lead to serious clinical syndromes of cardiovascular disease, 
such as myocardial infarction (heart attack), pulmonary embolism (blockage in an 
artery of the lungs), and stroke (blockage in an artery of the brain). Type V lesions 
may be silent or with clinical complications, depending on the degree of the 
obstruction. Depending on its morphology and its composition, the atherosclerotic 
lesion can be more or less susceptible to the disruption of the plaque surface that 
could lead to acute vessel closure. This pathological event is called plaque rupture, 
and is often considered as the onset to the progression of plaques to a Type VI lesion. 
The most common specific type of plaque susceptible to rupture is the inflamed thin 
cap fibro-atheroma (TCFA), which is a Type Va lesion with increased inflammation 
and a thin fibrous cap covering a lipid-rich, necrotic core. These lesions contain little 
VSMCs and collagen, the two main stabilizing components of an atherosclerotic 
lesion. TCFAs are considered vulnerable or high risk plaques, a term used to describe 
atherosclerotic lesions that are at increased risk of thrombosis and rapid stenosis 
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progression. Two additional types of atherosclerotic lesions are also considered as 
vulnerable plaques: The eroded plaque, which is often a Type Vc (VII) lesion with 
loss and/or dysfunction of the lumenal endothelial cells leading to thrombosis, and 
lesions with calcified nodules, which are type Vb lesions with heavy calcifications 
and loss and/or dysfunction of endothelial cells covering the calcified nodules, 
resulting in loss of the fibrous cap. In relation to these three types of vulnerable 
lesions, plaque erosion and plaque rupture of TCFAs account for most of the sudden 
coronary deaths, claiming 6 per 100,000 and 17 per 100,000 men per year in the 
elderly population respectively 17. In young victims of sudden coronary deaths, 
plaque rupture account for 60% of thrombi, and plaque erosion for the remaining 
40% 18. In recent years, early detection of vulnerable plaques has therefore become 
an important research goal, encouraging the development of novel imaging methods 
19,20, as it would result in a major decrease in the morbidity and mortality of 
cardiovascular disease. In addition, potential plaque stabilization therapies are being 
developed, based on the knowledge acquired from the findings in patients. However, 
the mechanism of vulnerable plaque development remains unclear as no animal 
model of vulnerable plaque or plaque rupture is currently established.  
In atherosclerosis research, mice are commonly used. The use of inbred strains kept 
under similar housing and dietary conditions reduces genetic variability and the 
effects of environmental factors, which could affect the outcome of atherosclerosis 
studies in patients. Furthermore, the pathology of the disease can be investigated at 
multiple time points, and (surgical) interventions can easily be introduced in these 
animals. However, wild-type mice are highly resistant to atherosclerosis due to their 
low levels of cholesterol in plasma. In addition, the main class of plasma lipoprotein 
in mice is the anti-atherogenic (high density lipoprotein) HDL. This is in contrast to 
the lipoprotein profile of humans, in which the main portion of plasma lipoproteins 
consists of pro-atherogenic very low density lipoprotein (VLDL) and LDL. Indeed, 
atherosclerosis can only develop in the relatively susceptible C57BL6 mouse strain 
after feeding the animals an extremely atherogenic diet for a prolonged period of time 
21. Several mouse models have been generated in which genetic modifications (i.e. 
overexpression or deficiency of specific genes) have made them more susceptible to 
the disease. The most commonly used models in atherosclerosis research are mice 
deficient in ApoE 22,23 or the LDL-receptor 24, both capable of developing advanced 
atherosclerotic lesions. Recent developments in studies using ApoE deficient mice 
have also indicated that they might be useful for assessing the mechanism involved in 
the progression of vulnerable plaque.  
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1.3 Flow patterns affecting vascular biology 
As stated previously, ECs play a crucial role in the onset of atherosclorosis, and they 
are responsive to a large number of different stimuli. However, most of the factors 
associated with the initiation of atherosclerosis have a systemic effect.  An additional 
stimulus is needed to clarify the specific localization of atherogenesis in the 
vasculature. A large body of evidence demonstrated that shear stress is this localizing 
factor. Wall shear stress or shear stress is defined as the tractive force per unit area 
applied by the flowing blood on the endothelium. Endothelial cells throughout the 
vasculature experience a variety of flow conditions with large differences in shear 
stress level (which is the actual force expressed in dynes, 1 dyne = 0.1 N/m2), and in 
shear stress gradients (which are changes in shear stress direction and/or shear stress 
levels over time). In the venous system, shear stress levels are low (between 0.76 and 
7.6 dynes/cm2) with minimal gradients because of the non-pulsatile nature of the 
flow. In the straight vessel segments, flow conditions are generally laminar and 
pulsatile, with higher shear stress levels (averages are between 11.4 and 30.4 
dynes/cm2 for large arteries, and between 19.0 and 60.8 dynes/cm2 for arterioles 
(reviewed in 25)). In the relatively high flow environment of the arterial system, blood 
is a suspension of particles that behaves approximately as a Newtonian fluid. Shear 
stress (σ) can therefore be determined by flow rate (Q), fluid viscosity (µ) and radial 
distance of the vessel lumen (d) according to the relationship: σ=4µQ/πd3, under the 
additional conditions that the vessel is a circular tube with a constant diameter, and 
the blood flow is stationary, resulting in a parabolic profile of blood velocity (i.e. 
assuming Poisseuille flow conditions)(reviewed in 26). Shear stress levels are actively 
maintained in the arterial circulation as vascular tissues respond to shear stress 
changes with acute adjustments in vascular tone and with chronic structural 
remodeling, resulting in adjustments of vessel diameter. Shear stress gradients are 
dependent on specific flow conditions. Flow conditions in the artery are specified by 
the Reynolds number (Re), which is a ratio of inertial over viscous effects. It can be 
described by the following formula: Re=4ρQ/πµD, where ρ is the density of blood, D 
the vessel diameter, µ the blood viscosity and Q is the flow rate. At very low flow 
rates, Re is low (below 1). This means that the force due to the viscosity of the blood 
(viscous force) dominate over the force dependent from flow rate (inertial force). As 
a result, blood flow follows the geometry of the vessel. When Re become larger, and 
viscous forces and inertial forces become comparable, secondary flows (vortices and 
non-axial flow profiles) arise. These secondary flows develop at arterial bends and 
bifurcations. When Re becomes even larger (larger than 2000), the blood flow 
becomes turbulent, with fully randomized lateral motion of the blood. Turbulence is 
dependent on vascular geometries, such as the presence of lumen stenosis, and on 
flow pulsality as a result of the cardiac cycle. Transient turbulence has been shown to 
occur in the human aorta at peak systole, during heavy dynamic exercise in much of 
the central arterial system and distal to arterial lumenal stenosis and aneurysms 26. 
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Shear stress has been related to atherosclerosis for several decades, and a large body 
of studies in both patients and animal models have provided evidence in particular for 
a role of low shear stress (<1.5 N/m2) in this disease 5,12,27-32. However, additional 
studies have also indicated that oscillations in shear stress with time dependent 
gradients correlate to plaque localization 33. Oscillations with time dependent 
gradients are changes in shear stress levels during the cardiac cycle. They are the 
result of the occurrence of secondary flow at vessel regions where viscous and 
inertial forces are comparable. Recent improvements of imaging techniques 
confirmed these early findings in patients in vivo 34,35. Additionally, recent 
experiments showed that besides temporal gradients in shear stress, spatial gradients 
in shear stress predict plaque location and macrophage accumulation in the rabbit 
aorta 36-39. Spatial gradients in shear stress are changes in shear stress at different 
locations and are mainly due to secondary flow.  Temporal gradients of shear stress 
are mainly due to pulsatile variations of vortices. These two last observations are of 
particular importance as they introduce dynamics in place and in time to the biology 
of fluid dynamics.  
 
Extensive studies on particle behavior near the vessel wall indicated that the 
predicted locations of macrophage accumulation coincide with regions where 
particles come in close contact with the endothelium. In addition, specific 
localization of other atherogenic events correlated with the above mentioned shear 
stress gradients 36-39. From these studies, we conclude that besides the mean shear 
stress levels other parameters derived from the velocity field potentially affect the 
localization of inflammation and plaque formation.  
In summary, given the complexity of shear stress fields, the search for specific shear 
stress conditions that predict plaque location and plaque inflammation is still under 
debate. In general, besides low shear stress, changes in the direction of the shear 
stress near the vessel wall over time leading to spatial gradients in shear stress is the 
most obvious condition. The latter will be further indicated as oscillatory shear stress 
in this thesis. The effects of low shear stress and oscillatory shear stress on the 
pathology of the vascular wall will be examined in the studies described in the next 
chapters. 
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1.4 Shear stress and gene expression  
 
The molecular mechanisms by which shear stress acts on the vessel wall by 
stimulating the endothelium have been extensively studied in vitro. Studies from 
different laboratories reported between 40 and 125 genes to be modulated by shear 
stress in cultured endothelial cells 3,40-49. Excellent reviews have been published 
regarding the number and interaction between shear stress responsive genes, and the 
role of transcription factors 3-6. Studies on individual genes in vitro (Table 1) and in 
vivo (Table 2) indicated that, in general, low shear stress is associated with an pro-
atherosclerotic phenotype and high shear stress with an athero-protective phenotype 
(Tables 1 and 2). The studies that evaluated oscillatory shear stress in vitro also 
suggest a more atherogenic effect for this type of shear stress than shear stress under 
laminar flow conditions, as they indicate that eNOS is downregulated 50,51, 
endothelin-1 is upregulated 50,51, and adhesion factors (e.g. vascular adhesion 
molecule-1 (VCAM-1 52), intercellular adhesion molecule-1 (ICAM-1 52), and E-
selectin 52) are upregulated, resulting in an increase in the adhesion of monocytes. In 
addition to these data, more than 40-120 genes have been associated with shear stress 
by gene-profiling studies; Table 3. From Table 3 it is clear that most of these studies 
have been performed in cultures, and that there is a great variability between 
laboratories despite close similarity of the protocols and cell types used. Although the 
reasons for these discrepancies are presently unknown, it has been postulated that the 
isolation of the endothelial cells might induce changes in the phenotype of these 
cells. Furthermore, only one study concentrated on the differential gene expression in 
conditions of laminar shear stress and disturbed shear stress in vitro 47. Disturbed 
flow regulates a different set of genes than laminar shear stress, which may explain 
the relation between shear stress oscillations and predilection sites for atherosclerosis. 
Therefore, this study extends earlier studies on single genes (see above). However, 
most studies relating gene expression to shear stress are performed in vitro only and 
extrapolation to in vivo conditions may be problematic. Also, interpretation of these 
results with respect to atherosclerosis remains difficult. Atherosclerosis in humans 
and animal models need respectively years and months to develop, a time span that 
can hardly be maintained in cell cultures. In addition, the pathology of atherosclerosis 
involves too many factors (involved in e.g. lipid metabolism and inflammation) and 
too many different cell types (ECs, VSMCs, macrophages and T-cells), to be 
successfully mimicked in an in vitro situation. Furthermore, atherosclerosis related 
genes that have been identified to be shear stress responsive in vitro may not have an 
overall (pro-atherosclerotic) effect as complex feedback mechanisms active in the 
vessel wall could act to preserve homeostasis. Davies et al. also studied the effect of 
shear stress on gene expression of the vascular endothelium, but used a more 
sophisticated approach by obtaining ECs located in areas of the porcine aorta that are 
naturally exposed to different shear stress conditions for mRNA analysis. They 
selected the aortic arch as a region of disturbed flow (secondary flow and 
turbulence), and the descending thoracic aorta as a region of undisturbed flow, and 
  
 17
compared the expression and activity of endothelial protein kinase C (PKC) in these 
areas 56. Furthermore, studies in mice using the natural sites of disturbed flow in the 
aorta for validation of in vitro findings could show increased activation of NFκ-B 57 
(indicated by translocation of this transcription factor to the nuclei), and upregulation 
of ICAM-1 and VCAM-1 58. These types of studies provide crucial insight for the 
role of shear stress in the development of pathologies in the vessel wall. However, 
these studies of predeliction sites for atherosclerosis associated to certain shear stress 
conditions do not provide direct causal evidence.       
In conclusion, the effect of low shear stress and oscillatory shear stress on gene 
expression in cultured ECs has been extensively studied. However, relevance of these 
mechanisms in the pathology of atherosclerosis is still largely unclear. This is due to 
the lack of a method capable of inducing these shear stress parameters under pro-
atherosclerotic in vivo conditions.  
 
Table 1: Shear stress and gene expression in ECs in vitro. 
 
Gene Function SS 
level 
duration 
(hours) 
Result Cell type Ref. 
VCAM-1 Adhesion Low 6 Up EC 59 
ICAM-1 Adhesion Low 6 Up HUVEC 60 
TF Clotting High 1-3 Up EC 60 
ET-1 Constrict High 6 Down EC 61 
COX-1 
COX-2 
Dilator 
Constrict 
High 12 Up HUVEC 62 
LOX-1 Lipid Low 8 Up BAEC 63 
SOD Anti-oxidant Low N.A. Up HUAC 64 
eNOS  Dilator High 4 Up HUVEC 65 
CNP Dilator High 3-8 Up HUVEC 62 
PDGF 
A/B 
Growth Low 1-2 Up HUVEC 66 
βFGF Growth High 9 Up BAEC 5 
TGF-β1 Growth High 3 Up EC 67 
ACE Growth Low 18 Up EC 68 
 
EC: endothelial cell; HUVEC: human umbilical vascular endothelial cell; BAEC: 
bovine arterial endothelial cell; VCAM: vascular adhesion molecule; ICAM: 
intercellular adhesion molecule; TF: tissue factor; ET-1: endothelin-1; COX cyclo-
oxygenase; LOX-1: lecitine-like ox-LDL receptor; SOD: superoxide dismutase; 
eNOS: endothelial nitric oxide synthase; CNP: C-natriuretic protein; PDGF: platelet 
derived growth factor; βFGF: basic fibroblast growth factor TGF-β1: transforming 
growth factor β1; ACE: angiotensin converting enzyme. Shear stress values are given 
with reference to the normal value of 1.5 N/m2. The response is expressed with 
respect to a housekeeping gene. N.A.: not available. 
  
Table 2: Shear stress related gene expression in blood vessels in vivo. 
 
Gene Function Flow Duration 
(weeks) 
Result Tissue  Ref. 
VCAM-1 Adhesion Down 5 Up Carotid 
Artery 
69 
ICAM-1 Adhesion Down 5 Up Carotid 
Artery 
69 
TF Clotting Up <1 Up Carotid 
Artery 
60 
β-FGF Growth Up 1-7 Up Carotid 
Artery 
70 
PDGF-A Growth Up 1 Up Mesenteric 
Artery 
71 
PDGF-B Growth Up 7 Up Mesenteric 
Artery 
71 
TGF-β Growth Up 7 Up Mesenteric 
Artery 
71 
MMP-2 and 
MMP-9 
Matrix 
degradation 
Up 1 Up Carotid 
Artery 
72 
MMP-2 and 
MMP-9 
Matrix 
degradation 
Down 1 Up Carotid 
Artery 
72 
VCAM: vascular adhesion molecule; ICAM: intercellular adhesion molecule; TF: 
tissue factor; ET-1: endothelin-1; βFGF: basic fibroblast growth factor; PDGF: 
platelet derived growth factor; TGF-β1: transforming growth factor β1; MMP: 
metallo-proteinase. The response is expressed with respect to a housekeeping gene. 
 18
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Table 3: Review of literature studying the effect of shear stress on gene expression  
 
Ref. Cell type SS 
(N/m2) 
Method Up 
 
Down Time 
(hours)
Control 
47 HAEC 0.001 Microarray 11 19 24 Static 
47 HAEC 1.3 Microarray 9 50 24 Static 
47 HAEC 1.3 Microarray 7 7 24 Laminar flow 
46 HAEC 1.2 Microarray 15 53 24 Static 
3 HUVEC 1.2 Microarray 32 20 24 Static 
73 HUVEC Turbulent Subtraction 63 - 0-20 Static 
73 HUVEC 1.2 Subtraction 5 - N.A. Static 
74 HUVEC 0.6 Diff display 13 20 0-48 Static 
75 HUVEC 1.5 Gene calling 60 47 6,24 Static 
48 HAEC 1.2 Microarray 27 33 1-24 Static 
49 HAEC 1.5 Microarray 19 91 1 Static 
49 HAEC 4.5 Microarray 25 25 1 Static 
46 HAEC 2 Diff.display 8 - 48 Static 
45 HUVEC 2.5 Diff. display 12 - 24 Static 
 
HAEC: human endothelial cells; HUVEC: human umbilical vascular endothelial cells 
N.A.: not available. 
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1.5 Shear stress and inflammation 
 
Accumulating evidence demonstrates that atherosclerosis is modulated by chronic 
inflammation 76,77. As stated previously, atherosclerotic plaques contain inflammatory 
infiltrates, mainly consisting of macrophages and T-cells. Of the entire T-cell 
population, the majority consists of CD4 (+) cells (70-80%), while the rest consists of 
CD8 (+) cells and natural killer cells 78,79. Co-localization studies and the cytokine 
secretion pattern indicate that these T-cells are activated and belong predominantly to 
the Th1 cell type 79,80. In addition, it has recently been shown that CD40, the 
counterpart of CD40L, is expressed on ECs, dendritic cells (DCs), VSMCs and 
macrophages. As CD40L is expressed on the surface of active T-cells 81, the T-cells 
in the plaque may regulate the activity of these cell types. Recent intervention 
experiments that either inhibit CD40-CD40L ligation or immunize animals with ox-
LDL showed large effect upon plaque progression and plaque composition 78. These 
studies indicate an important modulating role of an activated immune system in 
plaque composition.  
In order to investigate the role of inflammation in the formation of the predilection 
sites for atherosclerosis, one has to postulate that shear stress modulates 
inflammation in vivo. In healthy vessels, immuno-competent and antigen-presenting 
cells have been identified at the well-known predilection sites 82. As a result of these 
findings, Gozales and co-workers proposed the existence of vascular-associated 
lymphoid tissue (VALT) in accordance with the resemblance with mucosa-associated 
lymphoid tissue (MALT), and gut-associated lymphoid tissue (GALT). These regions 
are highly organized immunological regions within tissues, consisting of non-
encapsulated lymphoid tissue with germinal centers. Due to this organization, DCs 
and macrophages may come in close contact with B- and T-cells allowing their 
maturation after antigen presentation. In atherosclerosis, the number of DCs at these 
sites increases and the immature DC transforms into mature DCs 83. Although it is 
presently unknown why VALTs are located on the predilection sites, this may be due 
to the shear stress dependency of the expression of adhesion factors and pro-
inflammatory mediators on the endothelium, described above 52,84-87. Recently in a 
rare in vivo analysis of vascular regions exposed to disturbed blood flow, it was 
shown that altered shear stress can prime the endothelium to respond to pro-
atherosclerotic stimuli through upregulation of the inflammatory transcription factor 
NF-κB 57. In contrast, laminar flow with normal shear stress levels (laminar shear 
stress) promotes an anti-inflammatory and anti-oxidative expression profile, acting 
through promoter elements identified as shear stress responsive elements (SSREs), 
antioxidant responsive elements (ARE) and PPARγ-responsive elements57. 
Conversely, low shear stress triggers adhesion of leukocytes to activated endothelium 
through enhanced expression of ICAM-1, VCAM-1, and E-selectin. Oscillatory shear 
stress has recently been shown to upregulate the expression of bone morphogenic 
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protein (BMP-4), a member of the TGF-β family of cytokines, which was associated 
with increased ICAM-1 expression through an NF-κB-dependent mechanism88. 
These findings may explain the specific and local accumulation of immuno-
competent cells at predilection sites and provide evidence for an immunological 
mechanism underlying the role of (oscillatory) shear stress and atherosclerotic 
predilection sites.    
While the above mentioned studies indicated a role of inflammation in early 
atherosclerosis, it has recently been shown that accumulation of inflammatory cells 
causes plaque rupture in advanced atherosclerotic lesions. It has been postulated that 
during the progression of atherosclerotic lesions towards a more vulnerable plaque 
phenotype, activated T-cells, either directly or by CD40 ligation, amplify the 
activation of macrophages. These activated macrophages secrete matrix metallo 
proteinases (MMPs) that locally weaken the extracellular matrix, thereby causing a 
malignant progression of the plaque to vulnerability to rupture. Recently, 
inflammatory cells were detected predominantly upstream of human carotid plaques 
89 at the location where plaque ruptures are frequently observed. While these authors 
have implied that shear stress could play a role in the distribution of inflammatory 
cells, a direct relationship was not shown. In order to study this phenomenon, we 
have developed an experimental rabbit model that mimics the findings reported in 
patients (Figure 1). With a modification of our numerical techniques 10-12 we could 
correlate local shear stress to local macrophage accumulation. These experiments 
clearly show that regions upstream of the plaque contained more macrophages and 
are associated with higher shear stress values (Figure 1). Accumulation of 
macrophages not necessarily implies that these cells are active. In order to evaluate 
the activity of macrophages we measured the MMP activity upstream and 
downstream of the plaque. We tested the hypothesis that stimulated macrophages 
increase the production of metalloproteinases, which will induce collagen breakdown 
and provide possible local weak spots in the plaque, creating a state of plaque 
vulnerability 90-93. To evaluate if (oscillatory) shear stress is related to MMP activity, 
we performed a study in rabbits. In figure 2 an image depicts a relationship between 
MMP9 location and shear stress, indicating that at high shear stress regions upstream 
of the plaque the MMP9 levels are high. MMP9 has been identified in human 
ruptured plaques and has been associated with macrophage accumulation 92,93. Hence, 
the association of shear stress with MMP9 activity may favour a rheological effect 
underlying vulnerable plaque. We propose that the secondary flow induced by the 
(abrupt) narrowing of the blood vessel upstream of the plaque may favour the contact 
of particles in the bloodstream and the vessel wall. As a result, the occupancy of the 
adhesion factors upstream of the plaque increases, allowing a selective uptake of 
inflammatory cells upstream of the plaque. Alternatively the haemodynamic 
environment resulting from the curved streamlines may induce uptake of lipids and 
as a result create a region of endothelial dysfunction, adhesion factor expression and 
uptake of macrophages. 
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In summary, we conclude that shear stress oscillations, via direct or indirect 
induction of adhesion factors, may be associated with secondary lymphoid tissue in 
normal and atherosclerotic tissue (VALT). These findings make it plausible that the 
relation between shear stress and predilection sites is due to an immunological 
mechanism. In addition, our own data provide evidence that existing plaques, and 
specifically advanced lesions, can also be affected by shear stress variations via 
triggering of an immunological response.  
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1.6 Problem definition and hypothesis 
 
The mechanisms by which shear stress influence the biology of the vascular wall and 
induce atherosclerosis are still largely unclear. Although the effect of low shear stress 
and oscillatory shear stress on gene expression in cultured ECs has been examined 
extensively, the relevance of these findings for the progression of atherosclerosis has 
not been shown. This is due to the lack of a reproducible method capable of inducing 
these shear stress conditions in vivo under pro-atherosclerotic conditions. Shear stress 
may influence the vessel wall by inducing the expression of atherogenic genes by the 
endothelium. These atherogenic compounds contribute to an inflammatory response, 
which triggers the development of atherosclerotic plaques. By developing and 
validating a new device that can induce different shear stress conditions in an in vivo 
animal model, we are able to examine this mechanism, and provide data that show 
the relevance of the biological effects of shear stress on the vessel wall.  
Therefore, we have the following hypothesis: 
 
Shear stress affects the biology of the vascular wall and can induce the expression 
of atherogenic genes, making it susceptible to atherosclerosis. 
 
The experiments performed to test this hypothesis are described in the next chapters.  
 
 
1.7 Research objectives and thesis outline 
 
In this thesis, studies are described that focus on the relationship between different 
shear stress conditions and their biological effects on the vessel wall leading to 
atherosclerosis. The lack of a method that can induce different shear stress conditions 
in laboratory animals hampers the design of studies in vivo that could determine the 
role of shear stress in vascular biology.  
Therefore, the aims of the studies described in this thesis were:  
 
I) To develop and validate a new shear stress altering device (referred 
to as the cast) that is capable of inducing physiological and 
biological changes in an in vivo animal model. 
II) To study the in vivo response of shear stress related genes (e.g. 
eNOS) to low shear stress and oscillatory shear stress.  
III) To study the effects of low shear stress and oscillatory shear stress in 
vivo on the development of atherosclerosis and plaque stability. 
IV) To examine the effects of low shear stress and oscillatory shear 
stress on inflammation in the vessel wall. 
 
  
 24
The cast is described in chapter 3. The physiological effect of this device on shear 
stress is tested by Doppler measurements and CFD. The biological response of 
alterations in shear stress on the endothelium is validated by studying the response of 
the shear stress responsive gene eNOS.  We used an in-house developed transgenic 
mouse model in which a human eNOS gene fused to a green fluorescent protein 
(GFP) is driven by the humane NOS promoter. This mouse model is described in 
chapter 2. After the cast model was successfully validated, this method was used in 
all the subsequent studies described in this thesis. Regulation of eNOS protein levels 
and activity is very complex and occurs both at transcriptional and post-
transcriptional levels 94. Post-translational modification of eNOS by myristoylation 
and palmitoylation that targets the protein to the Golgi complex and the lipid rich 
domains of the cell membrane are both necessary for proper eNOS activation. We 
therefore studied the effect of shear stress on the cellular localization of eNOS. The 
findings of these experiments are described in chapter 4. Furthermore, influence of 
the drug rapamycin on eNOS responsiveness to shear stress is evaluated in chapter 5. 
As shear stress is strongly related to the onset of atherosclerosis, we tested the 
atherogenic properties of low shear stress and oscillatory shear stress in a mouse 
model for atherosclerosis (ApoE -/-). In addition, we examined the effect of these two 
different shear stress conditions on plaque vulnerability. The findings of this study 
are described in chapter 6. The immunological mechanism by which these shear 
stress conditions induce atherosclerosis and define plaque vulnerability is studied by 
examining the effect on expression of chemoattractants (chemokines) in chapter 7. 
Finally, the results obtained in these studies are summarized and discussed in chapter 
8 of this thesis. 
 
 
  
 
Figure 1: 3D reconstruction of an atherosclerotic rabbit aorta with IVUS, allowing 
the projection of wall thickness on the 3D lumen reconstruction. Indicated is also the 
shear stress distribution obtained by CFD. Atherosclerosis was induced in New 
Zealand White rabbits by a combination of denudation (surgical removal of the 
endothelium) and high cholesterol diet for two months. CFD modeling was based 
upon a commercially available finite element package as described before 7-9. On the 
left and right sides are indicated the macrophage distribution and the smooth muscle 
cell distribution. Lines in the figure indicate the approximate location of the 
histological cross sections. The position of these cross sections was determined by 
measurement at sacrifice. Note that upstream, where the shear stress is high, the 
macrophages accumulate. Full colour image of this figure is available in the colour 
section.  
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Figure 2: Relationship between metalloproteinase activity as determined by 
zymography 92, plaque location and shear stress distribution mapped upon the 3D 
reconstruction of the blood vessel. CFD was used as described in figure 1. Mapping 
of location was performed by selection on basis of shear stress distribution and 
correction for shrinkage after dissection. Note that the location of MMP9 activity is 
upstream of the plaque and associates with high shear stress values. MMP-2 is 
activated through the entire plaque region. A-E represent samples from the sections 
in different locations of the atherosclerotic vessel. R stands for the control sample. 
Full colour image of this figure is available in the colour section.    
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2.1 Abstract 
 
The activity of endothelial nitric oxide synthase (eNOS) is subject to complex 
transcriptional and post-translational regulation including the association with several 
proteins and variations in subcellular distribution. In the present study we describe a 
transgenic mouse model expressing eNOS fused to green fluorescent protein (GFP), 
which allows the study of localization and regulation of eNOS expression. We tested 
the functionality of eNOS in the eNOS–GFP mice. Expression of eNOS was 
restricted to the endothelial lining of blood vessels in various tissues tested, without 
appreciable expression in non-endothelial cells. Activity of the enzyme was 
confirmed by essaying the conversion of L-arginine to L-citrulline. NO production in 
isolated vessels was increased in transgenic mice when compared to non-transgenic 
control animals 4.88± 0.59 and 2.48± 0.47 µM NO, respectively, P<0.005) . Both the 
mean aortic pressure and the pulmonary artery pressure were reduced in eNOS–GFP 
mice (both ~30%, P<0.05). Plasma cholesterol levels were also slightly reduced 
(~20%, P<0.05). In conclusion, eNOS–GFP mice express functional eNOS and 
provide a unique model to study regulation of eNOS activity or eNOS mediated 
vascular events, including response to ischemia, response to differences in shear 
stress, angiogenesis and vasculogenesis, and to study the subcellular distribution in 
relation with functional responses to these events. 
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2.2 Introduction 
 
In endothelial cells, nitric oxide (NO) is generated by the enzyme endothelial nitric 
oxide synthase (eNOS) via the conversion of L-arginine to L-citrulline. NO produced 
by eNOS affects a number of biological processes in the vessel wall. It is important 
for the regulation of blood pressure and plays an important role in the aggregation of 
blood platelets, adhesion of leukocytes to the vessel wall and migration of vascular 
smooth muscle cells 1. A decrease in NO availability is one of the hallmarks of 
endothelial dysfunction, which can occur in a number of cardiovascular disorders, 
including hypertension, heart failure, diabetes and atherosclerosis 2. It has been 
shown in animal models that a decrease in eNOS activity results in accelerated 
atherosclerosis 3,4. Conversely, stimulation of eNOS activity by statin treatment has 
been implicated in the protective actions of these drugs 5-7.  
For these reasons, the regulation of eNOS activity is considered to be of major 
physiological and pathophysiological importance. Although eNOS was originally 
termed endothelial constitutive NOS (ecNOS) 8-10, several laboratories have found 
that its protein expression and enzymatic activity is under tight regulation 10-13. In 
addition to regulation at the transcriptional level, protein activity is controlled in 
several ways. Regulatory processes include N-myristoylation and cysteine 
palmitoylation, serine/threonine phosphorylation, and protein-protein interactions. 
These events affect the intracellular localization of eNOS which might influence its 
enzymatic activity.  Normally, eNOS is localized in two subcellular compartments: 
the Golgi complex and the plasma membrane 14. Although it has been suggested that 
translocation between these two compartments is important in the regulation of the 
enzymatic activity, it has been demonstrated that eNOS in both pools can be 
phosphorylated and activated 14. In vitro studies of cells transfected with eNOS 
cDNA fused to DNA encoding green fluorescent protein (GFP) have provided 
valuable information of eNOS localization and regulation. However, to date such 
studies have not been performed in vivo. Consequently, we developed a transgenic 
mouse model in which an eNOS–GFP fusion protein is expressed. The results 
indicate that the eNOS fusion protein is functionally intact. These eNOS–GFPtg mice 
can be used to study vascular reactions in which eNOS is involved, including 
angiogenesis or response to variations in shear stress. 
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2.3 Materials and Methods 
 
Generation of eNOS–GFP transgenic mice 
A genomic DNA fragment was isolated from a home made human cosmid library. It 
included 6 kb of 5’ sequence, the complete eNOS gene, and 3 kb of 3’ sequence. At 
the STOP codon of the eNOS gene, a linker was introduced that allowed the in frame 
insertion of a BamHI-NotI DNA fragment encoding eGFP which was derived from 
the pEGFP-N1 plasmid (BD-Sciences Clontech, Palo Alto CA). Fertilized oocytes 
from FVB mice were microinjected with a solution of 1-2 µg/ml in 8 mM Tris-HCl, 
0.1 mM EDTA and transplanted into the oviducts of pseudopregnant B10xCBA 
mice. Founder mice and offspring were genotyped by PCR on DNA isolated from tail 
biopsies. Primers used were: 5'-GTCCTGCAGACCGTGCAGC-3' (sense) and 5'-
GGCTGTTGGTGTCTGAGCCG-3' (antisense). Mice were backcrossed to C57Bl6 
for at least 5 generations (>96% C57Bl6). Transgenic mice used in the present study 
were hemizygous. All animal experiments were performed in compliance with 
institutional and national guidelines. 
 
Immunohistochemistry, fluorescence microscopy, confocal microscopy 
Immunohistochemistry experiments were performed according to Bakker et al. 15 on 
7 µm paraffin sections. The antibodies used were raised against the carboxy terminus 
of eNOS (Santa Cruz Biotechnology Inc., Santa Cruz, CA, cat.nr. sc-654). For 
confocal microscopy, mice were sacrificed using an overdose of isoflurane (1-chloro-
2,2,2-trifluoroethyl-difluoromethyl-ether). Subsequently, in situ perfusion fixation 
was performed by flushing 20 ml PBS through a cardiac puncture followed by 20 ml 
4% (v/v) paraformaldehyde in PBS. The common carotid arteries were then 
harvested, fixed in 4% paraformaldehyde in PBS at 4 °C, and mounted in 
Vectashield® (Vector Laboratories, Inc, Burlingame, CA) between glass slides. 
Samples were examined under a Zeiss LSM inverted laser scanning confocal 
fluorescence microscope. Images of GFP fluorescence were acquired after excitation 
with a 488-nm argon laser and after filtering the fluorescence with a 500-550 nm 
bandpass barrier filter. The thickness of the optical slice images is 0.6 µm. 
 
Western blotting 
Western blotting experiments were performed as described previously 16. The 
antibodies used were directed against human eNOS or human eNOS phosphorylated 
at Ser-1177, both obtained from Santa Cruz Biotechnology Inc., Santa Cruz, CA 
(cat.nr. sc-654 and sc-12972, respectively). 
 
eNOS enzyme activity and nitric oxide measurements 
eNOS activity was measured in the L-arginine to L-citrulline conversion assay using 
a nitric oxide synthase assay kit (Calbiochem, La Jolla, CA; cat.no. 482700) as 
described previously 16.   For NO measurements, mice were anaesthetised with 0.2 ml 
i.p. sodium pentobarbital (Apharmo BV, Arnhem, The Netherlands) and 
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intracardially perfused with 10 ml Krebs Henseleit buffer solution (118 mM NaCl, 
4.7 mM KCl, 3.0 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, 
0.5 mM EDTA, 10 mM D-glucose and 0.1 mM L-arginine, equilibrated with 95% air 
and 5% CO2 at room temperature resulting in a pH of 7.4). The aorta was dissected 
and in situ cannulated with two metal cannulas, proximal at the level of aortic arch 
and distal at the level of the diaphragm. The cannulas were connected to a homemade 
device keeping the vessel at its original length. Next, the vessel was transported to 
the set-up, where the cannulas were fixed to two holders. The two holders were 
placed in a chamber filled with Krebs buffer. The cannula at the proximal end of the 
vessel was connected to Tygon® tubing coming out of a reservoir with Krebs buffer. 
Between the reservoir and the cannula a flow pump (Watson Marlow, UK) and an 
infusion pump (Perfusor VI, B.Braun, Germany) were positioned. The settings of the 
pump were adjusted to perfuse the aorta with a constant flow of 10 ml/min, measured 
by an EMF flow sensor. This value was based on measurements of the cardiac output 
of our mice with a clinical Doppler device (Prosound 4000, Aloka, Japan) or by a 
transit-time flow probe (see below). Next, the aorta vessel was equilibrated by 
perfusing it for 30 minutes. During that period the experimental set up was switched 
to its calibration state and the NO-sensor was calibrated by infusing known NO 
concentrations through a tube mounted in parallel to the vessel (0.1 to 30 µM). Then, 
L-arginine (0.1 M) in Krebs buffer was added to the perfusate via the infusion pump. 
The NO-sensitive electrode was positioned at the distal end of the aorta, in order to 
measure the NO-production by the vessel. The electrode was connected to an NO 
measurement system (Iso-NO mark II, World Precision Instruments, USA). All data, 
including temperature, pressure drop, flow and NO measurements were stored in a 
PC equipped with a AD converter and analysis software (Acodas, Dataq Instruments, 
Natick, MA). 
 
Hemodynamics and heart weights 
Hemodynamic measurements were performed as described 16. Shortly, blood pressure 
measurements were performed in mice anesthetized with ketamine (100 mg/kg ip) 
and xylazine (20 mg/kg ip), intubated and ventilated with a mixture of O2 and N2 (1/2 
vol/vol). A flame stretched PE 50 polyethylene catheter was inserted into the right 
carotid artery and advanced into the aortic arch for measurement of aortic pressure 
and connected to a pressure transducer (Braun). For infusion of L-NAME, a second 
catheter was introduced into the right external jugular vein and advanced into the 
superior caval vein. After thoracotomy through the second right intercostal space, the 
ascending aorta was exposed and a transit-time flow probe (ID 1.5 mm; Transonics 
systems T206) was placed around the aorta for measuring aorta flow. Ten min after a 
second intraperitoneal bolus of 100 mg/kg ketamine and 20 mg/kg xylazine, baseline 
recordings were obtained. Then, a continuous 10 min intravenous infusion of L-
NAME (100 mg/kg) was started and measurements were continued until 10 min after 
completion of the infusion. For the measurements of pulmonary artery pressure, the 
second left intercostal space was opened and a 30G needle connected to a PE 10 
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polyethylene catheter was directly inserted into the pulmonary artery. Hemodynamic 
data were recorded and digitized using an on-line 4 channel data acquisition program 
(ATCODAS, Dataq Instruments, Akron, OH). Ten consecutive beats were selected 
for determination of heart rate, aortic and pulmonary artery pressures, and aortic 
blood flow. For determination of ventricular weights the heart was removed and the 
ventricles were separated from the atria, the aorta and the pulmonary artery. The right 
ventricle was carefully separated from the left ventricle (incl. septum) and the right 
and left ventricle were weighed on a microbalance (Sartorius AG Göttingen). For the 
measurements of dry weights, tissue fluids were removed by lyophilization. 
 
Cholesterol and Lipoprotein analysis 
Blood was collected by orbital puncture after an overnight fast. Plasma from 6-10 
mice was pooled and subjected to gel filtration analysis on two HR10/30 FPLC 
columns in tandem (Superdex 200 and Superose 6, both prepgrade, Pharmacia 
Biotech., Uppsala, Sweden) 17. Cholesterol concentrations were measured with the 
free cholesterol C kit (WAKO, Neuss, Germany) after hydrolysis of cholesterol esters 
with cholesterol esterase from Candida cylindracea. 
 
Data analysis  
Analysis of data was performed using two-way or one-way analysis of variance 
followed by Scheffé's test, as appropriate. Statistical significance was accepted when 
P<0.05 (two-tailed). Data are presented as mean ± SEM. 
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2.4 Results 
 
eNOS–GFP transgenic mice 
We aimed to create mice transgenic for human eNOS, in which the expression 
resembled that of the endogenous gene as much as possible, both with respect to the 
expression pattern as well as the regulation. Therefore, we used a DNA fragment to 
generate transgenic mice that comprised the complete human eNOS genomic 
sequence, including the natural promoter. This fragment was isolated from a human 
cosmid library. In addition to the eNOS gene, the DNA fragment contained ~6 kb of 
5' sequence, including the endothelial enhancer sequence identified by Laumonnier et 
al. 18, and ~3 kb of 3' sequence. At the STOP codon of the eNOS gene, a DNA 
fragment encoding enhanced GFP was inserted in frame with the eNOS gene, in 
order to obtain a DNA construct encoding an eNOS–GFP fusion protein. This 
fragment (Fig. 1a) was used for the generation of eNOS–GFP transgenic (eNOS–
GFPtg) mice. Fig. 1b shows sections from mouse aorta, taken from eNOS–GFPtg 
mice or wild type littermates (controls). Immunohistochemistry studies on these 
sections using an antibody directed against human eNOS revealed a strong staining 
of the endothelial layer of the aorta in the eNOS–GFPtg mice, while there was no 
staining in the media of the aorta (Fig. 1b, lower left panel). Sections from non-
transgenic controls showed virtually no staining (Fig. 1b, upper left panel). 
Inspection with fluorescence microscopy showed a strong fluorescent signal in the 
endothelial layer of the aorta from eNOS–GFPtg mice (Fig. 1b, lower right panel), 
which is much higher than the autofluorescence from the elastic lamellae that is 
present in both eNOS–GFPtg mice and in wild type controls (Fig. 1b, upper right 
panel). The subcellular localization was studied by confocal microscopy in the 
carotid artery (Fig. 1c). The expression pattern exactly matches the sites where eNOS 
is known to be primarily located: in the Golgi complex and at the plasma membrane. 
We performed Western blotting experiments with aorta and lung tissue from eNOS–
GFPtg mice and non-transgenic controls (Fig. 1d). Using an antibody directed against 
human eNOS, both the endogenous murine eNOS is detected, caused by cross-
reactivity of the antibody, as well as the eNOS–GFP fusion protein, which has a 
slightly higher molecular mass caused by the GFP moiety (approximately 130 kDa 
and 155 kDa, respectively; Fig. 1d, left panels). In addition, we used an antibody that 
recognizes eNOS that is phosphorylated on serine 1177 (P-eNOS), which is the 
activated form of the enzyme. P-eNOS–GFP is present in both aorta and lung tissue 
from eNOS–GFPtg mice (Fig. 1d, right panels). In order to determine whether the 
expressed eNOS–GFP fusion protein is catalytically active, enzymatic activity was 
measured in aorta and lung tissue from eNOS–GFPtg mice and non-transgenic 
controls. As shown in Fig. 1e, the transgenic mice show an increase in eNOS activity 
of approximately 35-fold in aorta and 27-fold in lung tissue. In addition, NO 
production was measured in isolated vessels ex vivo, using an NO sensor. Aortas 
from eNOS–GFP transgenic mice showed an increased NO production compared 
with aortas from control mice (Fig 1f). The data could be described by a first order 
  
kinetic reaction, which was confirmed by a Lineweaver-Burke transformation (data 
not shown).  
 
 
 
 
 
Figure 1. Transgenic mice expressing eNOS–GFP. a. The DNA construct used for 
the generation of eNOS–GFPtg mice consisted of the complete eNOS gene in which 
an eGFP encoding cassette was cloned in frame at the position of the eNOS STOP 
codon. The natural flanking sequences of the eNOS gene were left intact. b. Sections 
of aorta from control mice or eNOS–GFP transgenic mice, inspected with 
immunohistochemistry using an antibody directed against human eNOS (left panels) 
or by fluorescent microscopy (right panels). Original magnifications: 630x. c. Green 
fluorescence in endothelial cells from an intact carotid artery inspected with confocal 
microscopy. Double arrowheads point at fluorescence at the position of the plasma 
membrane, the white arrow at fluorescence at the position of the Golgi complex. The 
non-filled arrow points at the cell nucleus. Scale bar: 10 µm. d. Immunoblotting of 
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aorta (upper panels) or lung (lower panels) homogenates with antibodies directed 
against human eNOS (left panels), which show cross-reactivity with endogenous 
mouse eNOS, or antibodies directed against phosphorylated Ser-1177 from human 
eNOS (right panels). e. eNOS activity measured in aorta or lung homogenates by the 
L-arginine to L-citrulline conversion assay. n=9. *P<0.001. f. NO production in 
isolated aortas measured with an NO-sensitive electrode. n=11 (C), n=8 (Tg). 
*P<0.005. b, d-f: C: control mice, Tg: eNOS–GFP transgenic mice. 
 
Localization of eNOS–GFP 
In order to investigate the cell specificity of the 
expression of the transgene, sections from organs of 
eNOS–GFPtg mice were inspected by 
immunohistochemistry using an antibody directed 
against human eNOS (Fig. 2). eNOS 
immunoreactivity was detected in small blood 
vessels in the heart (Fig. 2a), in the sinusoids in the 
liver (Fig. 2b), in the peritubular capillaries and in 
the endothelial cells in the glomeruli in the kidney 
(Fig. 2c) and in the capillary sinusoids in the adrenal 
(Fig. 2d). eNOS protein was not found in the 
parenchymal cells of these organs. Sections from 
non-transgenic controls showed no 
immunoreactivity (not shown). This expression 
pattern was confirmed by fluorescence microscopy. 
Fig. 3 shows micrographs from heart (Fig. 3a,b), 
liver (Fig. 3c,d), kidney (Fig. 3e,f) and adrenal gland 
(Fig. 3g,h). The lining of the larger vessels was 
clearly fluorescent (Fig. 3c). A dense capillary 
network was fluorescent in the heart, surrounding 
the cardiomyocytes, and in the adrenal. The 
sinusoids in the liver, as well as the peritubular 
capillaries in the kidney showed a positive signal, 
just like the capillaries of the glomeruli in the 
kidney. The parenchymal cells of none of these 
organs showed appreciable expression. In sections 
from non-transgenic controls, no fluorescent signal 
was detected (not shown). 
 
 
Figure 2. Localization of eNOS–GFP in various organs from eNOS–GFPtg mice 
visualized by immunohistochemistry using an antibody directed against human 
eNOS. a. heart, b. liver, c. kidney, d. adrenal. Original magnifications: 400x. Full 
color version of this figure is available in the color section. 
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Figure 3. Localization of eNOS–GFP in various organs from eNOS–GFPtg mice 
visualized by fluorescence microscopy. a.,b.: heart, c.,d. liver, e.,f. kidney, g.,h. 
adrenal. Original magnifications: 100x (a.,c.,e.,g.), 400x (b.,d.,f.,h.). 
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Hemodynamic properties of eNOS–GFPtg mice 
We performed hemodynamic measurements in eNOS–GFPtg mice compared to non-
transgenic control mice. This was done in order to establish the functional activity of 
the eNOS–GFP fusion protein, as eNOS derived NO is an important modulator of 
vascular tone. As shown in figure 4a, the mean aortic pressure (MAP) was decreased 
in eNOS–GFP expressing mice compared to wild type litter mates by approximately 
29%. Treatment with the NO synthase inhibitor NG nitro-L-arginine methyl ester (L-
NAME) resulted in an increase of the MAP and abolished the difference between 
transgenic mice and wild type littermates. The increase in the MAP (∆MAP) caused 
by L-NAME treatment was greater in transgenic mice than in non-transgenic 
controls. There were no differences found in heart rate (Fig. 4b) or mean aortic blood 
flow (Fig. 4c) between transgenic or control mice, with or without treatment with L-
NAME. Consequently, the difference in MAP can be attributed to a difference in 
systemic vascular resistance (Fig. 4d). In addition to a lower pressure in the systemic 
bed, we also observed a lower mean pulmonary artery pressure in eNOS–GFPtg mice 
of 30% (Fig. 4e). We also analyzed the heart weights of the transgenic mice in 
comparison with controls. No differences were found (Fig. 4f). 
 
Plasma cholesterol levels in eNOS–GFPtg mice 
Finally, we measured levels of plasma cholesterol in eNOS–GFPtg mice with 
different genetic backgrounds as models for variations in plasma cholesterol levels. 
We compared wild type background, heterozygous low density lipoprotein receptor 
deficient background, which results in a condition of slight hypercholesterolemia, 
and apolipoprotein E deficient background, which results in a condition of more 
severe hypercholesterolemia. We found a slight decrease in cholesterol levels in all 
backgrounds when comparing eNOS–GFP transgenic animals with animals without 
this transgene (Fig. 5a). Next, we analyzed the lipoprotein profile in two of these 
backgrounds. In wild type background, plasma cholesterol is predominantly found in 
high density lipoproteins (HDL) 19. Thus, the cholesterol lowering observed in 
eNOS–GFP transgenic animals is found in HDL (Fig. 5b). In apolipoprotein E 
deficient background however, plasma cholesterol is present in the atherogenic 
lipoproteins, very low density lipoproteins (VLDL) and low density lipoproteins 
(LDL) 16. In this background, expression of eNOS–GFP results in a decrease in both 
VLDL+LDL and HDL (Fig. 5c). 
 
 
 
 
 
 
 
 
 
  
Figure 4. Hemodynamics and 
ventricular weights were 
measured in control mice (C) 
or eNOS–GFPtg mice (Tg) 
before and after addition of L-
NAME. a. Mean aortic 
pressure; b. heart rate; c. mean 
aortic blood flow; d. systemic 
vascular resistance; e. 
pulmonary artery pressure; f. 
ventricular wet weights; g. 
ventricular dry weights. a-d: 
n=10 (C), n=9 (Tg), e: n=8 
(C), n=6 (Tg), f-g: n=20 (C), 
n=12 (Tg). *: P<0.05 versus 
controls; †: P<0.05 versus 
controls before addition of L-
NAME; ‡: P<0.05 ∆ in C 
versus ∆ in Tg (before and 
after addition of L-NAME). 
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Figure 5. a. Plasma cholesterol 
concentrations of wild type, LDLR 
heterozygous knock out (LDLR+/-
) and apolipoprotein E 
homozygous knock out (ApoE-/-) 
mice with (Tg) or without (C) the 
eNOS–GFP transgene. *: P<0.01 
versus controls; **: P<0.001 
versus controls. b.,c. Fractionation 
of lipoproteins by gel filtration of 
plasma from mice with wild type 
background (b) or apolipoprotein 
E knock out background (c). 
Fraction 1-5 contain VLDL, 6-11 
contain LDL and 12-20 contain 
HDL. 
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2.5 Discussion 
 
We generated transgenic mice that express human eNOS in fusion with GFP. In order 
to preserve transcriptional regulation, we used a genomic construct which contains 
the intronic sequences as well as the natural flanking sequences, including the 
previously identified endothelial enhancer located 4.9 kilobases upstream of the 
transcription initiation site 18. The expression pattern was visualized either indirectly, 
via immunohistochemistry using antibodies directed against eNOS, or directly via 
fluorescence microscopy. Both techniques showed virtually the same distribution of 
the eNOS–GFP transgene in a variety of organs: endothelial cells of smaller and 
larger vessels in various organs are positive, while the parenchymal cells are not. 
These results indicate that the DNA construct used for microinjections resulted in 
expression of the transgene predominantly, if not exclusively, in endothelial cells.  
The functionality of the eNOS–GFP fusion protein was demonstrated in two different 
ways. Using the L-arginine to L-citrulline conversion assay, it was shown that eNOS 
enzyme activity is ~30 fold higher in eNOS–GFP transgenic animals compared with 
non-transgenic controls. In ex vivo measurements with an NO sensor, NO production 
by endothelial cells in isolated blood vessels was shown to be 1.8 fold higher when 
vessels from eNOS–GFP transgenic mice were used. 
The apparent discrepancy between these measurements can be explained by the 
difference between the methods that were used. In the L-arginine to L-citrulline 
conversion assay, a homogenate of aortic tissue was used. Cofactors and reagents are 
added to the assay in order to optimize the conditions for the enzymatic reaction. 
Therefore, the actual measurement represents the maximal eNOS activity, thereby 
reflecting the total amount of enzyme present. In contrast, the ex vivo measurements 
with the NO sensor were performed in intact blood vessels. As a consequence, the 
cellular regulation of the activity of the enzyme is still intact. In this system, the 
actual NO production is measured. This is much lower than the maximal enzymatic 
activity, probably because post-translational control of eNOS activity is intact. 
In addition, blood pressure measurements showed that the mean aortic pressure was 
lower in eNOS–GFP transgenic animals compared with non-transgenic controls. This 
is in agreement with findings in other transgenic models of eNOS overexpression 
16,20. In the latter models, pulmonary pressures have not been measured. However, 
these are expected to be decreased as well, as the pulmonary vasodilator response 
following NO inhalation in patients is well known 21,22. Indeed, we found lower 
pulmonary pressure in eNOS–GFP transgenic animals compared with non-transgenic 
controls.  
GFP expression has been used in various transgenic mouse models and in numerous 
in vitro studies using cultured cells. It is generally assumed that the GFP protein itself 
does not interfere with any biological function of other proteins studied. However, 
specific expression in cardiomyocytes has been reported to result in hypertrophy 23. 
Although the transgene in our mouse model is expressed in endothelial cells and not 
in cardiomyocytes, we measured the ventricular weights of transgenic and control 
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mice. No differences were found, demonstrating that hypertrophy probably does not 
occur in eNOS–GFPtg mice. 
Previously, we generated and studied transgenic mice overexpressing eNOS without 
GFP 16. In addition to a lower blood pressure, these animals displayed a decrease in 
plasma levels of cholesterol. Thus, we measured plasma cholesterol in eNOS–GFP 
transgenic mice and found a decrease of ~20% compared with non-transgenic mice 
(Fig. 5a). Plasma cholesterol in mice is for the larger part in HDL, which is generally 
believed to be atheroprotective 19. Therefore, atherosclerosis in mouse models is 
usually studied in a genetic background with increased cholesterol in atherogenic 
very low density lipoproteins (VLDL) and low density lipoproteins (LDL). We 
crossbred eNOS–GFPtg mice with two of these models. In the first place, we 
crossbred them to low density lipoprotein receptor deficient mice, resulting in a 
background of heterozygous deficiency. This genetic background causes mild 
hypercholesterolemia 24. In addition, we crossbred the mice in a apolipoprotein E 
deficient background, which causes more severe hypercholesterolemia 16. In both of 
these backgrounds, we found that expression of eNOS–GFP results in lower levels of 
plasma cholesterol (Fig. 5a). While in wild type background a reduction in HDL-
cholesterol was found (Fig. 5b), the effect in apolipoprotein E deficient mice was 
primarily in VLDL+LDL cholesterol (Fig. 5c). This is in agreement with our 
previous work, in which it was tentatively concluded that this effect contributed to 
the anti-atherogenic properties of elevated eNOS expression 16.  
The mouse model described in the present study can be used to study the unusually 
complex regulation of eNOS 11,13. Regulation takes place at the transcriptional level 
25-27, and is responsive to variations in shear stress 28,29. In addition, extensive 
regulation of eNOS activity at the post-translational level exists. These pathways are 
probably also active in the eNOS–GFPtg mice, as these are most likely responsible 
for the remarkable discrepancy between the level of protein overexpression and the 
physiological level of NO production (compare Fig. 1d,e with Fig. 1f). The post- 
translational regulatory mechanisms include protein–protein interactions, some of 
which affect the subcellular localization of the protein. eNOS is primarily located in 
the Golgi complex and in the caveolae in the plasma membrane, which were shown 
to be two pools of active enzyme 14, although others have suggested that active eNOS 
is largely restricted to caveolae 30-32. A number of proteins have been shown to 
interact with eNOS and affect its activity. Caveolin, the structural protein of the 
caveolae, forms an inhibitory complex with eNOS 32, for which further evidence was 
provided by studies in caveolin deficient mice 33. Upon activation by calcium, 
calmodulin can activate eNOS by displacing it from caveolin 34,35. Another protein 
that binds to eNOS and subsequently activates it is heat shock protein 90 36. The latter 
protein appears to play a role in the caveolin–calmodulin regulatory complex 37. 
Recently identified proteins that interact with eNOS have been termed NOSIP and 
NOSTRIN 38,39. The functions of these proteins have not been established yet. Still 
another way of post-translational regulation of eNOS activity is protein modification, 
  
 50  
like palmitoylation and myristoylation 40,41, or phosphorylation, especially of the 
serine at position 1177 (human eNOS) 42,43.  
The eNOS–GFPtg mice described in the present study are particularly suited to study 
various aspects of the complex regulation of eNOS activity. Subcellular localization 
under various conditions or dynamic changes in this pattern upon various stimuli can 
be studied, as well as interactions with other proteins or with the cytoskeleton 44. 
Valuable information has been achieved by studying expression of eNOS–GFP 
cDNA in transfected cells 45,46. Our model also allows ex vivo and in vivo studies, 
including real time imaging by intravital microscopy. These type of studies will be 
useful to further assess the impact of eNOS activity in processes like reactivity to 
variations in shear stress or angiogenesis under conditions of ischemia or in tumor 
growth. 
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3.1 Abstract 
 
The focal location of atherosclerosis in the vascular tree is correlated with local 
variations in shear stress. We developed a method to induce defined variations in 
shear stress in a straight vessel segment of a mouse. To this end, a cylinder with a 
tapered lumen is placed around the carotid artery, inducing a high shear stress field. 
Concomitantly, regions of low shear stress and oscillatory shear stress are created 
upstream and downstream of the device, respectively. This device was used in mice 
transgenic for an eNOS-GFP fusion gene. We observed a strong induction of eNOS-
GFP mRNA expression in the high shear stress region compared with the other 
regions (P<0.05). Quantification of eNOS-GFP fluorescence showed an S-like 
relation between eNOS-GFP levels and shear stress that could be described by a hill 
equation, thereby providing direct evidence that eNOS expression is shear stress 
responsive in an in vivo situation. In addition, we demonstrate in vivo shear stress 
responses of ET-1, ACE, SOD, and ACE. This model provides the opportunity to 
study the relation between shear stress alterations, gene expression and 
atherosclerosis. 
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3.2 Introduction 
 
Wall shear stress is the drag force acting on the endothelial cells as a result of the 
blood flow. In straight arteries, laminar flow with an average shear stress level of 1.5 
N/m2 prevail and this level is actively maintained by adjusting the vascular tone and 
by structural remodelling in response to shear stress1,2.  
The relation between low wall shear stress and the occurrence of atherosclerotic 
lesions in the vascular tree has been recognized since several decades 3,4, but the 
mechanism underlying this relation is unknown. Furthermore, it is not clear whether 
low shear stress (<1.5 N/m2) or oscillatory shear stress (exhibiting directional 
change) is more important for the development of atherosclerosis 5,6. It has been 
postulated that altered shear stress results in changes in gene expression and protein 
function 7,8. This was confirmed in experiments studying endothelial cells in flow 
chambers under well-controlled shear stress conditions in vitro 9 10. Such changes can 
underlie the observed susceptibility to atherosclerosis of the affected vascular 
regions. Indeed, endothelial cells located at athero-susceptible sites show a specific 
pattern of gene expression in vivo 11,12, indicating a relationship with shear stress. 
However, this relation has not been substantiated by direct causal in vivo evidence. 
Moreover, there is no in vivo model that generates oscillations in shear stress. 
Therefore, we developed a new method by which low and oscillatory shear stress is 
introduced in different segments of a straight vessel. The first aim of the present 
study is to demonstrate that the proposed method induces a complex shear stress field 
in vivo.  
To evaluate whether these changes in shear stress affect gene expression, we chose to 
monitor one of the best-characterized shear stress responsive genes, endothelial nitric 
oxide synthase (eNOS) 13,14. This was studied in an in-house developed transgenic 
mouse model in which eNOS expression and distribution can be easily monitored by 
virtue of a fusion of the protein with green fluorescent protein15. An additional 
selection of genes that have been reported to be shear stress responsive in vitro 
(endothelin (ET)-116-21, cyclo-oxygenase (COX)-122,23, angiotensin converting 
enzyme (ACE)24 and super oxide dismuthase (SOD)25,26) were also studied in the cast 
model using quantitative PCR techniques. 
 
 
  
 58  
3.3 Materials and Methods 
 
Animals 
Mice expressing an eNOS-GFP fusion protein were generated as described before 15. 
Mice were bred to C57BL/6 background for at least 10 generations (>99% C57BL/6), 
and were 15-20 weeks of age. Animal care and experiments complied with 
institutional and national guidelines.  
 
In vivo alteration of shear stress  
In order to induce standardized changes in shear stress, we designed a shear stress 
modifier, which was manufactured of the thermoplastic, polyetherketon. The device 
is referred to as cast throughout the study. The cast consists of two longitudinal 
halves of a cylinder with a cone shaped lumen (Figure 1a). The geometry of the cast 
has been designed with computational flow dynamics software 27 to produce vortices 
downstream of the cast when placed around the common carotid artery (Figure 1b). 
This downstream region will therefore be exposed to oscillations in shear stress 
(oscillatory shear stress region). The upstream inner diameter is 500 µm (non-
constrictive) and gradually declines to 250 µm at the downstream side of the cast 
(constrictive). This tapering induces a gradual increase in shear stress (high shear 
stress region). In addition, the constrictive stenosis decreases the blood flow, 
resulting in a low shear stress region upstream from the cast. Control casts consist of 
a cylinder with a continuous non-constrictive diameter of 500 µm. Adequacy of the 
cast design was evaluated by Doppler measurements. For surgery, the mice were 
anesthetized with isoflurane. Both halves of the cast were placed around the right 
common carotid artery and fixed with a suture. Animals with cast implants were 
sacrificed at 1-6 days after surgery by in situ fixation.  
 
Instrumentation of rabbits 
Two groups of rabbits were studied. In the first group (n= 5), the immediate effect of 
cast placement was studied while in the second group (n = 5) the chronic effect of a two-
week period of cast placement was evaluated. Two separate groups were studied, as we 
did not want to introduce catheters during instrumentation in the chronic group. In both 
groups, the rabbits were premedicated with a mixture of fentanyl (0.3 mg/ml) and 
fluanisone (0.6 mg/ml) (Hypnorm® 0.5 ml/kg i.m.) and anesthetized with an infusion of 
fentanyl (infusion rate: 0.3 mg/kg/hr) and a 2:1 mixture of N2O and O2. Subsequently, 
the rabbits were intubated and the respirator (Infant Respirator, Hoek Loos, Schiedam, 
The Netherlands) was adjusted to achieve and maintain physiological blood gas levels 
(7.35< pH <7.45; 35 mmHg<PCO2< 45 mmHg; PO2>100 mmHg). The marginal ear 
artery was cannulated for arterial pressure measurement with a fluid filled catheter 
(Amatek Inc, Paoli, PA), for arterial blood withdrawal and for the infusion of fentanyl. 
During instrumentation of group I and after two weeks in group II, the iliac artery was 
dissected and a 4 French (Fr) sheet (Fast Cath®, Daig inc. Minnetonka, MN) was placed 
for the advancement of guide wires and guiding catheters. In 50% of the cases the 
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diameter of the iliac arteries was too small and the aorta was directly punctured. After 
performing angiography (see below), the carotid artery was surgically exposed and 
dissected from its surrounding tissue. After a stabilization period of 30 minutes, 
recordings of baseline hemodynamics were performed. Next, in the acute group, a 
guiding catheter (Fast Cath®, Daig inc. Minnetonka, MN) was advanced into the 
entrance of one of the two carotid arteries, which was randomly selected. Thirty to sixty 
seconds after a bolus of nitroglycerine (0.5 mg; Cedocard®; Dyk inc., The Netherlands), 
injected through the guiding catheter, contrast material (Iodixanol, Nicomed b.v., Breda, 
The Netherlands) was injected and angiography was performed with an X-ray system 
(Cardioskop-U, Siemens Nederland b.v., The Haque, The Netherlands). Following this, 
the other carotid artery was imaged in the same way. Subsequently, in both groups, one 
of the carotid arteries was dissected and a 20 mHz range-gated Doppler sensor (model 
VF-1, Crystal Biotech, Hopkinton, Mass) was placed at an angle of 45 degrees. The 
range gating properties allowed us to determine minimal and maximal velocities over 
the cross section of the vessel lumen. The other carotid artery was used as a control 
vessel. 
As a next step, the cast was placed around the carotid artery and recordings of 
systemic hemodynamics and Doppler velocities downstream of the cast were 
repeated, followed by angiography as described above. The Doppler measurements 
distally from the constrictor were intended for the detection of velocity reversal. To 
that end, we carefully positioned the Doppler sensor to place the sample volume near 
the expected location of the vortex. 
In the acute group, the animal was terminated at the end of the measurement 
protocol. In the chronic group, after the placement of the constrictor around the 
carotid artery, the incision in the neck was closed with a two-layer suture. At the end 
of each procedure, acetylsalicylic acid (10 mg/kg i.m., Aspegic®, Lorex Synthelabo, 
Maarsen, The Neherlands) and Amoxicillin (25 mg/kg i.m., Clamoxyl®, SmithKline 
Beecham, Rijswijk, The Netherlands) were given to prevent trombocyte aggregation 
and wound infection, respectively. During the two-week follow-up period, 
clopidogrel (25 mg, p.o., Plavix®, Sanofi Winthrop, The Netherlands) and 
acetylsalicylic acid (Aspegic, 10 mg/kg, p.o.) were given daily. After two weeks all 
hemodynamic and angiographic measurements as described for the acute group were 
performed. 
 
Doppler measurements in mice. 
Mice were anesthetized with isoflurane, intubated, and ventilated with a 1:2 mixture of 
O2/N2O to which 2.3% of isoflurane was added.  The animals were maintained at 37°C 
on a heating-pad during the whole experiment, a neck incision was made and both the 
left and right common carotid arteries were dissected from connective tissue. Calibrated 
digital images were taken in order to measure vessel diameters. Doppler velocity signals 
were measured on both carotid arteries using a 20 MHz range-gated Doppler probe at a 
45° angle from the vessel wall. The cast was then placed around the carotid artery 
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upstream of the Doppler probe, and the measurement was repeated. Additionally, the 
Doppler signal in the left carotid artery after cast placement was recorded.  
 
Confocal microscopy 
Tissue samples were examined under a Zeiss LSM510LNO inverted laser scanning 
confocal fluorescence microscope (Carl Zeiss, Thornwood, USA). Images of GFP 
fluorescence were acquired by excitation with a 488 nm argon laser and were 
detected using a 500-550 bandpass barrier filter. Background fluorescence was 
corrected for by subtracting the image that was acquired after filtering the emission 
spectrum with a 560 nm longpass filter. To obtain an image of an intact whole 
mounted vessel, an optical slice of 40 µm thickness and 500 µm x 500 µm in cross 
sectional area was obtained using the 10x Axiovert lens. Next, the position of the 
table was changed in order to image several adjacent vessel sections encompassing 
the entire vessel segment under study. Individual images were fused to form a tile 
(Figure 1d) in order to provide a complete picture of the vessel.  
 
Quantitative PCR 
Carotid arteries treated with casts were divided into three different regions: 1 mm of 
the low shear stress region upstream of the cast, 1 mm of the high shear stress region 
in the cast, and 1 mm of the oscillatory shear stress region downstream of the cast. 
Similar 1 mm sections of the untreated contra-lateral carotid arteries from the same 
animals were isolated to serve as controls. Total RNA from each region was obtained 
using the RNAeasy kit (Qiagen, Cologne, Germany), treated with DNA-ase and 
cDNA was obtained by reverse transcription reaction. Primers were designed for the 
studied genes: mouse SOD, ACE, COX-1 and ET-1, and for human eNOS. Tissue 
samples of each region from 5 individual mice were pooled and mRNA expression 
levels were analysed by real time PCR using the iCycler iQ Detection System 
(Biorad, Veenendaal, The Netherlands) in three separate experiments. The 
hypoxanthine guanine phosphoribosyl transferase (HPRT) gene was used as a house 
keeping gene.  
  
Computational fluid dynamics  
In order to estimate the augmentation in wall shear stress distribution after cast 
placement, a 3-D computational fluid dynamical technique (CFD) was used 39. The 
CFD needed the vessel geometry as input, which was obtained from the contours of 
the GFP images, assuming a circular geometry and constant circumference of the 
intact vessel (Figure 1c). On the basis of this geometry a mesh was generated, which 
consisted of approximately 20.000 nodes. The boundary conditions for the 
calculations were: no slip conditions at the wall, stationary parabolic inflow at the 
entrance with a maximal velocity equivalent to a shear stress of 1.5 N/m2 and zero 
stress outflow. The combination of the mesh geometry and boundary conditions were 
used to solve the Navier-Stokes equations, applying a well-validated finite element 
software package (Sepran, Sepra, Delft, The Netherlands) in order to calculate shear 
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stress (Figure 1d,e). The accuracy of the calculations was set at 10-4 m/sec, which 
resulted in a numerical error of wall shear stress of approximately 1%.   
  
Analysis and statistics 
In order to relate the GFP signal to the shear stress calculations the in-house 
developed software automatically selected the same region as used for the CFD 
analyses. The centre-line of the vessel was generated using an iterative optimisation 
method. Lines of integration perpendicular to this centre-line served to average the 
GFP signal at similar positions as the shear stress calculations (Figure 1f). The 
relationship between shear stress and eNOS-GFP was described for each individual 
vessel by a sigmoid curve, applying an iterative algorithm. After setting initial 
parameters an optimal data set was selected on basis of a line search algorithm and a 
steepest decline algorithm.  
Diameters of the blood vessels were determined for the entire arterial segment under 
study before, immediately after, and 6 days after cast placement, using a high-
resolution digital camera coupled to the dissection microscope. Diameter analysis 
was performed of 2 mm segments immediately upstream and downstream of the cast. 
Vessel wall thickness was measured in cross-sections of the in situ fixated vessels.  
Statistical analyses were performed using one-way ANOVA followed by Dunnett’s 
ad-hoc test (SigmaStat, version 2.03, Systat Software Inc., Richmond, California, 
USA). The Student’s t-test was used in the Doppler evaluations. Data are presented 
as mean ± SEM. P values <0.05 were considered statistically significant.  
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igure 1: Design of the shear stress modifier: cast model. (a) The cast consists of 
along the vessel wall.   
 
F
two longitudinal halves of a cylinder with a conical lumen. (b) The theoretical design 
with induction of large vortices downstream of the cast in the carotid artery. 
Additionally, the conical lumen induces a stenosis of the vessel, causing a gradual 
increase in vascular shear stress in the cast area. Because of the stenosis, a region of 
low shear stress is created upstream of the cast. (c) Contours were obtained of GFP 
images, assuming a circular geometry of the vessel. (d) The computer generated 3 D 
mesh of the vessel lumen in which the shear stress was calculated. (e) The 
distribution of shear stress (N/m2) along the vessel. (f) Quantification of the GFP 
signal using the same images: The distribution of eNOS-GFP (in arbitrary units) 
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in rabbits induces flow reversal in the distal region. 
 a group of 10 New Zealand White rabbits, mean arterial blood pressure and heart 
ement. Average, 
able 1: Systemic hemodynamics before and after cast placement in rabbits 
N=1 ore cast t. 
Cast placement reduces the blood flow in the proximal region. 
 a group of eNOS-GFP transgenic mice, the average blood flow was initially 2.9  ± 
mon carotid arteries, 
3.4 Results 
 
Cast placement 
In
rate were not affected, immediately and two weeks after cast plac
maximal and minimal Doppler velocities were consistent with a laminar velocity 
profile before cast placement. However, after cast placement all animals exhibited 
reversal of velocity near the endothelium distal from the cast with an unchanged 
maximal velocity in the centre of the blood vessel (see Table 1). These reversals in 
velocity indicate the occurrence of vortices in the area downstream from the cast. 
 
 
T
 
0, * P<0.05 versus bef placemen
  
 
Before cast placement After cast placement 
2 weeks 
follow up 
Heart rate (beats/min) 200±13 200±12.5 196±9.8 
 
   
Minimal m/sec) -  -1  
Maximal velocity (cm/sec) 45.5±10.7 37.1±8.3 39.0 14 
        
Mean arterial pressure 
(mmHg) 
 
77±1.8 73±3.6 67±2.2 
 velocity (c 9.8±2.5 9.9±1.9*
 
0.4±2.8*
±
 
In
0.3 ml/min and 2.8 ± 0.2 ml/min in the right and left com
respectively (See supplemented data figure S1a). Directly after cast placement, the 
blood flow was significantly reduced to an average of 2.0 ± 0.2 ml/min (P<0.001) in 
the low shear stress region upstream to the cast in the right carotid artery. This 
reduction was observed in each animal. The reduction in blood flow was solely due 
to the increase in resistance from the stenosis caused by the cast, as vascular 
diameters upstream of the cast region before (538±39 µm) and immediately after 
(535±48 µm) cast placement remained unchanged. The vascular diameter 
downstream of the cast region also remained unchanged after cast placement (546±48 
µm vs. 593±91 µm, respectively). In the left carotid artery, the blood flow was not 
affected by cast placement around the right vessel (2.75±0.21 ml/min vs. 2.88±0.18 
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ear stress responsive in vivo. 
 mice instrumented with the cast, a gradual increase in fluorescence is clearly 
 in the cast (Figure 2a, 
th the low and oscillatory shear stress regions 
e further validated the cast model on its capacity to elicit a biological response, 
ml/min, respectively). Placement of a non-tapering control cast around the right 
carotid artery did not affect the blood flow in both carotid arteries (See supplemented 
data figure S1a). Vascular remodeling of the carotid artery was minimal both in the 
upstream and downstream segments during the time period used in this study (6 days; 
see supplement data figure S4).  
 
Expression of eNOS protein is sh
In
visible along the length of the vessel segment that was located
arrow). Both the fluorescent signal and the shear stress were quantified along the 
length of the carotid artery segment, and were found to increase along the decreasing 
diameter of the cast (Figure 2b). Similar responses were observed in all of the treated 
animals. In a time series of 1, 2, 4, and 6 days of cast implantation, the response is 
already present after one day and remains unchanged for at least 6 days (Results 
shown in data supplement figure S2). To exclude other factors introduced by tapering 
(like damage to the vessel wall and endothelium), control experiments were 
performed in which the blood vessel was ligated downstream of the cast, resulting in 
complete obstruction of the flow and consequently in the abolishment of shear stress. 
In this situation the cast model does not induce variations in eNOS-GFP expression 
(Figure 2c), indicating that there are no direct effects of the surgical procedure or the 
presence of the cast. In addition, placement of the non-constrictive control-cast does 
not result in changes in eNOS-GFP expression (Figure 2d), indicating that the 
geometry of the constrictive cast, inducing variations in shear stress patterns, is 
responsible for the observed effects.  
Next we assessed whether shear stress affects mRNA expression of the human eNOS 
transgene in the different regions. Bo
show a 3-fold decrease in eNOS mRNA expression compared to the control vessel 
(undisturbed shear stress) (Figure 2e), while the average eNOS expression in the high 
shear stress region is similar to control. The expression of endogenous murine eNOS 
was similarly affected by shear stress variations (see supplement data figure S3). 
 
Expression of known shear stress responsive genes in vivo. 
W
comparing the effect of low shear stress to oscillatory shear stress. In C57BL/6 
wildtype mice we measured mRNA levels of an additional subset of shear stress 
responsive genes. We found that SOD, ACE, COX-1 and ET-1 expression levels are 
decreased with respect to the control vessel. Distally from the cast, where vortices are 
active, all genes are further downregulated compared to the low shear stress regions 
with the exception of SOD (Figure 3), which remains unchanged. 
  
 
 
 
 
Figure 2: Effect of cast placement around carotid arteries on eNOS-GFP 
fluorescence. (a) Fluorescence of eNOS-GFP was imaged in the right carotid artery 
after the instalment of a tapering cast. The arrow indicates the position where the cast 
was situated (high shear stress region). The direction of the blood flow was from left 
to right. (b) Relation between shear stress and eNOS-GFP fluorescence: 
Representative example of the relation between the calculated shear stress and eNOS-
GFP fluorescence along a linear segment of the carotid artery of an individual mouse. 
(c) Effect on eNOS-GFP fluorescence following downstream ligation of the carotid 
artery with a tapering cast, or (d) placement of a non-tapering cast. Arrows indicate 
the cast region, and dashed lines mark the site of ligation. (e) eNOS mRNA levels of 
the human transgene in the segments of the right carotid artery after the instalment of 
a tapering cast: 1 mm immediately upstream of the cast (low shear stress), 1 mm in 
the cast (high shear stress) and 1 mm immediately downstream of the cast (oscillating 
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shear stress), and in 1mm of the contra-lateral control carotid artery (undisturbed 
shear stress). n =3 groups (5 animals per group), * P<0.05 versus low shear stress, †  
P<0.05 versus undisturbed shear stress. Note that Figure 2a is derived from the same 
picture as Figure 1c. 
 
 
Figure 3: Expression levels 
for endothelin-1 (ET-1), 
angiotensin converting enzyme 
(ACE), cyclo-oxygenase 
(COX-1) and superoxide 
dismuthase (SOD) in low shear 
stress conditions (Panel A) and 
oscillatory shear stress (Panel 
B). All values were normalized 
to the contra-lateral control 
vessel. This implies that values 
smaller than one are values 
smaller than the value of the 
control vessel. # P<0.05  
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 3.5 Discussion 
 
In the present study, we present a novel technique to induce complex shear stress 
fields in vivo. From the results we conclude that: (a) the technique induces changes in 
shear stress; (b) augmentation of shear stress results in elevated eNOS gene 
expression and eNOS protein levels as previously suggested by in vitro experiments. 
Augmentation of shear stress up-regulates eNOS within 1 day, lasting until at least 6 
days. These results are in agreement with previous findings 13,14,28. Control 
experiments with a non-tapered cast or the abolishment of shear stress in the tapered 
cast by blood flow arrest indicate that variations in local shear stress induce the 
observed responses in eNOS expression. Induction of oscillatory shear stress in the 
downstream area from the cast is demonstrated by Doppler sonography as well as by 
the loss of the alignment of endothelial cells with the flow direction. In addition, 
responses in SOD, ACE, COX-1 and ET-1 expression levels were observed in 
C57BL/6 wildtype animals under stimulation of the different shear stress parameters. 
These results demonstrate that the new cast model is effective in triggering responses 
in gene expression caused by variations in shear stress.  
 
Limitations of the study 
mRNA studies. Although the fluorescent signal is clearly increased in the high shear 
stress region compared with the undisturbed shear stress region (Figure 3a, 4a, and 
6a, middle panel), the eNOS mRNA levels were similar (Figure 2e). This could be 
due to differences in sampling. Confocal microscopy demonstrated significant 
variation in eNOS-GFP signal within the high shear stress region (Figure 2a).  
However, for RNA measurements complete segments were collected and therefore 
the data represent the average eNOS expression, masking variations caused by 
hemodynamic differences within the segments. Part of the discrepancy might also be 
due to a posttranscriptional mechanism altering the half-life of eNOS mRNA 13. 
When monitoring the expression of endogenous murine eNOS, we found responses 
in the four shear stress regions that were similar to those of eNOS-GFP, supporting 
our findings.   
Transgenic model. Over-expression of eNOS-GFP may result in a negative feedback 
by the increased NO production inhibiting transcription of the gene 29. Thus, the 
effect of shear stress on eNOS expression might have been underestimated in the 
present study. However, the expression of murine eNOS in wild type controls shows 
a similar response to the shear stress alterations induced by the cast. The observed 
effect of shear stress on eNOS-GFP is therefore not restricted to the human eNOS 
transgenic construct.  
The change in vessel geometry by cast placement may compress fibro-elastin layers 
of the vessel wall and thereby increase background auto-fluorescence. This does not 
affect our data however, because the auto-fluorescent signal was subtracted from the 
total GFP signal. The tapering effect of the cast could also compress the endothelial 
cells to make them fit into a smaller area, increasing the number of cells per area. Co-
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localization studies of the endothelium in the different shear stress regions do not 
show an increase in cell number per area or a decrease in cell size. In addition, the 
up-regulation of eNOS-GFP in single endothelial cells is observed, providing further 
evidence that the eNOS-GFP signal in the high shear vessel segment is not an artefact 
created by the tapered shape of the cast. 
 
In conclusion, the present study demonstrates that complex shear stress fields can be 
induced in straight vessels in vivo. Furthermore, information about the in vivo 
regulation of eNOS by shear stress can be obtained by using the cast model. This 
hemodynamic model provides therefore the opportunity to examine directly the effect 
of low, high, and oscillatory shear stress on the initiation and development of 
atherosclerotic disease.  
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3.6 Supplemented data 
 
 
Figure S1: Effect of cast placement around 
carotid arteries on blood flow. (a) Blood flow 
in the right common carotid artery and (b) 
left common carotid artery as measured by 
Doppler sonography before (black bars) and 
after (grey bars) cast placement in a group of 
eNOS-GFP transgenic mice. n =8, P<0.001 
(c) In a different group, blood flow in the 
right carotid artery (d) and left carotid artery 
was measured by Doppler sonography before 
(black bars) and after (grey bars) placement 
of a non-tapering, control cast around the 
right carotid artery. n =4,  P>0.05.  
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Figure S2: The time response of eNOS versus shear stress. Indicated are two 
parameters (of the three parameters) describing the behavior of a mathematical model 
(sigmoidal plot) that was fitted through the original data. It is clearly shown that; The 
GFP signal reaches a maximum at day 2 and slowly decreases at later time points (1 
day = 30 ± 2 AU, 2 days = 33 ± 3 AU, 4 days = 4 ± 5 AU, 6 days = 20 ± 5 AU) (a). 
The SS50 level (level of shear stress at which the maximum GFP signal is saturated 
for 50%) is maximal at day 1 and decreases by 50% on day 2, after which it remains 
constant (1 day = 8,5 ± 2 AU, 2 days = 4,8 ± 1 AU, 4 days = 5 ± 1 AU, 6 days = 5,5 
± 1 AU) (b). From these data we conclude that the eNOS shear stress response is fast, 
for most of the effect is apparent after 1 day, and a steady state is reached after two 
days. n =5 per time point, * P<0.05 versus day 2,  †  P<0.05 versus day 1. 
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Figure S3: Shear stress induces responses in endogenous murine eNOS mRNA 
expression of transgenic (eNOS-GFP) (a) and wildtype (c57bl6) (b) animals. These 
responses are similar to those observed in eNOS-GFP mRNA. n =5, * P<0.05 versus 
low shear stress, †  P<0.05 versus undisturbed shear stress, # P<0.05 versus high 
shear stress.  
 
 
 
Figure S4:  Vascular diameter changes before (I), immediately after (II) and after 6 
days of cast placement (III) in low shear stress (black bar) or oscillatory shear stress 
(white bar) region (a).  As outer diameters were measured, wall thickness was 
measured at the day of sacrifice in control (gray bar), low shear stress (black bar) and 
oscillatory shear stress (white bar) segments (b). Note that no difference in diameters 
or wall thickness before, immediately after, and after 6 days follow up was measured. 
N=8. 
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4.1 Abstract 
 
The specific location of atherosclerosis in the vascular tree is correlated with local 
variations in shear stress. We developed a method to induce defined variations in 
shear stress in a straight vessel segment of a mouse. To this end, a cylinder with a 
tapered lumen is placed around the carotid artery, inducing a high shear stress field. 
Concomitantly, regions of low shear stress and oscillatory shear stress are created 
upstream and downstream of the device, respectively. This device was used in mice 
transgenic for an eNOS-GFP fusion gene. We observed a strong induction of eNOS-
GFP levels in the high shear stress region compared with the other regions (P<0.05). 
Quantification of eNOS-GFP fluorescence or of immuno-reactivity to the Golgi 
complex or to PECAM-1 showed an increase in the high shear stress region (P<0.05) 
compared with non-treated carotid arteries. Co-localization of eNOS-GFP with either 
the Golgi complex or PECAM-1 also responded to alterations of shear stress. 
We showed that intracellular distribution and phosphorylation of eNOS is responsive 
to high and oscillatory shear in vivo; and these shear stress conditions result in eNOS 
redistribution with a relatively lower association to the Golgi complex.  
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4.2 Introduction 
 
Regulation of eNOS protein levels and activity is unusually complex and occurs both 
at transcriptional and post-transcriptional levels 1,2. Post-translational modification of 
eNOS by myristoylation and palmitoylation that targets the protein to the Golgi 
complex and to the lipid rich domains of the cell membrane are both necessary for 
proper eNOS activation. Shear stress activates eNOS predominantly through Akt 
dependent phosphorylation of eNOS at serine1177 3,4. Recently, it was shown that the 
fraction of eNOS localized in the Golgi complex is responsive to phosphorylation by 
Akt 5. This implies that shear stress activates eNOS when it is located in certain 
compartments of the endothelial cells. At present, it is unknown how shear stress 
affects the intracellular distribution of eNOS in vivo 6. Using the previously validated 
cast model and combining this with an in-house developed quantitative method to 
analyse intracellular components, we conducted a study on the effect of shear stress 
on eNOS cellular localization. We analysed the distribution of eNOS over the Golgi 
and cell membrane compartments in relation to the serine1177 phosphorylation of 
eNOS, in vessel regions exposed to different shear stress parameters.   
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4.3 Materials and Methods 
 
Animals 
Mice expressing an eNOS-GFP fusion protein were generated as described before 7. 
Mice were bred to C57BL/6 background for at least 10 generations (>99% C57BL/6), 
and were 15-20 weeks of age. Animal care and experiments complied with 
institutional and national guidelines.  
 
In vivo alteration of shear stress  
In order to induce standardized changes in shear stress, we designed a shear stress 
modifier, which was manufactured of the thermoplastic, polyetherketon. The device 
is referred to as cast throughout the study. The cast consists of two longitudinal 
halves of a cylinder with a cone shaped lumen. The geometry of the cast has been 
designed with computational flow dynamics software 8 to produce vortices 
downstream of the cast when placed around the common carotid artery. This 
downstream region will therefore be exposed to oscillations in shear stress 
(oscillatory shear stress region). The upstream inner diameter is 500 µm (non-
constrictive) and gradually declines to 250 µm at the downstream side of the cast 
(constrictive). This tapering induces a gradual increase in shear stress (high shear 
stress region). In addition, the constrictive stenosis decreases the blood flow, 
resulting in a low shear stress region upstream from the cast. Control casts consist of 
a cylinder with a continuous non-constrictive diameter of 500 µm. For surgery, the 
mice were anesthetized with isoflurane. Both halves of the cast were placed around 
the right common carotid artery and fixed with a suture. Animals with cast implants 
were sacrificed at 1-6 days after surgery by in situ fixation.  
 
Confocal microscopy 
Tissue samples were examined under a Zeiss LSM510LNO inverted laser scanning 
confocal fluorescence microscope (Carl Zeiss, Thornwood, USA). To study eNOS-
GFP expression on a cellular level, stacks of optical slices (0.5 µm by 20 µm by 20 
µm) were obtained using the 40x water immersion Axiovert lens. To investigate the 
location of serine1177-phosphorylated eNOS, PECAM-1 and the Golgi complex, 
images of Rhodamine fluorescence were taken applying a 543-nm excitation from a 
NeHe-laser, using a 560 nm longpass filter for detection. Images of GFP fluorescence 
were acquired by excitation with a 488 nm argon laser and were detected using a 
500-550 bandpass barrier filter.  
 
Fluorescence immunohistochemistry 
Following in situ perfusion and overnight fixation, common carotid arteries were 
washed in PBS and treated with 0.2% Triton X-100 (Sigma Chemical Co., 
Zwijndrecht, The Netherlands) in PBS. The arteries were subsequently incubated 
with 2.5% horse serum in PBS/0.2% BSA for 30 minutes, washed again in PBS/0.2% 
BSA, and incubated with rabbit polyclonal antibodies against phospho-eNOS 
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(serine1177) (New England Biolabs, Leusden, The Netherlands), PECAM-1 (Sigma 
Chemical Co., Zwijndrecht, The Netherlands), or mouse monoclonal antibodies 
against P115 (BD Biosciences Pharmingen, San Diego, USA) in PBS/0.2% BSA 
overnight at 4 C°. After washing in PBS/0.05% Tween-20 (Sigma Chemical Co., 
Zwijndrecht, The Netherlands), the arteries were incubated with mouse anti-rabbit 
IgG conjugated to R594 (Molecular Probes, Leiden, The Netherlands) or goat anti-
mouse IgG conjugated to Texas Red (Molecular Probes, Leiden, The Netherlands) in 
PBS/0.2% BSA for two hours at room temperature, followed by wash steps and were 
mounted in Vectashield.  
  
Analysis and statistics 
Localization was quantified as percentage of the total image area. Co-localization of 
eNOS with the Golgi complex or with the plasma membrane compartment was 
quantified as percentage co-localization area of the total eNOS area. In addition, 
phospho-eNOS was expressed in percentages of total eNOS. All software was 
developed in Matlab (The Mathworks, Delft, The Netherlands). 
All regression analyses were performed by a commercial package (SigmaStat, 
version 2.03, Systat Software Inc., Richmond, California, USA). Statistical analyses 
were performed using one-way ANOVA followed by Dunnett’s ad-hoc test. The 
Student’s t-test was used in the Doppler evaluations. Data are presented as mean ± 
SEM. P values <0.05 were considered statistically significant.  
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4.4 Results 
 
Shear stress alters the intracellular distribution of eNOS  
We compared the intracellular distribution of eNOS-GFP in the regions with different 
shear stress patterns. Endothelial cells in low, high and undisturbed shear stress 
regions are elongated in shape and are aligned with the direction of the flow. In 
contrast, endothelial cells in the oscillatory shear stress region appear disorganized 
(Figures 1a, 2a, 4a, middle panels). At the intracellular level, eNOS-GFP is mainly 
located at a perinuclear site where the Golgi complex is situated, and it is present at 
the plasma membrane (Figure 3a, undisturbed shear stress). We investigated whether 
shear stress has an effect on the localization of eNOS-GFP protein in the Golgi 
complex by en face immunostaining (Figure 1a). Quantification of the fluorescent 
signal showed a 3-fold increase in Golgi complex area in the vessel segment with 
high shear stress compared to undisturbed shear stress or low shear stress (Figure 1b). 
The eNOS-GFP area was increased by 8-fold and 7-fold in high shear stress and 
oscillatory shear stress respectively, compared to either low or undisturbed shear 
stress (Figure 1c). High shear stress and oscillatory shear stress decrease the 
localization of eNOS in the Golgi complex by approximately 2-fold compared to 
undisturbed shear stress (Figure 1d).  The difference in co-localization in the low 
shear stress area did not reach statistical significance.  
We also studied the effect of shear stress on the localization of eNOS at the cell 
membrane by en face immuno-histochemistry using a PECAM-1 antibody (Figure 
2a,). A 2-fold increase in PECAM-1 was observed in the high shear stress region 
(Figure 2b). The response of eNOS-GFP to the different shear stress fields was as 
observed before (cf. Figure 1c, 2c). More eNOS co-localized with PECAM-1 in the 
low and high shear stress region compared to the oscillatory shear stress region (2.5-
fold difference; Figure 2d). A statistically significant correlation was found between 
the eNOS area and the Golgi complex area (Figure 3). 
 
  
 
Figure 1: Intracellular localization of eNOS-GFP and Golgi complex in areas of the 
carotid artery experiencing different shear stress patterns after 2 days of cast 
placement. (a) In the upper panel: Golgi complex in corresponding vascular regions 
visualized by en face immunofluorescence staining. Indicated are: the low shear 
stress region  (low), the high shear stress region (high), the oscillatory shear stress 
region (oscillatory), and the control region (undisturbed).  Fluorescence was 
monitored by en face confocal microscopy in stacks of 500 µm x 500 x 40 µm each. 
In the middle panel: Fluorescence of eNOS-GFP in endothelial cells located in the 
three different shear stress regions and in the contra-lateral carotid artery. In the 
lower panel the upper and middle panels are merged, showing the co-localization 
signal in yellow. (b-d) Quantification of the localization of (b) the Golgi complex, (c) 
the eNOS-GFP and d) the co-localization signals in response to the different shear 
stress fields in percentages of the total area (b,c) or of the total eNOS-GFP signal (d). 
n = 4, * P<0.05 versus low shear stress. †  P<0.05 versus undisturbed shear stress. 
Full colour image of this figure is available in the colour section.  
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Figure 2: Intracellular localization of eNOS-GFP and PECAM-1 in regions of the 
carotid artery experiencing different shear stress patterns after two days cast 
placement. (a) In the upper panel: PECAM-1 in corresponding vascular regions 
visualized by en face immunofluorescence staining. Indicated are: the low shear 
stress region  (low), the high shear stress region (high), the oscillatory shear stress 
region (oscillatory), and the control region (undisturbed).  Fluorescence was 
monitored by en face confocal microscopy in stacks of 500 µm x 500 x 40 µm each. 
In the middle panel: Fluorescence of eNOS-GFP in endothelial cells located in the 
three different shear stress regions and in the contra-lateral carotid artery. In the 
lower panel the upper and middle panels are merged, showing the co-localization 
signal in yellow. (b-d) Quantification of the localization of (b) the PECAM-1, (c) the 
eNOS-GFP and d) the co-localization signals in response to the different shear stress 
fields in percentages of the total area (b,c) or of the total eNOS-GFP signal (d). n = 
5, †  P<0.05 versus undisturbed shear stress. # P<0.05 versus oscillatory shear stress. 
Full colour image of this figure is available in the colour section.  
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 Figure 3: The correlation 
between the Golgi complex area 
versus eNOS-GFP area (both as 
a percentage of the total area). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shear stress effects on eNOS phosphorylation 
To investigate whether shear stress has an effect on the phosphorylation of eNOS, en 
face immunostaining on carotid arteries was performed with antibodies against 
phospho-eNOS (serine1177) (Figure 4a). An increase in phospho-eNOS was 
observed in the high shear stress region compared to regions of low or undisturbed 
shear stress (6-fold), and oscillatory shear stress (2-fold) (Figure 4b). Phospho-eNOS 
was also increased in the oscillatory shear stress area compared to regions of low or 
undisturbed shear stress (5-fold) (Figure 4b). The eNOS-GFP response is similar to 
the results obtained before (cf. Figure 1c, 2c, and 4c). The fraction of eNOS that was 
phosphorylated –approximately 50%– did not change by alterations in shear stress 
(Figure 4d). 
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Figure 4: Intracellular localization of eNOS-GFP and phospho-eNOS in areas of the 
carotid artery experiencing different shear stress patterns after two days of cast 
placement. (a) In the upper panel: Phospho-eNOS in corresponding vascular regions 
visualized by en face immunofluorescence staining. Indicated are; the low shear 
stress region  (low), the high shear stress region (high), the oscillatory shear stress 
region (oscillatory), and the control region (undisturbed). Fluorescence was 
monitored by en face confocal microscopy in stacks of 500 µm x 500 µm each. In 
the middle panel: Fluorescence of eNOS-GFP in endothelial cells located in the three 
different shear stress regions and in the contra-lateral carotid artery. In the lower 
panel the upper and middle panels are merged, showing the co-localization signal in 
yellow. (b-d) Quantification of the localization of (b) thePhospho-eNOS, (c) the 
eNOS-GFP and d) the co-localization signals in response to the different shear stress 
fields in percentages of the total area (b,c) or of the total eNOS-GFP signal (d). n = 
5, * P<0.05 versus low shear stress. †  P<0.05 versus undisturbed shear stress. Full 
colour image of this figure is available in the colour section.  
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4.5 Discussion 
 
In the present study, we examined the effect of complex shear stress fields on eNOS 
cellular distribution and activation in vivo. From the results we conclude that: (a) 
intracellular distribution and phosphorylation of eNOS is responsive to high and 
oscillatory shear in vivo; and (b) these shear stress conditions result in eNOS 
redistribution with a relatively lower association to the Golgi complex. However, the 
fraction of eNOS that is activated by serine1177 phosphorylation is not responsive to 
in vivo changes in shear stress.  
 
The effects of shear stress on intracellular eNOS distribution  
The correct intracellular localization of eNOS is of crucial importance for its activity 
9. By using eNOS mutants which were kinetically identical to unmodified eNOS, it 
was demonstrated that mis-localization of the enzyme impairs the production of NO 
in response to agonists 10. Activation of eNOS by shear stress involves the Akt 
dependent phosphorylation of eNOS at serine1177 3,11. It was recently shown that 
mainly the fraction of eNOS localized in the Golgi complex is responsive to 
phosphorylation by Akt 5. Thus, the cellular distribution of eNOS in complex shear 
stress fields is essential for its function. To the best of our knowledge, the effect of 
shear stress on the intracellular re-distribution of eNOS in endothelial cells has only 
been evaluated once in blood vessels in vivo 12. 
Our study shows that the Golgi complex becomes more extended in response to the 
augmentation of shear stress. This finding is in agreement with a previous study 
showing a difference in Golgi complex areas between venous endothelium (low shear 
stress) and arterial endothelium (high shear stress) in rats 13. A significant part of 
eNOS bound to the plasma membrane is present at the cell-cell contact sites and co-
localizes with PECAM-1 13,14. We found that PECAM-1 itself is up-regulated under 
high shear stress. The relative distribution of eNOS to the PECAM-1 positive cell 
membrane region was not influenced by shear stress, indicating that intracellular 
eNOS and PECAM-1 increased to similar amounts in response to shear stress. In 
summary, our data show that both the cell membrane and the Golgi complex 
compartments of the eNOS pool are increased after augmenting shear stress. 
 
In vitro studies demonstrated that phosphorylation of serine1177 is shear stress 
responsive 15. Indeed, we found increased serine1177 phosphorylation of eNOS under 
high and oscillatory shear stress conditions. It was recently demonstrated that the 
eNOS pool residing in the Golgi complex is more responsive to Akt phosphorylation 
of serine1177 than eNOS residing in the cell membrane 5, indicating that the shear 
stress responsive eNOS pool is located predominantly in the Golgi complex. Rather 
unexpectedly, the relative fraction of eNOS located in the Golgi complex was 
unchanged in the low shear stress region, but decreased in the high and oscillatory 
shear stress regions. The correlation found between Golgi complex area and total 
eNOS area (Figure 3), demonstrate a possible response by the endothelial cells to 
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increase the size of the Golgi complex in order to accommodate more eNOS-GFP. 
When only the Golgi-localized eNOS fraction was taken into account, a similar 
correlation was found (r2=0.71, P<0.001). Therefore we hypothesize that chronic 
changes in shear stress in vivo induces adaptations in the extension of the Golgi 
complex, enabling the endothelial cells to accommodate more eNOS protein in this 
shear stress responsive intracellular compartment. This results in an absolute increase 
in eNOS phosphorylation and NO production, although the relative portion of eNOS 
that is phosphorylated remains unchanged.  
 
Limitations of the study 
The GFP reporter might interfere with eNOS localization. eNOS myristoylation and 
palmitoylation, which are both important for the localization 5, occur at the N-
terminus. It is unlikely that these processes are affected, because the GFP part is 
fused at the C-terminus of the eNOS protein 7. Although GFP could induce changes 
in protein folding, our experiments show normal localization of eNOS-GFP in the 
Golgi complex and plasma membrane 7 . Previous studies extensively studied the 
location and function of the eNOS-GFP fusion protein in vitro 13,14 16,17. These studies 
clearly indicate that the GFP moiety does not interfere with the localization and the 
function of eNOS.  
 
In conclusion, the present study demonstrates that intracellular distribution and 
phosphorylation of eNOS is responsive to high and oscillatory shear in vivo; and 
these shear stress conditions result in eNOS redistribution with a relatively lower 
association to the Golgi complex.  
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4.6 Supplemented data 
 
 
 
Figure 5: Experiments showing the specificity of the antibody directed against the 
phosphorylation site of human eNOS. Phospho-eNOS staining using phospho-eNOS 
ser1177 antibody in aortas of eNOS GFP transgenic (I) and eNOS deficient (II) mice. 
Indicated are eNOS GFP signal, DAPI nucleus signal, Phospho-eNOS signal, and co-
localization signal (yellow). In addition, control experiments were performed in 
aortas of eNOS GFP transgenic mice in which the first antibody was omitted (mock 
sample, panel III). Note that no phospho-eNOS signals in both eNOS deficient mice 
and mock samples were detected.  
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5.1 Abstract 
 
Rapamycin reduces atherosclerosis by an unknown mechanism.  Recent studies 
indicate that NO is involved, and that the effect is shear stress dependent. Because 
eNOS is anti-atherogenic and shear stress dependent, we evaluated in this study, 
whether rapamycin affects eNOS responsiveness to shear stress.  
With an in house developed flow modifier (referred to as cast) shear stress levels 
were varied over a large range of values in carotid arteries of transgenic mice 
expressing human eNOS fused to GFP. The mice were divided in control, low dose 
rapamycin (3 µg/kg/day) and high dose rapamycin (3 mg/kg/day) groups. The 
efficacy of treatment was confirmed by measurement of rapamycin serum levels (2.0 
± 0.5 ng/ml), and of p27kip1 expression in vascular tissue (increased by 2.4±0.5 fold). 
The effect of rapamycin treatment on eNOS was evaluated by eNOS quantification of 
expression (qPCR) and of intracellular protein levels by en face confocal microscopy. 
The cast-induced range of shear stress levels were calculated using computional fluid 
dynamics. In control carotid arteries, eNOS expression increased by 1.8±0.3 fold in 
response to rapamycin. In the cast treated vessels, rapamycin induced at high shear 
stress levels (> 10 Pa) a dose-responsive reduction in maximal eNOS expression. In 
addition, increasing concentrations of rapamycin induced an increase in eNOS at 
physiological shear (1.5-3.0 Pa).  
These results indicate that systemic administration of rapamycin protects the low 
shear stress regions from plaque initiation via an eNOS/shear stress dependent 
mechanism. In contrast, rapamycin decreases eNOS responsiveness to high shear 
stress, rendering a loss of protection via eNOS/shear stress mechanism in these 
regions. 
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5.2 Introduction 
 
Atherosclerosis is a lipid generated inflammatory disease of the large arteries. It is 
the primary cause of cardiovascular disease and the underlying cause of about 30% of 
all deaths in the Western society. It has been widely appreciated that atherosclerosis 
occurs at certain predilection sites in the vascular tree, like side branches and 
curvatures1,2. These observations cannot be explained by the systemic risk factors, 
and it has been postulated that local haemodynamic factors like endothelial wall 
shear stress are involved. Wall shear stress is the force, normalized per unit area, 
acting in plane of the endothelium as a result of the blood flow. Numerous studies 
have indicated that both low and oscillatory shear stress are crucial factors in 
atherogenesis 3-7. The response of the endothelium to shear stress occurs through 
adaptations in cell morphology, cell metabolism, and gene expression8,9. Among 
other things, this altered gene expression results in the production of vasoconstrictors 
and/or vasodilators, from which nitric oxide (NO) is one of the most relevant. NO is 
produced by nitric oxide synthase (NOS) enzymes, of which endothelial NOS 
(eNOS) is an isoform expressed by endothelial cells which is responsive to shear 
stress10. Therefore, changes in shear stress are partly acting through changes in eNOS 
expression and eNOS activity and this effect may play a role in pathological events, 
like atherosclerosis10-12. 
Rapamycin (sirolimus) is a macrolide antibiotic produced by the fungus Streptomyces 
hygroscopicus. In addition to immunosuppressive properties, rapamycin also 
prevents cell-cycle progression from the G1 to S phase, which results in the 
inhibition of growth factor-mediated and mitogen-induced cellular proliferation 13. 
Recent studies showed that rapamycin also has anti-atherogenic properties 14. While 
the mechanism is still under investigation, it has been proposed that an increased NO 
production as a result of increased eNOS expression and eNOS activation is involved 
15,16. As eNOS is a shear stress responsive enzyme 11,17-19, the beneficial effect of 
rapamycin in atherosclerosis may therefore be shear stress dependent. In a recent 
study we observed that the distribution of neointimal thickness in rapamycin-eluting 
stents is related to the shear stress pattern20. Therefore, we postulated that rapamycin 
modulates eNOS expression in response to shear stress. In order to test this 
hypothesis, we changed shear stress by an in house developed method that creates 
pre-defined patterns of shear stress in mouse carotid arteries in vivo 21. We used a 
transgenic mouse model that we developed previously in which the endothelial cells 
express the human eNOS gene fused to eGFP22. The method has been well validated 
in previous studies21. The GFP allowed us to monitor the effect of rapamycin on 
eNOS expression in response to shear stress in mice. 
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5.3 Materials and Methods 
 
Animals and experimental design 
For this study eNOS-GFP transgenic (tg) male and female mice older then 25 weeks 
of age were used. eNOS-GFPtg mice were generated with a DNA-construct encoding 
human endothelial nitric oxide synthase fused to enhanced green fluorescent protein 
as described previously 22 Rapamycin was given orally for a period of 11 days. The 
eNOS-GFP tg group consisted of a control group (n=12), a group treated with a low 
dose of rapamycin (3.0 µg/kg/day; n=6) and a group treated with a high dose of 
rapamycin (3.0 mg/kg/day; n=6). In addition, a series of mice were studied in which 
the carotid artery was ligated without rapamycin (n=3) and with a high dose of 
rapamycin (n=3) treatment. The Erasmus MC review board approved all procedures. 
Animal care and experiments were carried out in compliance with the institutional 
and national guidelines. 
 
Modification of shear stress 
In order to create predefined patterns of shear stress, a perivascular shear stress 
modifier was used as described previously 21. In short, the shear stress modifier, 
referred to as cast, was surgically positioned around the carotid artery of a mouse and 
immobilized with a 6/0 suture. Analyses were performed after 4 days of cast 
placement. This period was chosen on the basis of previous measurements showing a 
steady state in eNOS expression after 4 days. Thus, in rapamycin treated animals, the 
cast was placed at day 7 of the treatment.  
 
Confocal Microscopy 
The tissue samples were examined with a confocal laser scanning microscope system 
(LSM-510, Carl Zeiss Inc., Thornwood, NY, USA), equipped with an Argon laser 
(458, 488 nm) and two HeNe lasers (543 and 633 nm). The emission, which resulted 
from excitation of the tissue with a 488 nm Argon-Laser, was passed through a 560 
nm longpass filter to optimise detection of the green fluorescence of eGFP. After 
appropriate settings of the optics (20x/0.5 Plan-neofluar objective), of the resolution 
(8 bits), of the pinhole (1000 µm), and of the scan mode (plane, multitrack), images 
were captured. Adjacent optical images from one specimen were combined to form a 
tile in order to provide a complete picture of the vessel segment of interest. 
 
Computational fluid dynamics  
In order to estimate the changes in wall shear stress distribution after cast placement, 
we applied a well-validated 3-D computational fluid package (CFD)20,23-25. Boundary 
conditions, material properties and 3D vessel geometry are essential for CFD to 
generate a solution. The boundary conditions for the calculations were: no slip 
conditions at the wall, stationary parabolic inflow at the entrance with a maximal 
velocity equivalent to measurements obtained in a separate group of mice (see 
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supplemental data for details) and zero stress outflow. Three dimensional vessel 
geometry was obtained from the contours of the en face eGFP images, assuming a 
circular geometry and after correction for longitudinal shrinkage of the intact vessel. 
On basis of this vessel geometry, a mesh was generated, which consisted of 
approximately 25.000 nodes. Because viscosity of the blood is dependent on shear 
rate, we used a non-Newtonian fluid model (‘Carreau model’) to estimate viscosity25. 
The accuracy of the calculations was set at 10-4 m/sec, which resulted in a numerical 
error of wall shear stress of approximately 1%.   
 
Measurement of Rapamycin Levels 
Rapamycin levels in whole blood were obtained from a commercially available 
immunoassay (Abbot Laboratories, Abbot Park, USA) with a detection level of 2.5 
ng/ml. 
 
Gene expression analysis 
Carotid arteries were isolated from the eNOS-GFP transgenic animals untreated and 
treated with high concentration of rapamycin (n=5 per group). Total RNA from the 
samples was obtained using the RNAeasy kit (Qiagen, Cologne, Germany) and 
directly reversed transcribed into cDNA. PCR reactions were performed using a real-
time fluorescent determination in the iCycler iQ Detection System (Biorad, 
Veenendaal, The Netherlands). Gene expression levels of p27kip1 and eNOS were 
assessed. Target gene mRNA levels were expressed relatively hypoxanthine guanine 
phosphoribosyl transferase (HPRT).  
 
Data Analysis and Statistics 
The fluorescent vessel segment contours were traced manually and a bitmap was 
created on basis of these contours for further analysis. These regions served to 
reconstruct the blood vessel, generation of a 3-D mesh, performing computational 
fluid dynamics and for eNOS-GFP analysis. The analysis of eNOS-GFP consisted of 
automatic defining of lines perpendicular to the vessel centre line at location where 
shear stress was obtained from CFD. These lines served as a backbone for averaging 
eGFP thereby obtaining a longitudinal eGFP distribution. As a final step, eNOS-GFP 
values (y-axis) were related to local shear stress values (x-axis), and a non-linear 
curve fitting routine consisting of sigmoid relationship with an extra intercept was 
applied (see supplement data for details).  
Student’s t-tests were used to evaluate rapamycin serum levels, and eNOS-GFP and 
P27kip1 expression levels in the control and the rapamycin treated group. The 
estimated parameters of the sigmoid curve fit (eNOSss=0, EC50 and eNOSmax; see 
supplemental data for details) were tested with a two-way ANOVA. ∆eNOS was 
calculated as eNOSmax – eNOSss=0. For display purposes all eNOS and shear stress 
data were sorted and averaged for every 10 consecutive data-points and the resulting 
curve was presented with a standard deviation. Statistical significance was considered 
at p<0.05. All values are reported as mean±SEM. 
  
5.4 Results 
 
Animal characteristics and validation of treatment adequacy 
Weights of the animals for control, low and high dose rapamycin treated groups were 
26.3±1.4 g, 24.9±0.7 g and 27.8±1.1 g, at the start of the experiments respectively 
and did not change over time. The rapamycin plasma levels, after correction for 
background, were 2.0 ± 0.5 ng/ml after treatment with the highest dosage of 
rapamycin. These plasma levels were associated with a 2.4-fold increase of p27kip1 
gene expression levels in the vascular wall of the carotid arteries, as compared with 
the controls (Figure 1A).  
 
 
Figure 1: p27kip1 (A) and (human) eNOS (B) mRNA levels obtained for control 
conditions (white bars) and after rapamycin treatment (black bars) in mouse carotid 
arteries of 3 mice. qPCR analysis was performed in triplicate on pooled samples from 
6 animals per group. Note the upregulation of p27kip1 and (human) eNOS after 
rapamycin treatement. * P<0.05 versus control.  
 
Rapamycin affects the shear stress response of eNOS 
The basal expression of the human eNOS in the contra-lateral control carotid arteries 
increased by 1.8 ± 0.3 fold after treatment with the highest dose of rapamycin (Figure 
1B). In the carotid arteries with shear stress modification, intracellular eNOS levels 
increased in low shear stress regions after treatment with rapamycin (Figure 2, lower 
panel) and in regions exposed to physiological shear stress range (1.5-3.0 Pa). In high 
shear stress regions, intracellular eNOS levels decreased with increasing dosages of 
rapamycin (Figure 2, upper panel).  
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Figure 2: eNOS-GFP images captured for high shear conditions and low shear stress 
conditions. All pictures are captured at equal settings of the microscope. The dose 
dependent effects of rapamycin at low shear stress are opposite from the effects at 
high shear stress: eNOS expression increased at low shear stress and decreased at 
high shear stress. 
 
These observations were substantiated by the sigmoid curve fit analysis, which 
showed that eNOSmax was decreased from 67.4±14.6 (Arbitrary Units or AU) to 
34.1±7.7 (AU), and the EC50 was decreased from 10.7±2.6 N/m2 to 4.8±0.5 N/m2 
(Figure 3A,B), while the slope and intercept remained unaffected. In figure 3C, the 
average curves from all three groups (control, rapamycin low dose (LD), rapamycin 
high dose (HD)) are displayed.   
As it was difficult to obtain accurate measurements of eNOS protein at the lowest 
levels of the curve fit in a reliable way (Figure 3C), we also studied an extra series of 
mice, in which the carotid artery was ligated (i.e. zero shear stress) and eNOS protein 
levels were investigated (Figure 4). Ligation significantly reduced the eNOS-GFP 
signal in both control and the high dose rapamycin group. No significant effect of 
rapamycin on intracellular eNOS levels was observed in the contra-lateral control 
arteries (Fig. 4A, lower panels), while rapamycin treatment resulted in increased 
eNOS-GFP following ligation (Figure 4A, upper panels). These data clearly indicate 
that rapamycin increases eNOS expression at low shear stress. This effect is opposite 
from the response found at high shear stress levels.  
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Figure 3: Parameters derived from the sigmoid curve fit (eNOSmax, and EC50) 
at different rapamycin dosages (in figure 3A and 3B respectively). Low dose 
is 3µg/kg/day, and high is 3mg/kg/day. EC50 is the shear stress (in N/m2) at 
50% of the maximal GFP value. eNOSmax is the asymptote of the curve and 
represents the maximal eNOS-GFP level. Figure 3C: the average curve 
obtained from the control (C), low rapamycin dose (LD) en high rapamycin 
dose (HD). * P<0.05 versus control.  
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Figure 4: Captured eNOS-GFP images (A) and quantification of the eNOS-GFP 
signal under the following conditions: normal flow with rapamycin, normal flow 
without rapamycin, ligation without rapamycin and ligation with rapamycin. Note 
that the effect of rapamycin is minimal during normal flow conditions, but becomes 
significant during ligation. Ligation reduces eNOS-GFP expression significantly in 
both the – rapamycin and + rapamycin groups. *P<0.05 versus ligation + rapamycin 
group. 
 
The difference between minimal and maximal eNOS protein levels appeared to be 
dependent on rapamycin level as indicated by the relation between the difference of 
maximal and minimal eNOS protein levels as a function of rapamycin dosage. The 
relationship could be described by a linear regression line: ∆eNOS= -15*Rapa+41.4; 
r=0.6 (Figure 5).  
 
 
Figure 5: Relationship 
describing the difference of 
maximal and minimal 
eNOS protein levels as a 
function of rapamycin 
dosage. The relationship 
could be described by a 
linear regression line: 
∆eNOS= -15*Rapa+41.4; 
r=0.6; P<0.05. 
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5.6 Discussion 
 
Rapamycin has been used for treating in-stent restenosis because of its anti-
proliferative, and anti-inflammatory properties26-28. Recently, rapamycin was shown 
to reduce atherosclerosis with a mechanism independent of its effects on p27kip1 29. 
This might be explained by a reduction in pro-atherogenic cytokines and an increase 
of anti-atherogenic cytokines in ApoE deficient mice treated with rapamycine found 
by Elloso et al.30. In addition, Naoum et al. showed that rapamycin increased eNOS 
expression in ApoE deficient mice16 31,32. As the eNOS promoter is shear stress 
responsive31, and we previously found that rapamycin possibly modulates the shear 
stress responsiveness of the vessel wall20, we argued that rapamycin might affect the 
shear stress responsiveness of eNOS.  
 
The main findings of the present study are that rapamycin treatment in aged and 
gender matched animals with a short protocol (11 days): 1) Increased rapamycin 
plasma levels and tissue p27kip1 expression, validating the efficacy of the treatment; 
2) increased eNOS mRNA expression in carotid arteries in accordance with earlier 
studies; and 3) increased intracellular eNOS protein levels in cast treated carotid 
arteries at low shear stress levels, but decreased eNOS protein levels at high shear 
stress.  
 
The present study showed that rapamycin affects eNOS expression in response to 
shear stress, confirming the hypothesis mentioned above. Our data indicate that 
intracellular eNOS protein levels increased at low shear stress levels (<1.5 Pa) in 
response to rapamycin. Low shear stress regions in the arterial system are notorious 
as initiation sites for the development of atherosclerotic lesions. The expression and 
activation of eNOS is severely reduced at these sites as a result of the decrease in 
shear stress levels. Our findings indicate that systemic administration of rapamycin 
will provide protection against the onset of atherosclerosis by increasing eNOS 
availability at these predilection sites.  
 
Rapamycin also increased eNOS levels and expression patterns within the shear 
stress range, which is normally found in straight vessel segments (1.5-3.0 Pa; figure 
2). This finding is consistent with previous data, showing elevated eNOS levels in 
straight murine aortas after administration of rapamycin 16.  
The finding that eNOS levels are reduced in the high shear stress range (> 3.0 Pa) is 
new and implies that rapamycin might reduce the responsiveness of the putative 
shear stress sensor. High shear stress levels are also induced during exercise, and the 
vasodilatory response of the vessels in response to exercise has been reported to be 
due to enhanced release of NO by the endothelium. In a recent study, the coronary 
vessels of patients implanted with sirolimus eluting stents show impaired vasomotion 
in the vessel segments up- and downstream from the stented area, leading to 
vasoconstriction 33. Our present study may offer an explanation for these findings, as 
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rapamycin reduces eNOS expression during high shear stress conditions. Diffusion of 
rapamycin into the peri-stent vascular regions could therefore induce endothelial 
dysfunction by affecting the expression of eNOS, resulting in the observed paradoxic 
vasocontriction. 
 
Limitation of the method 
For the calculations of the shear stress field we performed a 3-D reconstruction of the 
blood vessel from the flat specimen assuming a cylindrical geometry. We have tested 
this assumption by measuring diameter of individual mice before sacrifice and 
compared these measurements with 3D reconstruction diameters. The difference 
between prediction and measurements never exceeded the 5%. Another assumption 
underlying our CFD calculations was that entrance shear stress was 1.5 N/m2.  
Four days of cast placement was used throughout the experiments. This period was 
chosen as eNOS expression changes induced by shear stress were in a steady state 
and the period was too short for fibrotic tissue to interfere with the measurements.    
Over-expression of eNOS-GFP may result in a negative feedback by the increased 
NO production inhibiting transcription of the gene. Thus, the effect of shear stress on 
eNOS expression might have been underestimated in the present study. However, the 
expression of murine eNOS in wild type controls shows a similar response to the 
shear stress alterations induced by the cast. The observed effect of shear stress on 
eNOS-GFP is therefore not restricted to the human eNOS transgenic construct.  
The GFP reporter might interfere with eNOS localization. eNOS myristoylation and 
palmitoylation, which are both important for the localization, occur at the N-
terminus. It is unlikely that these processes are affected, because the GFP part is 
fused at the C-terminus of the eNOS protein. Although GFP could induce changes in 
protein folding, our experiments show normal localization of eNOS-GFP in the Golgi 
complex and plasma membrane. Previous studies extensively studied the location and 
function of the eNOS-GFP fusion protein in vitro. These studies clearly indicate that 
the GFP moiety does not interfere with the localization and the function of eNOS.  
The change in vessel geometry by cast placement may compress fibro-elastin layers 
of the vessel wall and thereby increase background auto-fluorescence. This does not 
affect our data however, because the auto-fluorescent signal was subtracted from the 
total GFP signal. The tapering effect of the cast could also compress the endothelial 
cells to make them fit into a smaller area, increasing the number of cells per area. Co-
localization studies of the endothelium in the different shear stress regions do not 
show an increase in cell number per area or a decrease in cell size. In addition, the 
up-regulation of eNOS-GFP in single endothelial cells is observed, providing further 
evidence that the eNOS-GFP signal in the high shear vessel segment is not an artefact 
created by the tapered shape of the cast. 
 
In conclusion, our results indicate that systemic administration of rapamycin protects 
the low shear stress regions from plaque initiation via an eNOS/shear stress 
dependent mechanism. In contrast, rapamycin decreases eNOS responsiveness to 
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high shear stress, rendering a loss of protection via eNOS/shear stress mechanism in 
these regions. 
 
 
Acknowledgements   
R. Krams is a recipient of an established investigatorship of the Dutch Heart 
Foundation (Grant 2002T045). C. Cheng was financially supported by the 
Interuniversity Cardiology Institute of the Netherlands (ICIN-33) 
  
 103  
5.7 References 
 
1. Honda HM, Hsiai T, Wortham CM, et al. A complex flow pattern of low 
shear stress and flow reversal promotes monocyte binding to endothelial 
cells. Atherosclerosis. Oct 2001;158(2):385-390. 
2. Krams R, Wentzel JJ, Oomen JA, et al. Evaluation of endothelial shear stress 
and 3D geometry as factors determining the development of atherosclerosis 
and remodeling in human coronary arteries in vivo. Combining 3D 
reconstruction from angiography and IVUS (ANGUS) with computational 
fluid dynamics. Arterioscler Thromb Vasc Biol. 1997;17(10):2061-2065. 
3. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial 
cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol. 
1998;18(5):677-685. 
4. Buchanan JR, Jr., Kleinstreuer C, Truskey GA, et al. Relation between non-
uniform hemodynamics and sites of altered permeability and lesion growth at 
the rabbit aorto-celiac junction. Atherosclerosis. 1999;143(1):27-40. 
5. Shaaban AM, Duerinckx AJ. Wall shear stress and early atherosclerosis: a 
review. AJR Am J Roentgenol. 2000;174(6):1657-1665. 
6. Gnasso A, Irace C, Carallo C, et al. In vivo association between low wall 
shear stress and plaque in subjects with asymmetrical carotid atherosclerosis. 
Stroke. 1997;28(5):993-998. 
7. Chappell DC, Varner SE, Nerem RM, et al. Oscillatory shear stress 
stimulates adhesion molecule expression in cultured human endothelium. 
Circ Res. 1998;82(5):532-539. 
8. Galbraith CG, Skalak R, Chien S. Shear stress induces spatial reorganization 
of the endothelial cell cytoskeleton. Cell Motil Cytoskeleton. 1998;40(4):317-
330. 
9. Girard PR, Nerem RM. Shear stress modulates endothelial cell morphology 
and F-actin organization through the regulation of focal adhesion-associated 
proteins. J Cell Physiol. 1995;163(1):179-193. 
10. Fisslthaler B, Dimmeler S, Hermann C, et al. Phosphorylation and activation 
of the endothelial nitric oxide synthase by fluid shear stress. Acta Physiol 
Scand. 2000;168(1):81-88. 
11. Rizzo V, McIntosh DP, Oh P, et al. In situ flow activates endothelial nitric 
oxide synthase in luminal caveolae of endothelium with rapid caveolin 
dissociation and calmodulin association. J Biol Chem. 1998;273(52):34724-
34729. 
12. Gloe T, Riedmayr S, Sohn HY, et al. The 67-kDa laminin-binding protein is 
involved in shear stress-dependent endothelial nitric-oxide synthase 
expression. J Biol Chem. 1999;274(23):15996-16002. 
13. Marks AR. Sirolimus for the prevention of in-stent restenosis in a coronary 
artery. N Engl J Med. Oct 2 2003;349(14):1307-1309. 
  
 104  
14. Waksman R, Pakala R, Burnett MS, et al. Oral rapamycin inhibits growth of 
atherosclerotic plaque in apoE knock-out mice. Cardiovasc Radiat Med. Jan-
Mar 2003;4(1):34-38. 
15. Pham SM, Shears LL, Kawaharada N, et al. High local production of nitric 
oxide as a possible mechanism by which rapamycin prevents transplant 
arteriosclerosis. Transplant Proc. Jun 1998;30(4):953-954. 
16. Naoum JJ, Zhang S, Woodside KJ, et al. Aortic eNOS expression and 
phosphorylation in Apo-E knockout mice: differing effects of rapamycin and 
simvastatin. Surgery. Aug 2004;136(2):323-328. 
17. Li Y, Zheng J, Bird IM, et al. Mechanisms of shear stress-induced 
endothelial nitric-oxide synthase phosphorylation and expression in ovine 
fetoplacental artery endothelial cells. Biol Reprod. Mar 2004;70(3):785-796. 
18. Boo YC, Sorescu G, Boyd N, et al. Shear stress stimulates phosphorylation 
of endothelial nitric-oxide synthase at Ser1179 by Akt-independent 
mechanisms: role of protein kinase A. J Biol Chem. 2002;277(5):3388-3396. 
19. Ziegler T, Silacci P, Harrison VJ, et al. Nitric oxide synthase expression in 
endothelial cells exposed to mechanical forces. Hypertension. 
1998;32(2):351-355. 
20. Gijsen FJ, Oortman RM, Wentzel JJ, et al. Usefulness of shear stress pattern 
in predicting neointima distribution in sirolimus-eluting stents in coronary 
arteries. Am J Cardiol. Dec 1 2003;92(11):1325-1328. 
21. Cheng C, van Haperen R, de Waard M, et al. Shear stress affects the 
intracellular distribution of eNOS: direct demonstration by a novel in vivo 
technique. Blood. Aug 16 2005. 
22. van Haperen R, Cheng C, Mees BM, et al. Functional expression of 
endothelial nitric oxide synthase fused to green fluorescent protein in 
transgenic mice. Am J Pathol. Oct 2003;163(4):1677-1686. 
23. Gijsen FJ, Allanic E, van de Vosse FN, et al. The influence of the non-
Newtonian properties of blood on the flow in large arteries: unsteady flow in 
a 90 degrees curved tube. J Biomech. Jul 1999;32(7):705-713. 
24. Gijsen FJ, Palmen DE, van der Beek MH, et al. Analysis of the axial flow 
field in stenosed carotid artery bifurcation models--LDA experiments. J 
Biomech. Nov 1996;29(11):1483-1489. 
25. Gijsen FJ, van de Vosse FN, Janssen JD. Wall shear stress in backward-
facing step flow of a red blood cell suspension. Biorheology. Jul-Oct 
1998;35(4-5):263-279. 
26. Ong AT, Serruys PW, Aoki J, et al. The unrestricted use of paclitaxel- versus 
sirolimus-eluting stents for coronary artery disease in an unselected 
population: one-year results of the Taxus-Stent Evaluated at Rotterdam 
Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol. Apr 5 
2005;45(7):1135-1141. 
  
 105  
27. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a 
sirolimus-eluting stent with a standard stent for coronary revascularization. N 
Engl J Med. Jun 6 2002;346(23):1773-1780. 
28. Regar E, Serruys PW, Bode C, et al. Angiographic findings of the 
multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity 
Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit 
restenosis irrespective of the vessel size. Circulation. Oct 8 
2002;106(15):1949-1956. 
29. Castro C, Campistol JM, Sancho D, et al. Rapamycin attenuates 
atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient 
mice through a p27 Kip1 -independent pathway. Atherosclerosis. Jan 
2004;172(1):31-38. 
30. Elloso MM, Azrolan N, Sehgal SN, et al. Protective effect of the 
immunosuppressant sirolimus against aortic atherosclerosis in apo E-
deficient mice. Am J Transplant. May 2003;3(5):562-569. 
31. Govers R, Rabelink TJ. Cellular regulation of endothelial nitric oxide 
synthase. Am J Physiol Renal Physiol. 2001;280(2):F193-206. 
32. Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide 
synthase: role of protein kinases. Am J Physiol Cell Physiol. Sep 
2003;285(3):C499-508. 
33. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated 
with paradoxic coronary vasoconstriction. J Am Coll Cardiol. Jul 19 
2005;46(2):231-236. 
 
 
 
 106
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6: Atherosclerotic Lesion Size and 
Vulnerability are Determined by Patterns of 
Fluid Shear Stress  
osveld, M.J.A.P.  
C. Cheng, D. Tempel, R. van Haperen A. van der Baan, F. Gr
Daemen, R. Krams, and R. de Crom,  
Circulation, in review 
 
 
 
 
 
 
 
 107
 
 108
 
6.1 Abstract 
 
Atherosclerotic lesions are predominantly observed in curved arteries and near side 
branches, where low or oscillatory shear stress patterns occur, suggesting a causal 
connection. However, the effect of shear stress on plaque vulnerability is unknown, 
because the lack of an appropriate in vivo model precludes cause-effect studies. We 
developed a perivascular shear stress modifier inducing low, high, and 
low/oscillatory shear stress regions in mouse carotid arteries and studied plaque 
formation and composition. Atherosclerotic lesions developed invariably in low 
and/or oscillatory shear stress regions, whereas the high shear stress regions were 
protected. Low shear stress lesions were larger in size (intima/media: 1.38 ± 0.68 
versus 0.22 ± 0.04), contained less smooth muscle cells (1.9 ± 1.6% versus 26.3 ± 
9.7%) and less collagen (15.3 ± 1.0% versus 22.2 ± 1.0%), more lipids (15.8 ± 0.9% 
versus 10.2 ± 0.5%), and showed more outward vascular remodeling (214 ± 19% 
versus 117 ± 9%) than oscillatory shear stress lesions. Expression of pro-atherogenic 
inflammatory mediators and matrix-metalloproteinase activity was higher in the low 
shear stress regions. Spontaneous and angiotensin II induced intra-plaque 
hemorrhages occurred in the low shear stress regions only.  
Low shear stress and oscillatory shear stress are both essential conditions in plaque 
formation. Low shear stress induces larger lesions with a vulnerable plaque 
phenotype, while oscillatory shear stress induces stable lesions. 
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6.2 Introduction 
 
The occurrence of atherosclerosis is closely linked to local hemodynamic factors. 
Shear stress, the drag force acting on the endothelium as a result of blood flow, is 
thought to play a critical role in the development of endothelial dysfunction and 
atherosclerosis. This is based on the observation that atherosclerotic plaque formation 
occurs preferentially in areas such as the inner curvatures of coronary arteries, where 
the shear stress is low (<1.5 N/m2), or near bifurcations, where shear stress is 
oscillatory in nature (displaying directional change and flow separation) 1-3. 
Conversely, straight arterial segments with laminar flow have levels of shear stress of 
approximately 1.5 N/m2 and appear to be protected from atherosclerosis. The relation 
between shear stress and atherosclerosis is almost exclusively based on observational 
studies in humans and large animals 1,4,5. In addition, there is a large body of studies 
on the response of cultured endothelial cells on variations in shear stress (reviewed in 
6). While this work provides insight into the relationship between shear stress and 
plaque development, direct proof that deviations in shear stress induces 
atherosclerosis is lacking. In order to provide such evidence, an appropriate in vivo 
model that can generate complex shear stress fields is required. Furthermore, it is not 
clear whether low shear stress and oscillatory shear stress have different atherogenic 
properties. Therefore, our laboratory has recently developed a perivascular shear 
stress modifier (referred to as cast) that can induce changes in shear stress patterns in 
vivo in a straight vessel and in a defined manner. The cast (made of 
polyetheretherketon with a cone shaped lumen: 0.5 mm proximal inner diameter, 
0.25 distal inner diameter) causes a tapered stenosis when placed around the carotid 
artery of a mouse. As a result, three regions with different shear stress patterns are 
created in the vessel: low shear stress (upstream from the cast), high shear stress (in 
the cast) and oscillatory shear stress (downstream from the cast) (see figure 1 of 
supplemented online data) 7. The induction of the different shear stress conditions 
was validated by Doppler measurements 8, and the biological effect of the cast was 
validated by qPCR of shear stress responsive genes 7. In the current study, we use this 
model to assess the effect of in vivo alterations of shear stress on the development of 
atherosclerosis in apolipoprotein E (apoE–/–) deficient mice. Our findings reveal that 
atherosclerotic lesions develop under both low shear stress and oscillatory shear 
stress conditions within 6 weeks of treatment, whereas no lesions develop in the high 
shear stress region.  
Change in plaque composition can modify a stable atherosclerotic lesion into a 
plaque with a vulnerable phenotype, rendering its susceptible to rupture with dramatic 
consequences such as acute coronary syndrome and stroke. Therefore, it is important 
to understand the mechanisms that increase plaque vulnerability. While shear stress 
has been associated with specific plaque localization, it is presently unknown if this 
mechanical force has an effect on the vulnerability of the lesion. Therefore we 
analysed the composition of the atherosclerotic lesions that develop in the low shear 
stress and the oscillatory shear stress regions. Furthermore, expression of pro-
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inflammatory mediators known in literature to be correlated to increased plaque 
instability9,10 11 was studied. We demonstrate that low shear stress induces the 
development of extensive lesions with a vulnerable plaque phenotype, whereas 
oscillatory shear stress induces the growth of stable lesions. Using Angiotensin II 
administration, we show that intra-plaque hemorrhages occur exclusively in the 
atherosclerotic lesions of the low shear stress regions.  
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6.3 Materials and Methods 
 
Animals and diets 
ApoE–/– mice in C57BL/6J background were obtained from The Jackson 
Laboratory, Bar Harbor, ME. Male animals 15-20 weeks of age were assigned 
randomly to one of the 3 time points (see supplemented data). During the 
experimental period, all animals were fed a Western type diet containing 15% (w/v) 
cacoa butter and 0.25% (w/v) cholesterol (diet W, Hope Farms, Woerden, The 
Netherlands). All experiments were performed in compliance with institutional 
(Erasmus MC, Rotterdam, The Netherlands) and national guidelines.  
 
In vivo alteration of shear stress 
In order to induce standardized changes in shear stress, we designed a shear stress 
modifier, which was manufactured of the thermoplastic, polyetherketon. The device 
is referred to as cast throughout the study. The cast consists of two longitudinal 
halves of a cylinder with a cone shaped lumen (see Figure 1a of supplemented data). 
The geometry of the cast has been designed with computational flow dynamics 
software to produce vortices downstream of the cast when placed around the 
common carotid artery (see Figure 1b of supplemented data). This downstream 
region will therefore be exposed to oscillations in shear stress (oscillatory shear stress 
region). The upstream inner diameter is 500 µm (non-constrictive) and gradually 
declines to 250 µm at the downstream side of the cast (constrictive). This tapering 
induces a gradual increase in shear stress (high shear stress region). In addition, the 
constrictive stenosis decreases the blood flow, resulting in a low shear stress region 
upstream from the cast. Control casts consist of a cylinder with a continuous non-
constrictive diameter of 500 µm. The induction of the different shear stress 
conditions was validated by Doppler measurements 8. 
 
Surgical procedures 
After 2 weeks of Western diet, the animals were anaesthetised with isoflurane, and 
the anterior cervical triangles were accessed by a sagittal anterior neck incision. The 
right common carotid artery was dissected from circumferential connective tissues. 
The cast was placed around the right common carotid artery, wounds were closed and 
the animals were allowed to recover. Animals with cast implants were sacrificed at 6, 
9, and 12 weeks after surgery. For the induction of intraplaque hemorrhages, apoE –
/– mice received Western diet and were instrumented with the cast as decribed above. 
After 7 weeks of cast placement, the animals were treated with angiotensin II 
infusion of 400ng/kg/min (2 ng/µl in 200 µl volume) via a subcutaneously implanted 
osmotic minipump (Alzet, model 2004, Durect Corp, Maastricht, The Netherlands) 
for 2 weeks before they were sacrificed. 
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Tissue preparation and histology 
Animals were anaesthetized with isoflurane and blood samples were collected by 
orbital puncture. Through a cardiac puncture flushing with 20 ml PBS was 
performed, immediately followed by in situ perfusion fixation with 20 ml 4% (w/v) 
paraformaldehyde (Sigma Chemical Co., Zwijndrecht, The Netherlands) in PBS at a 
constant perfusion pressure of 100 mm Hg. The entire aortic arch with the origins of 
the right and the left common carotid arteries including 5 mm of these vessels were 
carefully prepared. For visualization of surface area occupied by atherosclerosis, the 
aorta and its major branches were stained with Oil-red-O 12.  
Quantification of histological data was performed on 7 µm cryosections at 140 µm 
intervals. In addition to standard hematoxylin/eosin staining, macrophages were 
detected using AIA31240 antibodies (1:3000, Accurate Chemical and Scientific, New 
York, USA), smooth muscle cells by antibodies against VSMC α-actin Cy3 (1:200, 
Sigma, Chemical Co., Zwijndrecht, The Netherlands). Antibodies against PECAM-1 
(Sigma Chemical Co., Zwijndrecht, The Netherlands) were used to visualize the 
endothelium. Lipid deposition was analyzed with Oil-red-O staining and collagen 
with picrosirus red. Data analysis was performed using a microscopy image analysis 
system (Impak C, Clemex Technologies, Quebec, Canada). 
 
Cholesterol analysis  
Blood samples were taken by orbital puncture at the time of sacrifice. Total plasma 
cholesterol concentrations were measured enzymatically using a commercially 
available kit (Boehringer Mannheim GmbH, kit 236691) 
 
In situ zymography  
A PBS solution of DQ™ gelatin (1mg/ml) (Molecular Probes, Leiden, The 
Netherlands) in 1% agarose (Sigma Chemical Co., Zwijndrecht, The Netherlands) is 
applied to the slides and incubated for 2 hours at room temperature. Activity was 
detected by assessing the fluorescent signal using confocal microscopy.  
 
Gene expression analysis 
Freshly isolated carotid arteries were divided into three different regions (1 mm 
downstream from the cast, 1 mm in the cast, and 1 mm upstream from the cast) and 
these segments from 10 individual mice were pooled per region. Total RNA from the 
samples was isolated using the RNeasy kit (Qiagen, Venlo, The Netherlands) and 
linearly amplified following standard Eberwine T7 protocol 13. Quantitative PCR 
reactions were performed using the iCycler iQ Detection System (Biorad, 
Veenendaal, The Netherlands). Primers were designed for VCAM-1, ICAM-1, IL-6, 
CRP, and VEGF. Target gene mRNA levels were expressed relatively to the 
housekeeping gene Hypoxanthine-Guanine Phosphoribosyl Transferase (HPRT). For 
additional material and methods section, see supplemented online data. 
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Statistical analysis 
Statistical analysis was performed using two-way ANOVA analysis of variance 
(between more than two shear stress areas and between different time points). When 
only low shear stress and oscillatory shear stress for 1 time point were compared, the 
two-tailed Student t test was used. Data are presented as mean ± SEM. P values 
<0.05 were considered significant.  
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6.4 Results 
 
Low shear stress and oscillatory shear stress both induce atherosclerotic plaque 
formation, whereas high shear stress protects against atherosclerosis 
In order to study the effect of the 3 different shear stress fields on lesion formation, 
apoE–/– mice were fed an atherogenic diet, instrumented with the cast, and sacrificed 
at different times points (6, 9, and 12 weeks). Whole mount lipid staining of aortic 
arches and carotid arties showed that atherosclerotic lesions have already developed 
at the earliest time point (Figure 1A) in the inner curve of the aortic arch and at the 
beginning of the side branches. These are the natural sites of shear stress related 
plaque initiation 14. In addition, lipid deposits have started to develop in the low shear 
stress and the oscillatory shear stress regions in the carotid artery instrumented with 
the cast at 6 weeks. At 9 and 12 weeks, the lesion areas grow markedly larger in the 
low shear stress regions (Figure 1, B and C). In the oscillatory shear stress regions, a 
gradual increase in lesion area can be appreciated as well (Figure 1, A-C), but these 
are considerably smaller than the lesions in the low shear stress regions. No 
atherosclerotic lesions were present in the high shear stress region at the earliest time 
point, and moderately sized lesions developed only in 2 out of the 7 mice (29%) at 9 
weeks and in 3 out of the 6 mice (50%) at 12 weeks of cast implantation eventually, 
whereas all of the animals developed lesions under low and oscillatory shear stress 
from week 6 on. Controls included the contra-lateral, non-treated carotid arteries, 
sham operated animals (Figure 1D) and animals treated with a non-constrictive cast 
(Figure 1E). In none of these conditions, any lipid staining could be observed even 
after 12 weeks of cast placement. Plasma cholesterol levels were increased in animals 
on Western diet (6 weeks:  24.7±1.1 mmol/l; 9 weeks: 24.4±1.1 mmol/l; 12 weeks: 
32.8±2.1 mmol/l) compared to animals on normal chow diet (10.9±3 mmol/l). Plasma 
cholesterol concentrations between animals treated with the cast or the non-
constrictive cast were not different (12 weeks, cast: 32.8±2.1 mmol/l versus 12 
weeks, non-constrictive cast: 31.9±0.4 mmol/l). These results indicate that the diet, 
the surgical procedure, or the material of the cast did not contribute to the observed 
atherosclerotic lesion formation in the straight segment of the carotid artery.  
 
 
Figure 1: Low shear stress and oscillatory shear stress induce atherosclerosis in apoE  
–/– mice fed an atherogenic Western diet. Whole mount aortic arches and carotid 
arteries were stained with Oil-red-O for atherosclerotic lesions. The white lines 
demarcate the previous position of the cast with the high shear stress region. 
Upstream from the cast is the low shear stress region, and downstream from the cast 
is the oscillatory shear stress region. Animals were instrumented with a cast after 2 
weeks of the beginning of the diet and sacrificed after 6 (A), 9 (B), or 12 (C-E) weeks 
of cast placement.  No lesions are detected in the carotid arteries of sham operated 
mice (D) or in the carotid arteries of animals instrumented with a non-constrictive 
cast (E). Representative images are shown from groups consisting of 6-8 animals. 
Colour version of this figure is available in the full colour section.  
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Low shear stress is associated with more extensive lesions than oscillatory shear 
stress 
Figure 2A shows micrographs of carotid artery morphology after 9 weeks of cast 
placement in the low, high and oscillatory shear stress regions, respectively, as well 
as in the contra-lateral carotid artery (undisturbed shear stress). In the high shear 
stress region, the appearance of the vessel is largely similar to that of the undisturbed, 
control region. In contrast, in the low and oscillatory shear regions atherosclerotic 
lesion formation is obvious. However, the lesions have a strikingly different 
morphology. 
Platelet endothelial cell adhesion molecule-1 (PECAM-1) staining reveals an intact 
endothelium in all the regions studied at all time points (shown for 9 weeks in Figure 
2B).   
Measurements of the intima/media ratios showed that the atherosclerotic lesion areas 
in the low shear stress regions were much more extensive than those in the oscillatory 
regions (1.38 ± 0.68 versus 0.22 ± 0.04, respectively; Figure 2C). In both regions, the 
plaque size was significantly larger than in the undisturbed region. In contrast, no 
significant difference in intima/media ratios was observed between the high shear 
stress and undisturbed regions (Figure 2C). Vascular remodeling was evaluated by 
comparing the cross-sectional area of the vessel wall obtained from the low and the 
oscillatory shear stress regions of the instrumented carotid artery and the untreated 
contra-lateral carotid artery (control region). Remodeling was observed in the low 
shear stress region, where the relative cross-sectional vessel area was approximately 
2-fold increased compared with the control region, while there was no significant 
change in the oscillatory shear stress region (Figure 2D). At 6 and 12 weeks, similar 
differences in intima/media ratios and in vascular remodeling between the different 
shear stress regions were found (data not shown). 
 
 
Figure 2: Histological analyses of carotid arteries at 9 weeks after cast placement in 
apoE–/– mice fed a Western diet. (A) Representative images are shown from the low, 
high, and oscillatory shear stress regions as well as from the contra-lateral non-
treated carotid artery (undisturbed shear stress) (hematoxylin and eosin staining, 
original magnifications 100X). (B) Representative images showing PECAM-1 
staining (red) of the intact endothelium in the four different shear stress regions. 
Auto-fluorescence of the elastic lamellae is in green and the cell nuclei stained with 
DAPI are in blue. Original magnifications: 100 X. Histological analyses were 
performed by quantification of the intima/media ratio (C), and of the relative cross-
sectional area of the vessel wall (D), which was obtained by measuring the area 
confined by the external elastic lamina of the instrumented carotid artery and 
expressed as percentage of the cross-sectional area of the contra-lateral non-treated 
carotid artery. * P<0.05 versus low shear stress. † P<0.05 versus oscillatory 
shear stress. Colour version of this figure is available in the full colour section.  
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Low shear stress induces lesions with a vulnerable plaque phenotype, while 
oscillatory shear stress induces the development of stable lesions 
In order to examine the effect of low shear stress and oscillatory shear stress on 
plaque composition, we performed (immuno)-histochemical analyses at 9 weeks after 
cast placement. As no lesions developed in the control vessels, the percentage of 
plaque components in the intimal area of these vessels cannot be analyzed and are 
therefore excluded. Macrophages and lipids were abundantly present in lesions of 
both low and oscillatory shear stress regions (Figure 3A). Quantification of the 
macrophage-positive areas showed no relative difference between lesions in the low 
shear stress and oscillatory shear stress regions (Figure 3B). However, the lipid 
content was significantly higher in the lesions located in the low shear stress regions 
than in the lesions located in the oscillatory shear stress regions (15.8 ± 0.9% versus 
10.2 ± 0.5%, respectively; Figure. 3B). Further analysis of lesion components 
revealed that low shear stress lesions contained only thin layers of smooth muscle 
cells and collagen situated in the cap of the lesion, whereas in the oscillatory shear 
stress lesions the smooth muscle cells and collagen-positive areas were more 
uniformly distributed in the intima (Figure 3A). This pattern was also observed at the 
other time points studied (data not shown). The low shear stress lesions contained 
less vascular smooth muscle cells (1.9 ± 1.6% versus 26.3 ± 9.7%) and less collagen 
(15.3 ± 1.0% versus 22.2 ± 1.0%) than oscillatory shear stress lesions at week 9 
(Figure 3B). In order to assess the observed reduction in collagen, matrix metallo-
proteinase (MMP) activity was measured by DQ gelatinase assay (Figure 3A). An 
increase of about one third in MMP activity was found in the low shear stress region 
compared to the oscillatory shear stress region (Figure 3B). 
 
Expression of pro-atherogenic inflammatory mediators is more prominent in the low 
shear stress region 
Gene expression analysis revealed increased expression of pro-inflammatory 
mediators in the low shear stress region compared to the expression in the oscillatory 
shear stress region (Figure 4). Expression of Vascular Cell Adhesion Molecule-1 
(VCAM-1) and Intercellular Adhesion Molecule-1 (ICAM-1), involved in the 
adhesive interactions between endothelial cells and leukocytes, were both 
upregulated by 3 fold in the low shear stress region compared with control, whereas 
only VCAM1 was 50% upregulated in the oscillatory shear stress region. Expression 
of the C-reactive protein (CRP) was increased by 3 fold in the low and by 2 fold the 
oscillatory shear stress region compared with control. The expression levels of the 
pro-atherogenic growth factor, vascular endothelial growth factor (VEGF), were 
increased by 5 fold in the low shear stress lesions exclusively. Finally, expression of 
the pro-inflammatory cytokine interleukin 6 (IL-6) was increased by 14 fold in the 
low shear stress and by 2 fold in the oscillatory shear stress region, compared with 
control. 
 
  
 
Figure 3: (A) Cross-sections of carotid arteries 9 weeks after cast placement in 
apoE–/– mice on a Western diet (100X magnification) stained for macrophages 15, 
lipids (Oil red-O), vascular smooth muscle cells (anti α-actin), or collagen 
(picrosirius red) in the low shear stress and the oscillatory shear stress region. MMP 
activity was studied by DQ gelatinase assay. (B) Quantification of macrophages, 
lipids, vascular smooth muscle cells, and collagen in the intimal area of the low shear 
stress and the oscillatory shear stress region, and of MMP activity. Data are the 
average values of sections from 5 different animals.  * P<0.05 versus low shear 
stress. Colour version of this figure is available in the full colour section.  
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Figure 4: Vascular gene 
expression levels of pro-
inflammatory mediators 
involved in the progression of 
atherosclerosis in carotid 
arteries 9 weeks after cast 
placement in apoE–/– mice fed 
a Western diet. Shown are the 
effects of low shear stress 
versus oscillatory shear stress 
on the expression of VCAM-1, 
ICAM-1, CRP, VEGF, and IL-6 
measured by quantitative PCR. 
Data are obtained from a pool 
of 10 animals from four 
different PCRs. * P<0.05 versus 
low shear stress.  
 
 
 
 
 
 
 
Intra-plaque hemorrhages are exclusively observed in lesions in the low shear stress 
region 
In order to obtain further evidence of plaque instability in the low shear stress region, 
the more extensive group of mice was studied after 9 weeks of cast placement. Intra-
plaque hemorrhages, an established sign of plaque vulnerability, could be observed in 
4 out of 14 animals (28%). Traces of blood plasma and (partly degraded) 
erythrocytes were found in the basal region of the plaque close to the internal elastic 
lamina or in the necrotic core, while plaque integrity was preserved (Table 1 and 
Figure 5, A and B). Intra-plaque hemorrhages were never observed in lesions of the 
oscillatory shear stress region. We tested whether an increase in blood pressure 
would give rise to an even more pronounced vulnerable plaque phenotype 16,17. To 
this end, Angiotensin II was chronically administrated to the mice via osmotic mini-
pumps (400ng/kg/min) during the last two weeks of a 9 weeks period of cast 
placement. Efficacy of the treatment was validated by a raise in mean blood pressure 
(from 95 ± 3 mmHg to 127 ± 3 mmHg; P<0.001). More extended intra-plaque 
hemorrhages were observed in atherosclerotic lesions in the low shear stress region 
with an increased frequency of 6 out of 8 animals (75%) compared to the control 
group (Table 1 and Figure 5, C, E, F). Angiotensin II stimulation did not induce intra-
plaque hemorrhages in the lesions initiated by oscillatory shear stress (Figure 5, D). 
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Deposition of iron, the product of degraded hemoglobin and suggestive for the 
presence of intramural thrombi, is detected by Prussian blue reaction (Figure 5, F). In 
several cases, atherosclerotic lesions became detached from the vascular wall, 
causing a false lumen (Figure 5, G and H). Plaque rupture or erosion could not be 
detected, even with angiotensin II stimulation. 
 
 
Figure 5: Intra-plaque 
hemorrhages in the lesions 
located in the low shear stress 
region. ApoE–/– mice were 
fed a Western diet and 
instrumented with a cast 
around the carotid artery. 
(A,B) After nine weeks, intra-
plaque hemorrhages were 
found in approximately 28% 
of the animals analyzed. 
Arrowheads point at 
accumulations of red blood 
cells near the internal elastic 
lamina (A) or in the necrotic 
core (B). (C-H) After 7 weeks 
of cast placement, the animals 
were treated with angiotensin 
II infusion (400ng/kg/min) via 
a subcutaneously implanted 
osmotic minipump (Alzet, 
model 2004, Durect Corp) and 
were sacrificed 2 weeks later. 
Intra-plaque hemorrhages were 
frequently observed (in 6 out 
of the 8 animals): (C) 
overview of an atherosclerotic 
lesion with intra-plaque 
hemorrhages in the low shear 
stress region; (D) overview of 
an atherosclerotic lesion in the 
oscillatory shear stress region. No intra-plaque hemorrhages can be detected; (E) 
detail from intra-plaque hemorrhage in the low shear stress atherosclerotic lesions; 
(F) the same detail as in (E) stained for iron deposits (arrowheads) with the Prussian 
blue reaction; (G): overview of a carotid artery with a large false lumen (FL); (H) 
detail showing the depressed lumen (arrowheads). 7 µm cryosections were stained 
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with eosin and hematoxylin. Representative pictures from 6 animals are shown. 
Original magnifications: 100 X (C, D, G); 400 X (A, B, F, G, H). Colour version of 
this figure is available in the full colour section.  
 
 
Table 1: Distribution of cast induced atherosclerotic lesions showing the occurrence 
of intra-plaque hemorrhages without and with angiotensin II stimulation. 
 
 control angiotensin II 
 
animals in group 
 
14 
 
8 
shear stress regions low oscillatory low oscillatory 
intra-plaque hemorrhages 4 0 6 0 
% of intimal area 0 0 2 0 
false lumen 5.5±3.2* 0 29.7±7.9* 0 
 
Low shear stress (LSS), oscillatory shear stress (OSS). Shown are frequency of false 
lumens and intra-plaque hemorrhages, and the mean % ± sem of the area in the 
plaque occupied by intra-laminal bleeding in the animals with intraplaque 
hemorrhages. *P<0.05 versus OSS, #P<0.05 versus control group.  
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6.6 Discussion 
 
In this study we provided evidence that variations in shear stress patterns profoundly 
affect the initiation of atherosclerosis and induces the development of atherosclerotic 
plaques with a vulnerable phenotype.  We conclude that both low and oscillatory 
shear stress are highly pro-atherogenic, because: 1) well-developed lesions are 
present from the earliest time point (week 6) in all of the cast-treated animals under 
both hemodynamic conditions; 2) lesions are absent in the straight segments of the 
contra-lateral, non-treated carotid arteries; and 3) the high shear stress area in the 
carotid arteries treated with the cast is protected from atherosclerotic lesion 
formation. In addition, low shear stress is a key factor in induction of plaques with a 
vulnerable phenotype. Damage to the endothelium due to cast placement could have 
also elicited a non-specific atherogenic response and reduce shear stress 
responsiveness. However, immuno-histological staining with PECAM-1 showed that 
the endothelium was intact in all of the examined shear stress regions after 9 weeks 
of cast placement (Figure 2B). In addition, in a previous study, the cast was used in 
mice transgenic for an endothelial nitric oxide - green fluorescent (eNOS-GFP) 
fusion gene 18. We examined the expression of eNOS, which is endothelial cell 
specific, by monitoring the GFP signal en face, and found continuity of the 
endothelium in the treated carotid arteries directly after 1 day of cast placement 8. 
Taken together, these data clearly show that the cast does not induce a non-specific 
atherogenic response by damaging the endothelium.  
No atherosclerotic lesions were present in the high shear stress regions at 6 weeks 
after cast placement. Only small sized lesions that were not significantly different in 
intima/media ratio compared with control developed at later time point in some but 
not all of the treated ApoE -/- mice. These findings are in agreement with the 
generally accepted notion that plaques do not develop in high shear stress conditions 
19-21. Upregulation in the expression of eNOS in response to the high shear stress 
stimulation could be part of the anti-atherogenic properties of high shear stress 22. 
Indeed, in previous studies we observed that eNOS levels were increased in the high 
shear stress regions of the cast treated vessels 8, suggesting that these vessel areas are 
more protected from the development of atherosclerosis 22. Placement of a non-
constrictive sham-cast made of the same material as the tapered cast (polyetherketon) 
does not induce atherosclerosis in the up and down stream regions. Thus, cast 
material or design does not cause a non-specific inflammatory response in the vessel 
wall that might lead to atherosclerotic disease.  It has been reported that placement of 
a perivascular, non-constrictive cuff can induce intima hyperplasia or atherosclerosis 
in the treated vessel area 23. This is remarkable, as in our control experiments 
placement of the non-constrictive sham-casts does not induce such a response. The 
development of atherosclerosis in these cuff models could have been elicited either 
by the material or the surgical procedure itself. More importantly, the cuffs are placed 
around the femoral arteries, which could respond differently to the placement of the 
device than the carotid arteries, used in this study. The superficial location of the 
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femoral artery, and movement of the hind limps by the animals could have limited 
the blood flow in cuffed vessels for periods of time, resulting in low shear stress and 
the induction of atherosclerosis.   
Although the relation between shear stress and atherogenesis has been well 
documented, to the best of our knowledge nothing is known about the effect of this 
hemodynamic force on the composition of the plaque. Vulnerable atherosclerotic 
lesions are characterized by high percentages of “destabilizing” components (lipids 
and macrophages), and low percentages of “stabilizing” components (vascular 
smooth muscle cells and collagen). Morphologically, the destabilizing components 
are accumulated in pools underneath a thin fibrous cap with little infiltration of 
vascular smooth muscle cells 24,25. Shear stress could determine the vulnerability of 
the lesion by altering the gene expression of the endothelial cells (e.g. upregulation of 
adhesion molecules, pro-inflammatory factors, and factors that mediate vascular wall 
permeability), and by increasing the interaction of pro-atherogenic components in the 
blood (lipoproteins and monocytes) with the activated endothelium 26-28. We 
quantified the lesion components of the different shear stress regions in order to test 
whether shear stress patterns indeed affect plaque vulnerability. Low shear stress 
lesions contained more lipids, less vascular smooth muscle cells, and less collagen 
compared with lesions in the oscillatory shear stress region. At the same time, the 
lesions present in the low shear stress region displayed lipid pools and foam cells 
underneath a thin fibrous cap containing little vascular smooth muscle cells. 
Conversely, in the lesions induced by oscillatory shear stress, a thick fibrous cap 
heavily infiltrated with vascular smooth muscle cells covers the lesion, which contain 
similar relative amounts of macrophages but less lipids than the lesions in the low 
shear stress regions. Furthermore, outward vascular remodeling, which is considered 
one of the characteristic features of vulnerable plaques 29, is more prominent in the 
low shear stress region. These findings indicate that oscillatory shear stress induces 
the growth of more stabilized plaques, whereas low shear stress initiates the 
development of lesions with a vulnerable phenotype.  
This was further substantiated by the occurrence of intra-plaque hemorrhages (both 
before and after administration of angiotensin II) in the lesions located in the low 
shear stress region. Intra-plaque hemorrhages are considered prominent markers of 
plaque instability 17,25,30,31. Without angiotensin II stimulation, the more extended 
lesions developed in the low shear stress regions showed small intra-plaque 
hemorrhages close to the internal elastic lamina in 28% of the treated animals. Those 
were never observed in the lesions located in the oscillatory shear stress region. 
Angiotensin II administration increases the mechanical strain on the lesions by 
raising blood pressure. Recently, several groups have also shown that Angiotensin II 
infusion into hyperlipidemic mice profoundly augments lesion formation independent 
from elevated blood pressure. Angiotensin II could therefore also have augmented 
the inflammatory process by increasing the Th1 response 32 or by increasing 
angiogenic properties of the plaque 33, resulting in the observed effect on the plaques 
located in the low shear stress area. However, despite the multi-potent ability of 
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angiotensin II to affect plaque vulnerability, our data clearly demonstrated that only 
the plaques triggered by low shear stress were susceptible to more severe and 
increased occurrence of intra-plaque haemorrhages in response to angiotensin II 
stimulation.  
In order to understand the mechanism by which shear stress determines lesion 
vulnerability, we hypothesized that different shear stress patterns elicit divergent pro-
atherogenic inflammatory responses in the vascular wall. It has been reported that 
VCAM-1 and ICAM-1 expression respond to low shear stress and oscillatory shear 
stress conditions in cultured endothelial cells 34-36. We could confirm these findings in 
vivo, and found that low shear stress induces higher expression levels of VCAM-1 
and ICAM-1 than oscillatory shear stress. Therefore, leukocyte recruitment is 
probably elevated in these regions. Although there was no difference found in the 
relative lesion area occupied by macrophages, the larger lesions in the low shear 
stress region contain considerably higher number of macrophages than the lesions in 
the oscillatory shear stress regions. Consequently, differences in infiltration 
efficiency of monocytes induced by low and oscillatory shear stress could result in 
the observed differences in lesion size. We also found increased expression levels of 
the atherosclerosis markers IL-6 and CRP in the lesions of the low shear stress area, 
indicating enhanced pro-atherogenic inflammatory activity 9,10. IL-6 is an important 
factor for increased plaque vulnerability, as it stimulates recruitment of macrophages 
and leukocytes, and is a crucial regulator of extracellular matrix remodeling 
(increasing activity of matrix metalloproteinases such as MMP-9). Actually, more 
MMP activity was observed in low shear stress compared to the oscillatory shear 
stress region. Macrophages have been shown to induce collagen breakdown in 
fibrous caps of human atherosclerotic plaques associated with cellular expression and 
zymographic evidence of MMP activity 37. Increased Collagen breakdown in the low 
shear stress lesions by MMP activity contributes to weakening of the fibrous cap, 
increasing its vulnerability to rupture.  
The augmented inflammatory response also causes a decline in vascular smooth 
muscle cells mainly due to inhibition of proliferation by interferon-γ (released by 
leukocytes) and increased apoptosis 25. As a result, lesions induced by low shear 
stress contained relatively less vascular smooth muscle cells than lesions induced by 
oscillatory shear stress. Thus, low shear stress appears to induce larger plaques with a 
stronger inflammatory response, giving rise to lesions with characteristics of a 
vulnerable plaque.  
 
In summary, the present study identifies shear stress patterns as an essential factor in 
atherosclerotic lesion development, size, composition and vulnerability. Future 
studies are needed to elucidate the pathways by which endothelial cells initially react 
to shear stress during the atherogenic process and will be important for our 
understanding of the development of the vulnerable plaque. With the pro-atherogenic 
shear stress fields induced by the cast, we have generated an animal model in which 
both stable and unstable lesions can be studied in one straight vessel segment. Intra-
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plaque haemorrhages have been previously observed in other atherosclerosis-prone 
mousemodels (reviewed in 38). In our model, however, intra-plaque hemorrhages 
occurred more frequently in a controlled fashion, even without additional stimuli 
such as angiotensin II. This will create opportunities to further study the molecular 
pathways involved and evaluate therapies aimed at plaque stabilization. 
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7.1 Abstract 
 
Low and oscillatory shear stress are strongly correlated to atherosclerosis. Recent 
studies also designate a significant role for chemokines in atherogenesis. No studies 
have yet been performed in which the direct effect of shear stress on chemokine 
expression during atherogenesis is investigated. We studied the time dependent 
expression of chemkines/chemokine receptors in response to these hemodynamical 
forces in ApoE -/- mice.  
Using an extravascular device, referred to as the cast, we induced regions of low, 
high, and low/oscillatory shear stress (LSS, HSS and OSS, respectively) in the 
carotid artery. We studied expression of MCP1, KC (mouse homologue of IL8), 
RANTES, eotaxin1, ELC, SDFα, NAP-2, IP10, fractalkine, and CCL14 by Q-PCR in 
the LSS and OSS vessel segments at different time points. No lesions were present 
after 1 week of shear stress modification. Shear stress alteration did induce 
expression of chemokines: Expression of IP10 was more observed in the LSS region, 
whereas MCP1 and IL8/KC were equally upregulated in both LSS and OSS regions. 
After 3 weeks, lesions start to develop in both shear stress areas, and specific 
upregulation of IL8/KC and IP10 was observed in under LSS stimulation. After 9 
weeks, lesions with a vulnerable plaque phenotype (thin fibrous cap, large necrotic 
core) were found in the LSS region, whereas stable lesions were found in the OSS 
region. Equal levels of MCP1 expression were observed in both regions, while 
expression of fractalkine was only found in the LSS region. Placement of non-
constrictive casts did not induce chemokine expression or lesion formation. 
Quantitative analysis of immunohistochemistry data confirmed these results: At 1 
week MCP1 expression was detected in VSMCs in the media, and IP10 expression in 
ECS and VSMCs. Fractalkine could be detected at 9 weeks in the media and intima 
of the LSS lesions. At 9 weeks, CCR2 (MCP1 receptor) expression was only 
observed on a few monocytes located on top of the plaque in both the LSS and the 
OSS region, indicating that recruitment of monocytes via MCP1 was limited. 
Conversely, plaques in the LSS region contained more CX3CR1 (fractalkine 
receptor) expressing cells in the intima. Blockage of fractalkine using a neutralizing 
antibody inhibited the growth and the development of vulnerable plaque in the LSS 
regions.   
We conclude that LSS or OSS triggers expression of chemokines (MCP1, IL8/KC) 
involved in atherogenesis. Increased expression of IP10 induced by LSS could be 
involved in the subsequent development of lesions with a vulnerable plaque 
phenotype. Upregulation of fractalkine during LSS induced atherogenesis is crucial 
for vulnerable plaque formation.   
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7.2 Introduction 
 
Shear stress, the drag force per unit area acting on the endothelium as a result of 
blood flow, plays a critical role in plaque initiation, location, and progression. Both 
low shear stress and oscillatory shear stress have been implied as pro-atherogenic, 
while high shear stress protects against atherosclerosis. In previous studies, we 
demonstrate that low shear stress and oscillatory shear stress are both crucial 
conditions for the induction of atherosclerosis. However, important dissimilarities in 
their atherogenic abilities are present that results in the outcome of two different 
types of plaques. Low shear stress induces the development of large-sized lesions 
with a vulnerable plaque phenotype, whereas oscillatory shear stress triggers the 
growth of more stabile lesions after 9 weeks of cast placement1.  
Several studies indicated the role of inflammatory cells in the pathogenesis of 
plaques with a vulnerable phenotype. Accumulation of inflammatory cells occurs 
through a cascade of mechanisms leading to rolling, arrest and migration. Shear 
stress plays an important role in this process: it exerts torque on the rolling cells2,3, 
and it affects the density of adhesion factors4,5. Both in low shear and oscillatory 
shear stress, torque is low and expression of adhesion factors is increased.  
Recent studies indicate that avidity and affinity of integrins plays an important role in 
the strength of receptor-ligand binding6, thereby determining the possibility of 
accumulation of the inflammatory cells. These processes are initiated and modulated 
by chemokines7,8. Chemokines are a family of small, secreted proteins consisting 
roughly of C-C and C-X-C subgroups9. As studies in humans indicate a strict spatial 
localization of the inflammatory cells in plaques10, we postulated that this could be 
due to a decisive role of chemokines in controlling this process. To the best of our 
knowledge, data depicting a role for low or oscillatory shear stress in the regulation 
of chemokines come from a limited number of in vitro studies, that point to a shear 
stress dependent expression of MCP111,12 , and IL813. The role of shear stress 
regulated chemokine expression in atherosclerosis development still needs to be 
investigated. Therefore, the first aim of the study is to characterize the chemokine 
expression pattern induced by shear stress during atherogenesis. Furthermore, as 
chemokines could modulate the development of vulnerable plaques or inhibit 
stabilization of atherosclerotic lesions, the second aim of this study was to 
characterize the chemokine expression pattern that defined vulnerable or stable 
plaque development. For both purposes, we compared the response of the 
chemokines Monocyte Chemoattractant Protein 1 (MCP1), KC (mouse homologue of 
Interleukin 8 (IL8)), RANTES, eotaxin1, EBI1-ligand chemokine (ELC), stromal 
cell-derived factor 1 (SDFα), neutrophil-activating protein 2 (NAP-2), interferon γ-
inducible protein 10 (IP10), fractalkine, and CCL14 (all known or suggested to be 
involved in atherosclerosis or to be regulated by shear stress11,13,14), on low and 
oscillatory shear stress stimuli at different time points. We analyzed two early time 
points (1 and 3 weeks after cast placement) and time point 9 weeks after cast 
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placement when the advanced lesions with the different plaque characteristics are 
present.  
 
On basis of our findings we selected several candidate genes that were tested for their 
protein levels in the plaque, confirming the findings observed in the gene-expression 
analysis. Finally, one candidate gene – fractalkine – was selected, for its arrest 
properties and chemo-attracting properties15. Fractalkine is located in the membrane 
of several cells, including the endothelial cell, making it sensitive to shear stress. In 
addition, it was exclusively expressed in the by low shear stress induced lesions with 
the vulnerable plaque phenotype. The functional implication of this protein in this 
process was studied by treatment with a fractalkine neutralizing antibody. 
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7.3 Materials and Methods 
 
Mice 
Mice deficient in apolipoprotein E (apoE-/-) expression in a C57BL/6J background 
were obtained from Jackson Laboratories. Animals 15-20 weeks of age were 
assigned randomly to one of the 3 time points (see below). During the experimental 
period, all animals were fed a Western type diet consisting of 15% (w/w) cacoa butter 
and 0.25% (w/w) cholesterol (diet W, Hope Farms, Woerden, The Netherlands). 
After a two weeks period of Western diet, shear stress in the right common carotid 
artery was altered by cast placement as previously described. Animals with casts 
implants were sacrificed at 1, 3, and 9 weeks after surgery.  
To study the effects of fractalkine blockage, ApoE-/- animals were injected in the tail 
artery three times a week with 25µg of neutralizing rabbit α-mouse fractalkine 
antibody (Ebioscience, Malden, The Netherlands) or rabbit IgG isotype control 
antibody (Ebioscience, Malden, The Netherlands). Mice received the injections after 
six weeks of cast placement up until the 9 weeks time point at which the animals 
were sacrificed. The Erasmus MC institutional review board approved all animal 
studies described in this manuscript. 
 
Gene expression analysis 
Freshly isolated vessel segments were each divided into three different regions (0.5 
mm proximal from the cast, 1 mm in the cast, and 0.5 mm distal to the cast) and 
pooled per region (n=10). Total RNA from the samples was extracted using the 
RNAeasy kit and was linearly amplified following an Eberwine T7 protocol or, when 
necessary directly reversed transcribed into cDNA. QPCR reactions were performed 
using a real-time fluorescent determination in the iCycler iQ Detection System 
(Biorad, Veenendaal, The Netherlands). Primers were designed for MCP1, KC, 
RANTES, eotaxin1, ELC, SDFα, NAP-2, IP10, Fractalkine, and CCL14. Target gene 
mRNA levels were expressed relatively to the housekeeping gene HPRT.  
 
Cholesterol analysis 
Blood samples were taken under anaesthesia by orbital puncture at the time of 
sacrifice. Total plasma cholesterol concentrations were measured enzymatically using 
a commercially available kit (Boehringer Mannheim GmbH, kit 236691).  
 
(Immuno)histological assessment  
Both the right and the left common carotid arteries were harvested after in situ 
fixation and were subsequently imbedded in cubes of liver. These cubes were 
immersed in OCT compound, and frozen in liquid nitrogen. Subsequently, 
cryosections of 6 µm were obtained from the entire right carotid artery and each 
staining was performed on sections equally spaced throughout the arteries at 120 µm 
intervals. Macrophages were detected using anti CD68 antibody (Santa Cruz 
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Biotechnology, Santa Cruz, USA), and smooth muscle cells by antibodies against 
VSMC α-actin (Sigma, Chemical Co., Zwijndrecht, The Netherlands). Lipid 
deposition was analysed with Oil-red-O staining and collagen with picrosirus red. 
Fractalkine, MCP1, IP10 (Sigma Chemical Co., Zwijndrecht, The Netherlands), and 
CX3CR1 polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, USA) and 
R594 or Fitch labeled second antibodies (Molecular Probes, Leiden, The 
Netherlands) were used for fluorescent detection by a Zeiss LSM510LNO inverted 
laser scanning confocal microscope (Carl Zeiss, Thornwood, USA). 
Haematoxylin/eosin staining was assessed by light microscopy.  
 
Analysis and statistics 
Data analysis was performed using a microscopy image analysis system (Impak C, 
Clemex vision Image analysis system; Clemex Technologies, Quebec, Canada). To 
assess intima formation in the different shear stress fields, the intima/media ratio was 
analysed on haematoxylin/eosin stained sections. The media area was defined as the 
layer between the internal and external elastic lamina. The intimal area was defined 
as the area between the endothelial lining and the internal elastic lamina. In order to 
quantify the expression of different chemokines in the vessel, the area of the entire 
arterial wall positive for the specific staining was expressed as a percentage of the 
total area enclosed by the external elastic lamina and the lumen. To assess the 
percentage of the different plaque components, the area within the intima positive for 
each staining was expressed as a percentage of the total intimal area. All cross 
sections stained were averaged per region of shear stress, i.e. low, oscillatory and 
high shear stress.  
Gene expression was calculated after normalization on the house-keeping gene 
HPRT. Statistical analysis was performed using two-way ANOVA analysis of 
variance taking time and location as independent variables. Data are presented as 
mean ± SEM. P values <0.05 were considered significant. 
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7.4 Results 
 
Extent of atherosclerosis 
Cast placement around the common carotid artery induces low shear stress upstream, 
and oscillatory shear stress downstream from the cast. To study the effects of these shear 
stress fields on atherogenesis, a time series was performed (time points 1, 3, and 9 
weeks, N = 5 mice per time point). No significant difference in intima/media ratio was 
observed between the different shear stress areas after 1 week of cast placement due to 
minimal atherogenesis (Fig. 1a,b). From 3 weeks on, intima/media ratio in the low shear 
stress region significantly increased (Fig. 1b), but the difference between oscillatory 
shear stress regions and control regions remained insignificant. Evaluation of the 
intima/media ratio at 9 weeks showed that lesions in the low shear stress area were 
larger in size compared to those in oscillatory shear stress and control regions. The 
intima/media ratio in the oscillatory shear stress region became significantly larger than 
in the control at the same time point. Furthermore, lesions that developed under low 
shear stress conditions showed a vulnerable plaque phenotype, containing large necrotic 
cores underneath a thin fibrous cap, whereas the lesions in the oscillatory shear stress 
had a more stable morphology (Fig. 1a).  
 
Gene expression of specific chemokines in shear stress induced atherosclerosis 
To investigate the effect of low shear stress and oscillatory shear stress on chemokine 
expression under pro-atherogenic conditions, we screened the linear amplified pools of 
antisense RNA from vessel segments exposed to the different shear stress conditions 
after 1, 3, and 9 weeks of cast placement in ApoE -/- mice. As indicated by the results 
described above, no plaques were observed in both shear stress regions after 1 week of 
cast placement. The results obtained from this time point will therefore show the effect 
of shear stress alteration on the vessel wall without an existing ahterosclerotic lesion. 
Furthermore, at time point 3 weeks, the effect of shear stress on the carotic artery with 
an early atherosclerotic lesion is studied. Finally, at 9 weeks after cast placment, the 
specific chemokine expression of advanced lesions is analysed. From the 10 chemokines 
assessed in this study, 4 of them (MCP1, IL8/KC, IP10, and fractalkine) were 
upregulated in response to alterations in shear stress at different time points. No shear 
stress responsive upregulation in the expression of the other chemokines (RANTES, 
eotaxin, ELC, NAP-2, SDF-α and CCL14) was observed (See online supplemented 
data, Table 1). After 1 week, quantitative RT-PCR showed an increase in expression of 
the chemokines: MCP1, and IL8/KC in the altered shear stress regions compared to 
control, and IP10 was more expressed in the low shear stress than in the oscillatory 
shear stress region (Fig. 2a). After 3 weeks of cast placement, the increased gene 
expression levels in MCP1 were maintained in both low shear stress and oscillatory 
shear stress regions, while. IL8/KC and IP10 were only upregulated in the low shear 
stress region (Fig. 2b). After 9 weeks of cast placement the expression of MCP1 and 
  
IP10 returned to baseline levels (Fig. 2c). Remarkably, upregulation of fractalkine was 
detected in the low shear stress regions at this specific time point only.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Representative hematoxylin and eosin-stained cross-sections of murine 
carotid arteries at different time points after cast placement in mice on western diet 
(20X magnification). Shown is the response of the vessel wall to oscillatory shear 
stress (OSS, lower panel), low shear stress (LSS, middle panel) versus control 
(undisturbed shear stress, upper panel) after one (right row), three (middle row), and 
nine weeks (left row) of cast placement. The arrows in the panel indicate to 
accumulation of macrophages in fatty streaks (a). Comparison of the intima/media 
ratio in the low shear stress region (white bar) with the oscillatory shear stress region 
(black bar) versus control (gray bar) at the three different time points (b). *P<0.05 
versus control. #P<0.05 versus low shear stress.   
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Figure 2:  Expression levels of 
upregulated chemokines in carotid 
arteries at different time points after 
cast placement in mice on western 
diet measured by qPCR using 
pooled amplified RNA samples (10 
animals per pool, N=3). Shown are 
the expression levels of MCP1, 
IL8/KC, IP10, and fractalkine after 
one week (a), three weeks (b), and 
nine weeks (c) of cast placement. 
*P<0.05 versus control. #P<0.05 
versus low shear stress.   
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Validation of the gene expression profile of chemokines  
To verify the results obtained from the linear amplified samples, we repeated the RT-
PCR experiments for those chemokines that were significantly upregulated with pooled 
samples of non-linear amplified cDNA. In accordance with the linear amplified data we 
measured an increased expression of fractalkine in the low shear stress region compared 
to oscillatory shear stress after 9 weeks of cast placement, whereas at earlier time points, 
no fractalkine response was observed (Fig. 3a). In contrast to fractalkine, but in 
accordance with the amplified data, MCP1 expression levels were upregulated in both 
low and oscillatory shear stress regions at most of the studied time points (Fig. 3b). As 
expected, IL8/KC expression was increased in week 1 in both the low and the 
oscillatory shear stress regions (Fig. 3c), while it was differentially upregulated in low 
shear stress regions after 3 weeks of cast placement. Finally, the low shear stress region 
showed increased expression of IP10 after 1 week of cast placement compared to 
oscillatory shear stress (Fig. 3d), and IP-10 was differentially expressed at 3 weeks of 
cast placement in the low shear stress region. In order to exclude possible non-shear 
stress related effects of the cast on chemokine expression, we performed control 
experiments with sham-casts. These were made of the same material as the real cast, but 
did not induce the alterations in shear stress due to a non-constrictive luminal geometry. 
Placement of the sham-casts failed to cause lesion formation in both the upstream or 
downstream location from the device even after 9 weeks of instrumentation. Gene 
expression analysis on cDNA obtained from both locations did not reveal upregulation 
of MCP1 or fractalkine (Fig. 3e).  
Total cholesterol levels were increased in animals on the atherogenic Western diet (1 
week  = 27.3± 2.0nM, 3 weeks = 22.4± 0.9nM, 9 weeks = 24.3± 2.4nM) compared to 
animals on chow (10.9± 3.0nM). However, total cholesterol concentrations between 
animals treated with the cast or the non-constricting sham-cast were not different (9 
weeks cast = 24.3± 2.4nM versus 9 weeks sham-cast = 25.5± 3.0nM). This indicates 
that the response in chemokine expression observed with the cast is the result of low or 
oscillatory shear stress only. 
 
Protein levels follow gene expression levels of selected chemokines. 
Next, we evaluated the protein levels of a selected group of responsive chemokines. 
We studied fractalkine, because it was the only chemokine that was specifically 
expressed in the atherosclerotic lesions with a vulnerable plaque phenotype. More 
fractalkine was detected in the low shear stress region compared to the oscillatory 
shear stress and control regions  (Fig. 4a,b, upper panel) at 9 weeks, which is the only 
time-point at which the gene was expressed. We also evaluated MCP1, as the 
relevance of this chemokine for the pathology of atherosclerosis is well-known. 
Immunohistological analysis of vessel segments at 1 week, which is the time-point 
with the highest MCP1 expression, confirmed the upregulation of MCP1 under both 
shear stress conditions  (Fig. 4a,b, middle panel). In addition, we selected one of the 
chemokines that were early upregulated during low shear stress induced 
atherosclerosis development.  Differential gene expression of IP10 between the low 
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shear stress and the oscillatory shear stress areas at 1 week, the only time-point at 
which this chemokine was significantly differentially expressed, was observed  (Fig. 
4a,b, lower panels).   
 
  
 
 
Figure 3: Validation of the expression levels of the upregulated chemokines by qPCR 
using pooled non-amplified CDNA samples (5 animals per pool, N=3). Shown are the 
expression levels of fractalkine (a), IL8/KC (b), MCP1 (C), and IP10 (d) at the three 
different time points assessed. Placement of a non-constrictive, control cast that does not 
alter the laminar shear stress, did not induce changes in gene expression. No difference 
(between control and the regions situated upstream and down stream from the control 
device) in expression of MCP1 or fractalkine was observed in the carotid arteries of 
ApoE -/- deficient mice, even after 9 weeks of cast placement and western diet (e). 
*P<0.05 versus control. #P<0.05 versus low shear stress. 
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igure 4: Validation of result of a selected group of chemokines by immuno-
he role of chemokines in advanced atherosclerotic lesions with stable and instable 
exclusively upregulated in the 
 
F
histological analysis of the protein levels in carotid arteries at different time points after 
cast placement in mice on western diet. Shown are representative cross-sections of 
murine carotid arteries stained for fractalkine after 9 weeks of cast placement (upper 
panel), and MCP1 (middle panel) and IP10 (lower panel after 1 week of cast placement, 
in the control, low and oscillatory shear stress regions (20X magnification) Chemokine 
expression is specified by a red signal. Green auto-fluorescence designates the intimal 
and medial areas (a). The results of the immuno-histological quantification of the 
chemokine signals. The percentages of fractalkine at time point 9 weeks (upper graph), 
MCP1 at time point 1 week (middle graph), and IP10 at time point 1 week (lower graph) 
in the vessel area of the low shear stress (LSS) and the oscillatory shear stress (OSS) 
regions are shown (b). N=5. *P<0.05 versus control. #P<0.05 versus low shear stress. 
Colour version of this figure is available in the full colour section. 
 
T
phenotypes: fractalkine expression and cell recruitment. 
From our findings, we concluded that fractalkine is 
atherosclerotic lesions induced by low shear stress. These lesions were identified as 
lesions with a vulnerable phenotype at the 9 weeks time point. Fractalkine is therefore 
an interesting candidate to be evaluated as a potential target for treatment of vulnerable 
  
plaques. We selected this chemokine for further studies, and assessed the effect of low 
and oscillatory shear stress on the accumulation of CX3CR1 (i.e. fractalkine receptor) 
positive cells accumulation in advanced lesions to determine its contribution on the 
pathology of vulnerable lesions. More CX3CR1 expressing cells were detected in the 
intima of lesions situated in the low shear stress region as compared to the oscillatory 
shear stress regions  (Fig. 5a,b). Further analysis identified CX3CR1/CD11b double 
positive cells with rounded monocyte-like morphology in the lesions (Fig. 6, upper 
panel). In addition, small numbers of CX3CR1/CD68 double positive macrophages 
were found with the characteristics of foam cells (Fig. 6, middle panel). Double staining 
for CX3CR1 and VSMC α-actin, did not clearly show any smooth muscle cells 
expressing the fractalkine receptor (Fig. 6. lower panel). Thus cells expressing CX3CR1 
in the vulnerable atherosclerotic lesions consist mainly of CD11b-positive monocytes 
and some CD68-positive macrophages/foam cells.  
 
  
 
igure 5: The effect of fractalkine expression on cell recruitment in the mature F
lesions. Shown are representative cross-sections of murine carotid arteries double 
stained for CX3CR1 (red signal) and nuclei (blue signal). In the upper panel, 
CX3CR1 positive cells in the low shear stress lesions (indicated by arrows) are 
shown. The lumen is indicated by an (*), and the intima contours are traced by a 
white line. In the upper panel, CX3CR1 positive cells in the oscillatory shear stress 
lesions are shown. The lumen is indicated by an (*), and the intima contours are 
traced by a white line (a). The results of the immuno-histological quantification of 
the chemokine signal. The percentages of CX3CR1 positive area at time point 9 
weeks in the intima in the low (LSS) and the oscillatory shear stress (OSS) region 
(b). N=5. #P<0.05 versus low shear stress. Colour version of this figure is available 
in the colour section.  
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igure 6: CX3CR1 expressing cells located in the advanced lesions are mainly 
onocytes and macrophages. Shown are representative cross-sections of murine 
 
 
F
m
carotid arteries double stained for CX3CR1 (middle column) and CD11b, CD68, and 
VSMC α-actin (left column, from upper to lower panels), respectively. In the third 
column, the (yellow) co-localization signal is shown. The lumen is indicated by a (*) 
and the intima contours are traced by a white line. Colour version of this figure is 
available in the full colour version.   
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he role of fractalkine in shear stress induced atherosclerosis: blocking study 
ext, we studied the possible effect of fractalkine blockage on plaque composition and 
ulnerability. Macroscopic and microscopic analysis of hematoxin-eosin-stained 
ctions of liver, lung, spleen and draining lymphnodes of the carotid artery did not 
reveal any abnormalities in animals treated with the rabbit polyclonal IgG neutralizing 
antibody against fractalkine in the fractalkine group or the rabbit polyclonal IgG control 
antibody in the control group. Furthermore, FACS analysis on spleen-derived and 
peripheral blood leukocytes showed no differences in the numbers of CD3+ cells or in 
the CD4+/CD8+ cell ratios between the two groups (data not shown). Animals in the 
fractalkine group showed a 50% reduction of plaque area in low shear stress regions 
(Fig. 7a), i.e. in the regions with a differential upregulation of fractalkine. Analysis of 
plaque composition showed roughly a doubling in collagen content in both the low and 
oscillatory shear stress regions in response to fractalkine blockage (Fig. 7b), which was 
only partly related to increments in vascular smooth muscle cells content, as VSMC 
content did not increase in the oscillatory regions of the fractalkine group  (Fig. 7c). 
Further analysis revealed that the fractalkine-neutralizing antibody approximately 
halved CD68 positive macrophage content and lipid accumulation in the vulnerable 
plaques compared with the control group (fig. 7d). However, in the oscillatory shear 
stress regions, no differences between the fractalkine and the control group were 
observed  (fig. 7e).  Both shear stress regions showed no effect on the CX3CR1 positive 
area in response to fractalkine antibody treatment, although a trend toward increase was 
observed in the instable lesions of the low shear stress region (Fig. 7f).  
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Figure 7: Fractalkine function was inhibited during cast-induced atherogenesis in 
ApoE KO mice by administration of a neutralizing antibody from week 6 till week 9. 
In the left column, Representative cross-sections are shown. These are stained for: 
(2a) lesion morphology by H/E, (2b) macrophages, (2c) lipids, (2d) VSMCs, (2e) 
collagen, and (2f) fractalkine receptor (CX3CR1). The lumen is indicated by a (*) 
and the intima contours are traced by a white line. In the right column, the lesion area 
is shown in the first graph, followed by results of the (immuno-) histological 
quantification of the different plaque components. The percentages of positive area at 
time point 9 weeks in the intima in the low (LSS) and the oscillatory shear stress 
(OSS) region are indicated, comparing the control antibody group (A) with the a-
fractalkine antibody group (B). N=8. *P<0.05 versus control antibody group. Colour 
version of this figure is available in the full colour section.   
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7.5 Discussion 
 
The high mortality accompanying atherosclerosis has been associated with rupture of 
vulnerable plaques. The morphology of vulnerable plaques consists of characteristic 
triage: large lipid core, think fibrous can and a large inflammatory component. The 
inflammatory component has been shown to be prominent in plaques with a 
vulnerable phenotype. Uptake and migration of inflammatory cells have been 
examined extensively and a cascade model has been emerged from these studies. 
This model describes rolling, arrest and migration as a sequential process17. Arrest of 
inflammatory cells on the endothelial layer is due to a force balance, where a balance 
exist between shear stress induced disruptive torque and the formation of adhesive 
bonds2,3. Shear stress has been shown to affect essential steps in this cascade model. 
Low shear stress enhances the expression of some of the selectins and integrins18,19, 
thereby increasing their density on the endothelial layer. It also lowers the torque, 
favouring binding of blood cells to the endothelium. Furthermore, recent studies 
indicate that clustering and the activity of integrins affects the strength of these 
bonds, and that chemokines actively regulate these processes. Their role in shear 
stress induced plaque formation is presently unknown. In order to study their role in 
 atherogenesis, and may 
ot play an important role in vulnerable plaque formation. Other mechanisms must be 
involved to affect the types of plaque that develop under these shear stress 
conditions.  
Two genes (IP10 and IL8/KC) were indicated as differentially upregulated in the 
early phase of vulnerable plaque formation. IP10 is a chemoattractant for 
monocytes20 and T-lymphocytes21 and is induced by production of interferon-γ (IFN-
γ). Only a small number of studies have yet identified this chemokine to play a role in 
vascular disease. However, as IFN-γ has been associated with vulnerable plaque 
formation, this chemokine may be of importance for this disease. Indeed, increased 
serum levels of IP10 have been associated to coronary artery disease in patients 22.  
IL8/KC and its receptor CXCR2 are involved in the accumulation of neutrophils and 
macrophages during atherogenesis, and high expression of CXCR2 by macrophages 
the formation of vulnerable plaque, we performed a literature based screening of 10 
chemokines by applying qPCR. Interestingly, 4 of the selected genes: MCP1, 
IL8/KC, IP10 and fractalkine were upregulated, and these were further studied.   
MCP1 has been shown to be present in human atherosclerotic lesions and in plaques 
induced in animal models. It is involved in monocyte/macrophage recruitment and 
knock out studies indicate an important role in atherogenesis. MCP1, in the present 
conditions, does not differ in expression levels between low and oscillatory shear 
stress stimulus. These findings are in accordance with cell culture studies showing a 
role for both low and oscillatory shear stress in MCP1 production by endothelial 
cells. This lack in differential expression and the decline in MCP1 expression after 
the first week of shear stress stimulation, may imply that the MCP1/CCR2 (MCP1 
receptor) interaction is predominantly important during early
n
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nced lesions of patients and LDL receptor deficient mice23. In 
findings, we found increased expression of CXCR2 in the 
ated 
is detected in adva
greement with these a
mature lesions after 9 weeks of cast placement (data not shown). However, increased 
IL8/KC expression was only detected at the earlier time points. This implies that 
IL8/KC/CXCR2 interaction is mainly involved during the early events of 
atherogenesis. In mice, macrophage inflammatory protein 2 (MIP-2) and granulocyte 
chemotactic protein 2 (GCP-2) can also bind to the CXCR2 receptor24, and these 
chemokines could have effected CXCR2 expression in the mature lesions, either by 
increasing the influx of CXCR2 expressing blood cells (neutrophils and macrophages 
for GCP-2 and MIP-2 respectively), or by inducing the expression of this chemokine 
receptor in the cells which are already situated in the intima.  
 
From the upregulated chemokines, fractalkine is the only one that is exclusively 
expressed in the low shear stress induced vulnerable plaque. Fractalkine is a unique 
chemokine that not only acts as a chemoattractant, but also as an adhesion molecule 
expressed on endothelial cells upon stimulation25. The fractalkine receptor CX3CR1 
is expressed on lymphocytes, macrophages, VSMCs26 and ECs its expression is 
regulated by IFN-γ27,28. Functional studies with knock out mice indicate that 
CX3CR1 or fractalkine deficiency results in decreased atherosclerotic lesion growth, 
associated with a reduction in the accumulation of macrophages and foam cells29,15,30.  
In the present study, we observed more CX3CR1 positive cells in the plaques loc
in the low shear stress region compared to oscillatory shear stress plaques, suggesting 
that there is an effect of fractalkine expression on cell recruitment. Subsequent 
analysis of CX3CR1 positive cells identified predominantly monocytes and 
macrophages, and few VSMCs co-localizing with the fractalkine receptor. These 
findings were consistent with our functional studies where we blocked 
fractalkine/CX3CR1 interaction by administrating a fractalkine-neutralizing 
antibody. Inhibition of fractalkine function decreased plaque growth, and prevented 
the development of plaque with a vulnerable phenotype within the low shear stress 
region. The exact mechanism is presently unknown, but the reduced accumulation of 
lipids and macrophages, indicate a reduction in the number of foam cells. In addition, 
the lesions contained increased amounts of extracellular matrix (collagen) and 
VSMCs, thereby increasing collagen synthesis. Importantly, inhibition of 
fractalkine/CX3CR1 interaction had only limited effect on the by oscillatory shear 
stress induced stable lesions. This might indicate a role for shear stress in the 
fractalkine-mediated effects. However, as the by fractalkine induced effects were 
only observed after 9 weeks of cast placement, other factors maybe involved. For 
instance, inward vascular remodeling might have increased shear stress locally, or 
inflammatory mediators released from within the vessel wall during low shear stress 
induced atherogenesis (e.g. IFN-γ) might be responsible in upregulation of this 
chemokine. In spite of this, expression of fractalkine remains a distinctive (indirect) 
effect of low shear stress, and the findings presented in this (blocking) study are 
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Fractalkine 
etermines plaque vulnerability, as blockage of fractalkine/CX3CR1 interaction in 
important, for they clearly show the critical role of fractakine in the development of 
vulnerable plaque.  
 
In conclusion, different shear stress fields have yielded different responses in 
chemokine expression. Low shear stress induces the development of lesions with a 
vulnerable plaque phenotype, characterized by increased expression of multiple 
chemokines  (KC/IL8, and IP10) that may result in a more efficient recruitment of 
monocytes compared to the oscillatory shear stress induced lesions. This 
subsequently leads to the development of remarkably larger atherosclerotic lesions, 
with a more severe inflammatory response, resulting in the vulnerable plaque 
phenotype1 with the observed characteristic fractalkine expression. 
d
advanced lesions prevents the development of the vulnerable plaque phenotype. 
Stabilization of vulnerable plaques in patients by inhibiting fractalkine-fractalkine 
receptor interaction might provide an effective therapy, thereby preventing future 
acute coronary events as a result of sudden plaque rupture.  
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Data obtained by qPCR 
sing pooled amplified RNA samples. (10 animals per pool, N=3). *P<0.05 versus 
us low shear stress. 
Table S1: Expression levels of chemokines in carotid arteries at different time points 
after cast placement in mice on western diet.  
Shown are the expression levels of RANTES, eotaxin, ELC, NAP-2, SDF-α, and 
CL14 after one, three, and nine weeks of cast placement. C
u
control. #P<0.05 vers
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8.1 Summary 
 
Studies in the hemodynamic field point to a strong relation between shear stress and 
the onset to vascular diseases such as atherosclerosis. Data from in vitro studies using 
sheared endothelial cells have provided insight into the possible mechanisms 
involved. However, the lack of an appropriate in vivo model to introduce pro-
atherogenic shear stress parameters has hampered investigation of the effects of this 
hemodynamic force on the vessel wall. In this thesis, we developed and validated a 
new shear stess model to be applied in vivo. We studied the effects of low, high and 
oscillatory shear stress on the pathology of atherosclerosis. 
 
The Cast model 
In chapter 1, a new method to study shear stress in vivo is introduced. We have 
developed a device (the cast), which is a cylinder with a cone shaped lumen made of 
the thermoplastic polyetherketon. Placement of the cast around the straight vessel 
segment of the common carotid artery of a mouse alters the normal laminar flow, 
creating controlled deviations in shear stress. Upstream from the cast, a region of low 
shear stress is created. In the vessel segment situated inside the cast, the tapered 
geometry creates a region with gradually increasing shear stress. Downstream from 
the cast, the stenosis created by the device induces oscillatory shear stress. With this 
unique model, we are able to look at the full response of the vessel wall to shear 
stress, complete with its (indirect) effects on the intima and the immune response. In 
addition, three significant shear stress fields (low shear stress, high shear stress and 
oscillatory shear stress) are examined in this causal system.  
 
The effect of shear stress on eNOS expression  
In the first study, we implanted the cast around the carotid artery of wild type 
(C57BL/6) and transgenic mice. The physiological effects of our method were 
successfully validated by Doppler echography. In order to evaluate if the method also 
triggers a biological response, we decided to study eNOS, which is a shear stress 
responsive gene that is known to be involved in cardiovascular disease 1,2. We 
showed in vivo that the response in expression of eNOS to shear stress is dose-
dependent using an in-house developed transgenic mouse (chapter 3). In this mouse 
model, human eNOS expression and distribution can be easily monitored by virtue of 
a fusion of eNOS with green fluorescent protein (GFP). The fusion protein is driven 
by the human eNOS promoter, which is known from in vitro studies to be shear stress 
responsive (chapter 2). Regulation of eNOS protein levels and activity is very 
complex and occurs both at transcriptional and post-transcriptional levels. Post-
translational modification of eNOS by myristoylation and palmitoylation that targets 
the protein to the Golgi complex and the lipid rich domains of the cell membrane are 
both necessary for proper eNOS activation 3. Shear stress activates eNOS 
predominantly through Akt dependent phosphorylation of eNOS at serine1177 4. 
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Recently, it has been shown that the fraction of eNOS localized in the Golgi complex 
is responsive to phosphorylation by Akt 3. This implies that shear stress activates 
eNOS when it is located in certain compartments of the endothelial cells. The effects 
of shear stress on the phosphorylation and the intracellular localization of eNOS in 
vivo are not known. We therefore analysed the phosphorylated state and intracellular 
distribution of eNOS to the Golgi compartment and the cell membrane in vessel 
regions exposed to the three different shear stress fields. Under high shear stress 
conditions, more eNOS protein (in absolute values) are located in the Golgi complex 
and the cell membrane, and the Golgi complex itself has become extended, probably 
in order to accommodate/process more proteins as the endothelial cells become more 
activated. Phosphorylation of eNOS has also increased after high shear stress 
stimulation. These results indicate that high shear stress is atheroprotective as it 
increases eNOS expression. The extra amount of eNOS protein is located in the 
correct cellular compartments where it can be phosphorylated and activated to 
produce NO. Remarkably, eNOS expression and phosphorylation is also increased 
under oscillatory shear stress conditions, pointing towards some degree of protection 
against vascular disease. Conversely, the vessel segments exposed to low shear stress 
show a significant reduction in eNOS expression and therefore are less protected 
against the onset of atherosclerosis. Measurements of the mRNA levels of the human 
eNOS trangene, the endogenous mouse eNOS and of a number of shear stress 
responsive genes (identified in in vitro studies 5-7, clearly indicate that the cellular 
response to the alterations in shear stress induced by the cast, is not limited to the 
eNOS transgene (chapter 4). In addition, we show with the placement of a non-
constrictive cast (also made of polyetherketon), that the surgical procedure or the 
material of the device does not induce the observed biological response of the 
vascular wall. Taking together the evidence obtained from this study, we conclude 
that our new cast model is a suitable model to investigate shear stress responses in 
vivo.  
In a follow-up study, we used the same experimental setup to study the effects of 
rapamycin on the shear stress responsiveness of the eNOS gene. Rapamycin is a 
well-known pharmaceutical compound that is frequently used in the clinic in coated 
stents. It prevents cell-cycle progression, and has anti-atherogenic and 
immunosuppressive properties. Recent publications suggest that rapamycin affects 
the shear stress responsiveness of the vessel wall . We show that oral administration 
of rapamycin increases the expression of eNOS in the low shear stress regions while 
in the high shear stress regions the maximal eNOS response is decreased (chapter 5). 
These results imply that rapamycin is mainly athero-protective in the low shear stress 
regions of the arterial system.   
 
The effect of shear stress on atherosclerosis 
Evidence for a relation between athersclerosis and shear stress is mainly deducted 
from observational studies where certain shear stress fields are correlated to the 
location of atherosclerotic lesions 8,9. Additional evidence that also provides insight 
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into the possible mechanisms, come from experiments in which different cellular 
components of the plaque are tested on their shear stress response in vitro (reviewed 
in 10). As the endothelium is directly exposed to the blood flow and should therefore 
be highly adapted to sense and react to shear stress, the most studied cell type is the 
endothelial cell. The many factors produced by endothelial cells in response to shear 
stress may be grouped into functional classes including vasoactive compounds (e.g. 
endothelin 1 (ET1), eNOS, and angiotensin converting enzyme (ACE)), growth 
factors (e.g. Platelet derived growth factors (PDGFs)), adhesion molecules and pro-
inflammatory factors (e.g.VCAM1, ICAM1, E-selectin, MCP1 and PECAM1), 
coagulation/fibrinolysis/complement factors (e.g. tissue factor), and extracellular 
matrix (ECM) modifying factors (e.g. matrix metalloproteinase 2 and 9). 
Summarizing these findings and translating them into a vascular response, we can 
assume that low shear stress and oscillatory shear stress prime the endothelium to the 
development of atherosclerosis. We tested the pro-atherogenic properties of low and 
oscillatory shear stress directly in ApoE deficient mice on high cholesterol, high fat 
diet (Western diet). Low shear stress and oscillatory shear stress are indeed 
atherogenic. Six weeks after cast placement, plaques develop in both the low and 
oscillatory shear stress regions, whereas the high shear stress area remains protected 
from atherosclerosis. Further study at later time points reveals a remarkable 
morphological difference between the lesions developed under low shear stress and 
oscillatory shear stress. Nine weeks after cast placement atherosclerotic lesions 
induced under low shear stress conditions are more extensive than plaques developed 
under oscillatory shear stress. In addition, the plaque composition is very different. 
The atherosclerotic lesions that developed under a low shear stress stimulus contain 
less plaque stabilizing components, such as collagen fibers and VSMCs, and more 
plaque destabilizing components such as lipids than plaques from the oscillatory 
shear stress region. We also observed more outward remodeling, neo-vascularization 
and increased metallo proteinase activity in the low shear stress lesions. These 
findings suggest that these atherosclerotic lesions have a vulnerable plaque 
phenotype. High risk/vulnerable atherosclerotic lesions are strongly associated to 
thrombosis and the onset of acute coronary syndromes in patients. Several forms of 
plaques have currently been identified as vulnerable lesions: eroded plaques, 
inflamed thin cap atheromas (TCFA), and calcified plaques 11,12. The plaques induced 
by the low shear stress stimulus in our cast model highly resemble the TCFA in 
morphology. The TCFA is described in the literature as a plaque with a thin fibrous 
cap containing only one or two layers of VSMCs covering a lipid-rich, necrotic core. 
The cap and shoulders of the plaque are heavily infiltrated with blood cells (mainly 
monocytes and macrophages). The plaques in the low shear stress region have indeed 
a thin fibrous cap with one to three layers VSMCs covering large lipid-rich, necrotic 
cores. In the shoulder areas of the plaque, accumulations of inflammatory cells are 
often observed. Conversely, lesions in the oscillatory shear stress region show a more 
homogenous distribution of VSMCs and collagen, resulting in an extensive cap, and 
contain only small lipid pools with little to no necrosis. More compelling evidence is 
  
 161
the exclusive occurrence of intra plaque-hemorrhages (IPH) in plaques of the low 
shear stress regions in 14% of all treated animals. Remnants of blood plasma and 
erythrocytes are found, mainly in the upstream area of the plaque, close to the 
internal elastic lamina. The frequency and the severity of these IPHs increase to 75% 
if angiotensin II is administered to the animals. Taking together the results from 
chapter 6, we conclude that low shear stress and oscillatory shear stress are both 
crucial conditions for the development of atherosclerosis. Low shear stress triggers 
the growth of more extensive and more instable lesions than oscillatory shear stress, 
with the characteristics of a vulnerable plaque.  
 
The effect of shear stress on inflammation 
Shear stress plays an important role in regulating the inflammatory processes that 
initiate and enhance the growth of the atherosclerotic lesions. Studies have also 
indicated that shear stress regulates the expression of chemokines 13-15. Chemokines 
are an extensive family of small peptides that are potent activators and 
chemoattractants for leukocyte subpopulations and some non-haemotopoietic cells. 
They function by binding to G-protein coupled chemokine receptors that results in 
the initiation of different signaling cascades. In vivo and in vitro studies showed that 
chemokines are produced by a variety of cells and play important roles in the 
development and progression of many physiological and pathological conditions 
including atherosclerosis 16,17. Although expression of adhesion molecules is crucial 
for the adhesion and migration of leucocytes into the inflamed vessel wall, 
chemokine expression is important as well because it determines the specificity of the 
immune response by selecting which type of blood cells are drawn into action. In our 
cast model, we studied the expression of chemokines in response to shear stress 
alterations during the early phase of atherosclerosis development, and compared that 
to their responses in mature atherosclerotic lesions. Ten candidate genes were 
selected from the literature on basis of identified shear stress responsiveness or 
association with atherosclerosis. They were studied in ApoE deficient mice after one 
(no detectable atherosclerosis present, endothelium consists of monolayer of rounded 
cells with decreased eNOS production in the low shear stress region, pointing 
towards endothelial dysfunction), three (onset of the formation of fatty streaks in both 
low and oscillatory shear stress regions), and nine weeks (advanced atherosclerotic 
lesions in both low and oscillatory shear stress regions) of cast placement. Our data 
showed the early upregulation of both MCP1 and IL8 in response to shear stress. 
MCP-1 plays a role in the recruitment of monocytes to sites of injury and infection. 
Mice genetically deficient for MCP-1 or its receptor, CCR2, are protected from 
vascular lesions in several atherosclerosis models 18,19. In our model both low shear 
stress and oscillatory shear stress were capable in eliciting a strong response of 
MCP1 in the first week that declined at the later time points, suggesting that MCP1 
mainly plays a role in recruiting monocytes in the early phase of plaque initiation. In 
the previous study, gene expression analysis of pro-inflammatory mediators has 
suggested that the difference in plaque phenotype results from an augmented 
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inflammatory response to low shear stress compared to oscillatory shear stress stimuli 
(chapter 6). In this study, we found that differential expression levels of interferonγ-
inducible protein (IP10) and fractalkine characterized the development of vulnerable 
atherosclerotic lesions. IP10 expression was only induced in the low shear stress 
regions in the early time points, whereas fractalkine was not expressed till 9 weeks 
after cast placement, in the vulnerable plaques of the low shear stress region 
exclusively. Further study indicates that fractalkine receptor (CX3CR1) expressing 
cells are present in high numbers in the vulnerable lesions. Blockage of fractalkine 
using a neutralizing antibody reduces the growth of the by low shear stress induced 
vulnerable plaque and stabilizes these type of lesions. Because of their association to 
plaque instability, we identify IP10 and fractalkine as interesting candidates for more 
extensive studies to elicit their function in the pathology of the disease (chapter 7).  
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8.2 General discussion and future perspectives 
 
The use of the new cast model enables us to study the direct effects of low, high and 
oscillatory shear stress on the vessel wall in mice. Low shear stress diminishes eNOS 
expression, whereas high and oscillatory shear stress increase basal eNOS expression 
levels. In ApoE-/- mice fed a high fat, high cholesterol diet, both low shear stress and 
oscillatory shear stress can trigger an inflammatory response by increasing the 
expression of the chemokines IL8 and MCP1, initiating the development of 
atherosclerosis. Low shear stress triggers an augmented inflammatory response 
compared to oscillatory shear stress, characterized by early upregulation of IP10, late 
upregulation of fractalkine, and the development of extensive atherosclerotic lesions 
with a vulnerable plaque phenotype. Oscillatory shear stress stimulates the growth of 
smaller plaques with a stable phenotype.  
The remarkable observation that different shear stress fields trigger different types of 
plaques may be partially explained by the differential expression of the chemokines 
IP10 and fractalkine. IP10 is a chemoattractant for monocytes and lymphocytes, and 
promotes T-cell adhesion to endothelial cells. Only a small number of studies have 
yet identified this chemokine to be associated to vascular disease. Fractalkine is a 
unique chemokine that functions not only as a chemoattractant but also as an 
adhesion molecule and is expressed on endothelial cells activated by pro 
inflammatory cytokines, such as interferon-γ and tumor necrosis factor-α. The 
fractalkine receptor, CX3CR1, is expressed on lymphocytes and on macrophages. 
Soluble fractalkine causes migration of natural killer (NK) cells, cytotoxic T-
lymphocytes, and macrophages, whereas the membrane-bound form captures and 
enhances the subsequent migration of these cells in response to secondary stimulation 
with other chemokines. High levels of fractalkine mRNA expression have been 
observed in some, but not all, human arteries with advanced atherosclerotic lesions. 
Combadiere et al. have reported that fractalkine expression is upregulated in 
atherosclerotic lesions of ApoE deficient mice. In addition ApoE combined with 
CX3CR1 deficiency results in decreased atherosclerotic lesion formation with 
reduced macrophage accumulation compared to ApoE-/- mice without the extra 
deficiency. Furthermore, gene polymorphisms at amino acids 249 and 280 of human 
CX3CR1 are a known genetic risk factor for coronary artery disease. CX3CR1-
V249I/T280M heterozygosity is associated with a reduced risk of acute coronary 
events. This protective effect might be explained by the decreased ability of 
monocytes to adhere to vascular endothelium. Another intriguing aspect of this 
chemokine is that it is related to chemotaxis of certain sub-populations of monocytes 
with specific functions. It was demonstrated that fractalkine preferentially mediates 
arrest and migration of CD16 (+) monocytes. These cells produce high levels of 
proinflammatory cytokines and may represent dendritic cell precursors in vivo. The 
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CX3CR1-fractalkine pathway could therefore be one of the main recruitment 
strategies of dendritic cells into the intima during a strong inflammatory response. In 
contrast, MCP-1 was shown to be a potent chemokine for CD16 (–) but not CD16 (+) 
monocytes. Dendritic cells have been recently identified in vulnerable lesions in 
patients, where they might contribute to plaque destabilization through activation of 
T-cells. In a recent screening experiment conducted on our model, we detected higher 
numbers of CD11 (+) (dendritic cell marker) cells in the instable atherosclerotic 
lesions located in the low shear stress area (preliminary results not shown). Further 
investigation to identify which type of cells are drawn into the lesion by the IP10 and 
the fractalkine pathway, will help to elucidate the difference in pro-atherogenic 
effects of the low shear stress and oscillatory shear stress. 
The observed difference in eNOS response elicited by alterations in shear stress 
could be a major   factor in the development of more stabilized lesions in the 
oscillatory shear stress field. Increased availability of NO by upregulation of the 
eNOS protein protects the vessel wall from inflammation by inhibiting platelet and 
inflammatory cell adhesion and activation. In addition, high concentrations of NO 
trigger apoptosis resulting in shutdown of the secretory pathways of pro-
inflammatory cells, followed by cell death and non-inflammatory clearance by 
macrophages. Therefore, the increased NO production in the oscillatory shear stress 
area may provide an effective mechanism to remove harmful inflammatory blood 
cells from the intima, resulting in the development of small (less recruitment of 
monocytes means less growth) and stable (less inflammation, due to clearance of 
inflammatory cells) lesions observed with our cast model. Indeed, previous findings 
from our group indicate that increased eNOS expression in transgenic mice protects 
against atherosclerosis 20. Conversely, the decrease in eNOS expression in the low 
shear stress area translates into a loss of this protection system. Additional studies in 
which NO production is actively inhibited (e.g. by using the non-specific NOS 
inhibitor L-NAME for the whole period of cast-induced atherosclerosis development) 
should abolish this protection mechanism, resulting in a destabilization of the lesions 
developing under oscillatory shear stress condition, providing evidence for this 
hypothesis. However, ENOS in atherosclerosis is uncoupled and produces 
peroxynitrite, which is harmful. It might therefore be that high eNOS expression is 
harmful in atherosclerosis (reviewed in 21).  
 
Placement of the cast around the carotid artery of ApoE deficient mice results in 
vulnerable plaque upstream and a stable plaque downstream from the device. This 
finding has two important aspects: 1) the vessel wall responds differently to different 
shear stress fields; and 2) it also provides a potential model for studying plaque 
vulnerability. The mechanisms that affect lesion stability and induce the growth 
towards a vulnerable lesion are still unclear. The progress is hampered by a lack of an 
adequate and reproducible animal model for vulnerable plaque. Comparisons of the 
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atherosclerotic lesions of ApoE deficient mice with human plaques show striking 
similarities. The mouse atherosclerotic lesions can contain large lipid cores, intra 
plaque haemorrhages, and thin fibrous caps that are capable of rupture. In addition, 
buried caps representing healed ruptures, have also been identified in mouse 
atherosclerotic lesions. However, these types of lesions resembling thin cap fibrous 
atheromas are rare in the aortic root and the thoracic aorta and have been mainly 
found in aged animals (older than 42 weeks), resulting in long and elaborate 
experiments. In literature, only a handful of additional murine models have been 
described that could be used for vulnerable plaque studies. Most of them are using 
ApoE deficient mice, crossed with a mouse line with a deficiency in an additional 
gene (e.g. SRB1) or overexpressing an atherogenic transgene (e.g. p53 22). These 
mouse models also provide reproducible methods to induce vulnerable lesions in a 
short period of time. However, compared to our cast model only one of these 
systems, the ApoE deficient/p53 transgenic mice, show frequent intraplaque 
haemorrhages. A drawback in these models is that they limit the scientist to study the 
mechanisms of the one gene that is altered, because the effects of a third genetic 
modification might be influenced by the overexpression or deficiency of the second 
gene. An efficient and reproducible murine model that does not require a second gene 
modification, has been described by Johnson et al 23. His group studied the 
brachiocephalic artery in young ApoE deficient mice, and showed plaque rupture 
(defined as a visible breach in the cap with intra plaque haemorrhages intruding) in 
68% of animals after 8 weeks of feeding a Western diet. Particularly noteworthy of 
this study is that it clearly shows that a murine model can be used to test the effect of 
pharmaceutical compounds on plaque rupture, as treatment with Pravastatin reduced 
incidents of acute plaque rupture to 36% in the brachiocephalic artery.  
The cast model provides a highly reproducible method to induce vulnerable lesions 
within a short period of time (9 weeks). In addition, stable lesions develop 
downstream from the cast in the same vessel segment that can be used for 
comparison. Shear stress alteration is the only stimulus needed for these plaques to 
develop, and no additional expression of a pro-atherogenic transgene, or extra gene 
deficiency except for ApoE is required. The cast can therefore be implanted in any 
ApoE deficient line carrying a second deficiency or transgene of interest, thus 
providing a wide research potential, making this murine model suitable for basic and 
intervention studies. 
 
In recent years, the rapid development of microarray technology has enabled 
scientists to study gene expression profiles in complex disease systems in high 
throughput. In relation to shear stress, most of these high throughput gene expression 
studies have been performed using HAECs or HUVECs. As indicated earlier in the 
introduction, although these studies are technically easy to perform, results obtained 
from cultured endothelial cells may not accurately reflect the molecular events that 
take place in the vessel wall. A more desirerable approach is the use the endothelium 
located at the areas exposed to variations in shear stress. However, these populations 
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of endothelial cells located at these specified predilection sites may have adapted 
early in development to the remarkable shear stress conditions dominating in these 
areas, resulting in a decrease of their shear stress response. Differential gene 
expression patterns identified by comparing these cells to cells located in areas of the 
arterial system with laminar flow conditions will highlight the genes that account for 
these cells’ adaptation system. However, it will possibly conceal the genes 
responsible for the pathological events in the onset of vascular disease, as the 
endothelium would have already counteracted their expression. The cast model 
provides cause-effect studies from which shear stress alteration results in 
atherosclerosis. The effect of shear stress alteration on endothelial cells, which have 
been previously exposed to laminar shear stress, results in a gene expression profile 
that is directly related to early atherogenic events. A carefully prepared study in 
which only RNA material isolated from the treated endothelium is used for 
microarray analysis would provide a useful gene-profile of the endothelial shear 
stress response in the vessel wall. In addition, since we have also shown in the cast 
model that the different shear stress regions introduce different types of plaques, we 
could study the gene expression patterns that characterize the onset to vulnerable 
atherosclerotic lesions using the same technology.    
 
Finally, the interpretation of the observed effects of shear stress on atherosclerosis in 
an in vivo situation remains, even with the use of our validated cast model, difficult. 
Although the placement of the cast creates well-controlled shear stress fields, 
continuous plaque growth will eventually alter the original shear stress conditions. 
For example, extensive plaques creating more than 50% stenosis might have a similar 
effect on the blood flow as the cast (depending on the angle at which the flow is 
separated) and create oscillatory shear stress in the downstream shoulder area. In the 
upstream shoulder of the plaque, shear stress levels are gradually increased 
depending on the size of the stenosis downstream. Currently, a protocol is developed 
in order to study blood flow in the mice during atherogenesis using micro CT 
(computer tomography). This provides the 3D in vivo dimensions needed to 
reconstruct the vessel in order to calculate the different shear stress fields. A better 
understanding of how the shear stress is altered during atherogenesis in our cast 
model will improve our understanding of the acquired data for future atherosclerosis 
studies. 
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Nederlandse samenvatting (Summary in Dutch)  
 
Atherosclerose is de belangrijkste doodsoorzaak in de westerse wereld. 
Atherosclerotische laesies ontwikkelen zich op specifieke plaatsen in slagaders, te 
weten in binnenbochten en aftakkingen. Dit wordt geassocieerd met veranderingen in 
het bloedstroomprofiel. “Shear stress” of afschuifspanning is de hemodynamische 
kracht die door de bloedstroom wordt uitgeoefend op het  
“endotheel”, de cellaag waarmee bloedvaten aan de binnenzijde zijn bekleed. In een 
recht stuk vat met een normaal laminair stromingsprofiel, wordt de shear stress actief 
gereguleerd en op een ingestelde waarde gehouden. Een verlaging in die shear stress 
waarde (lage shear stress) wordt in verband gebracht met het ontstaan van 
atherosclerose. Tevens wordt oscillatie in shear stress (oscillatoire shear stress), 
waarbij het endotheel een tijdelijke terugstroming ondervindt gedurende de hart 
cyclus,  geassocieerd met atherosclerose. Onderzoek naar het effect van shear stress 
op gekweekte endotheelcellen heeft laten zien dat beide hemodynamische condities 
(dus zowel lage als oscillatoire shear stress) expressie van genen kan activeren die 
atherosclerose bevorderen. Ondanks deze waarnemingen is er nog weinig bekend van 
het onderliggende mechanisme van het door shear stress geïnduceerde 
atherosclerotische proces. Dit komt ten dele omdat er geen goed proefdiermodel 
bestaat, waardoor er slechts weinig in vivo studies zijn gedaan. In dit project 
bestuderen we de effecten van shear stress op de vaatwand die de ontwikkeling van 
atherosclerose beïnvloeden. Hierbij maken we gebruik van een door ons zelf 
ontwikkeld kunststof implantaat (hier cast genoemd), dat een cilinder is met een taps 
toelopende binnenzijde. Deze kan om het rechte deel van de arteria carotis communis 
(a.carotis, halsslagader) van het proefdier worden aangebracht en induceert dan 
veranderingen in het normaal laminaire stromingsprofiel, waardoor gecontroleerde 
veranderingen in het shear stress profiel ontstaan. In de richting van de bloedstroom 
ontstaat er voor de cast een verlaging van shear stress. In het deel van het bloedvat 
dat zich in de cast bevindt, wordt door de tapse vormgeving van de cast de shear 
stress geleidelijk verhoogd. Na de cast ontstaat door de versmalde uitstroomopening 
van de cast een gebied van oscillatoire shear stress (Hoofdstuk 1). Door gebruik te 
maken van dit unieke model, hebben we de volgende in vivo effecten van shear stress 
bestudeerd:  
 
Het effect van shear stress op genexpressie: De cast werd geïmplanteerd rondom de 
a. carotis van wildtype en transgene muizen. We konden aantonen door middel van 
bloedstroommetingen met Doppler echografie dat de cast inderdaad de verwachte 
verlaging and oscillaties in shear stress induceerde. We toonden verder aan dat de 
expressie van het eiwit endothelial nitric oxide synthase (eNOS) dosis-afhankelijk 
reageerde op veranderingen in shear stress in vivo in een transgeen eNOS-GFP 
muismodel (Hoofdstuk 3). In deze muizen is het eNOS eiwit gefuseerd aan een 
tweede (markerings-)eiwit, genaamd green fluorescent protein (GFP), waardoor ieder 
eNOS eiwit is gelabeld met een groen fluorescerend signaal (beschreven in 
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Hoofdstuk 2). Tevens toonden we aan dat de cellulaire lokalisatie van eNOS ook 
afhankelijk is van shear stress: meer eNOS is gelokaliseerd in het Golgi complex en 
is gebonden aan het celmembraan wanneer de shear stress toeneemt. Ook de activatie 
van eNOS, gemeten in deze studie d.m.v. analyse van mate van fosforylering van het 
eiwit, is toegenomen. Metingen aan de mRNA niveaus van het transgene (humane) 
eNOS, het endogene (muizen) eNOS, en van een aantal aan shear stress gerelateerde 
genen (geselecteerd op basis van gepubliceerde resultaten van in vitro studies), 
toonden duidelijke effecten aan, die duiden op een algemeen shear stress effect dat 
niet beperkt is tot het transgen (Hoofdstuk 4). We concluderen uit deze studie dat het 
nieuwe cast model in staat is om veranderingen (lage shear stress en oscillatoire shear 
stress) te induceren in vivo, en dat het op effectieve wijze veranderingen in 
genexpressie induceert. In een vervolgstudie hebben we tevens gekeken naar het 
effect Rapamycine, dat in de kliniek wordt toegediend aan de vaatwand via gecoate 
stents om restenosis te verhinderen, op shear stress gevoeligheid van het eNOS eiwit. 
Wij toonden aan dat toediening van rapamycine een verhoging in eNOS expressie in 
lage shear stress gebieden induceert, terwijl in hoge shear stress gebieden de 
maximale eNOS respons wordt verlaagd (Hoofstuk 5). Dit impliceert dat m.n. in de 
lage (meer atherosclerosis gevoelige) shear stress gebieden rapamycine een 
beschermende werking geeft.   
 
 
Het effect van shear stress op atherosclerose: Vervolgens werd het atherosclerose 
bevorderende effect van lage en oscillatoire shear stress bestudeerd in apoE 
deficiënte muizen, het meest gebruikte diermodel in onderzoek naar atherosclerose. 
We toonden in deze dieren een causaal verband aan tussen veranderingen in shear 
stress en atherosclerose. Laesies ontwikkelden zich in de lage and oscillatoire shear 
stress gebieden binnen 6 weken na cast plaatsing, terwijl het hoge shear stress gebied 
vrij bleef van atherosclerotische plaques. Lage shear stress induceerde grotere laesies 
die na 9 weken cast plaatsing lagere percentages collageen en gladde spiercellen en 
een hoger percentage lipiden in de intima bevatten. Ook vertoonden de 
vaatsegmenten in het lage shear stress gebied meer outward remodelling (groei naar 
buiten), meer neo-vascularisatie, meer metallo-proteïnase activiteit (en dus afbraak 
van collageen) en een verhoogde expressie van pro-inflammatoire factoren. Verder 
induceerde infusie van angiotensine II verhoogde incidentie van bloedingen in de 
laesies van het lage shear stress gebied. We concluderen dan ook uit deze studies dat 
zowel lage als oscillatoire shear stress noodzakelijk zijn voor het ontstaan van 
atherosclerose en dat met name lage shear stress de groei van grotere, meer instabiele 
laesies stimuleert, die de kenmerken hebben van een onstabiele plaque (Hoofdstuk 
6).   
 
Het effect van shear stress op inflammatie: Lange tijd is al bekend dat bij het ontstaan 
van atherosclerose ontstekingsprocessen zijn betrokken. Veranderingen in shear 
stress kunnen hierbij als atherosclerose bevorderende stimulus werken omdat er 
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aanwijzingen zijn dat het de expressie van adhesie-moleculen en chemokinen kan 
beïnvloeden. Chemokinen zijn een familie van eiwitten die helpen om inflammatoire 
cellen uit de bloedstroom te “vangen” en deze vervolgens laten migreren in de 
vaatwand naar de ontstekingshaard. Deze gesecreteerde stoffen dragen hierdoor bij 
aan het atherosclerose proces. Hoewel de expressie van adhesiemoleculen cruciaal is 
voor adhesie en migratie van bloedcellen, wordt de specificiteit van de respons met 
name bepaald door de chemokinen.  We bestudeerden chemokine-expressie 
gedurende de vroege fase van de shear stress respons van de vaatwand en vergeleken 
dat met de shear stress respons bij volledig ontwikkelde atherosclerotische laesies. 
Hiervoor bekeken we het expressiepatroon van 12 verschillende chemokinen en 
chemokinereceptors in ApoE deficiënte muizen na een (alleen endotheliale 
dysfunctie waarneembaar), drie (fatty streaks) en negen weken (gevorderde 
atherosclerotische laesies) na plaatsing van de cast. We vonden een aanzienlijke 
inductie in expressie van een aantal duidelijk aan atherosclerose gerelateerde 
chemokinen (o.a. monocyte chemoattracting protein (MCP1) en interleukine 8 (IL8)) 
wat duidt op een pro-inflammatoire respons opgewekt door zowel lage als oscillatoire 
shear stress. Tevens vonden wij expressiepatronen in de onderzochte chemokinen in 
de gebieden met lage shear stress die karakteristiek zijn voor de groei van instabiele 
laesies. Met name de chemokinen fractakine (alleen aanwezig in de vulnerable 
leasies) en Interferon-gamma-inducible Protein-10 (IP10, alleen aanwezig in de 
vroegere tijdspunten van het door lage shear stress gestimuleerde gebied) zijn door 
hun associatie met het plaque stabiliteit interessante kandidaten voor verder 
onderzoek (Hoofdstuk 7). 
 
De conclusies van de voorafgaand beschreven studies kunnen als volgt worden 
samengevat (Hoofdstuk 8): 
 
Door het gebruik van het cast model zijn we in staat de directe effecten op de 
vaatwand van lage, hoge en oscillatoire shear stress te bestuderen. Door lage shear 
stress vervalt de bescherming van eNOS op de vaatwand. Daarentegen verhoogt 
oscillatoire shear stress de basale eNOS expressie. Zowel lage als oscillatoire shear 
stress induceren een inflammatoire respons. Hierbij komen chemokinen vrij die het 
atherogene proces activeren en bevorderen. Een verlaging in shear stress resulteert in 
het ontstaan van een atherosclerotische laesie met een instabiel fenotype. Oscillatoire 
shear stress resulteert in het ontstaan van stabiele atherosclerotische laesies. Het 
uiteindelijke verschil in mate van stabiliteit kan mogelijk worden verklaard door het 
karakteristieke chemokinenexpressie patroon dat we hebben gevonden in het lage 
shear stress gebied. Vroege expressie van IP10, en late expressie van fractakine, kan 
door het beïnvloeden van de differentiatie van de monocyten/macrofagen in de 
plaque, de functie van deze cellen sturen en zo doende het inflammatieproces 
bevorderen. Het blocken van fractalkine resulteert in het stabiliseren van de 
ahterosclerotische plaque. Verder onderzoek naar de samenstelling van de in de 
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atherosclerotische laesie aanwezige macrofagenpopulatie kan de rol van deze shear 
stress gevoelige chemokinen verduidelijken. 
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Iemand bedanken is schijnbaar toch een kunst, aangezien veel mensen klagen dat ze 
onvoldoende gewaardeerd worden door hun collega’s. Veel AIO’s maken dan ook 
een hele waslijst van het dankwoord, onder het motto “Je zou maar iemand 
vergeten!” Ikzelf heb er minder moeite mee. Ere wie ere toekomt. Dat geldt ook voor 
het uiten van dank. Dus hierbij, de mensen die me met raad en daad hebben 
bijgestaan gedurende deze lange jaren AIO-zijn: 
 
Beste Rob. Jij eerst, omdat je hoe dan ook de kapitein bent op dit onstuimige schip. 
Van jou heb ik geleerd dat origineel werk loont (en hoe!). Jouw creativiteit, grote 
kennis op fysiologisch gebied, nauwgezetheid en enthousiasme heb ik toch erg 
gewaardeerd, ook al laat ik dat niet altijd blijken. Jij hebt mij gestimuleerd om niet 
alleen hard door te werken, maar ook heel kritisch mijn resultaten te blijven bekijken. 
Soms verliep niet alles even gladjes, maar gelukkig loste de meeste problemen op als 
suiker in hete thee zodra dingen netjes konden worden besproken. Al met al heb ik de 
afgelopen vijf jaar met steeds meer plezier voor je gewerkt. Ik ben overtuigd dat het 
de komende jaren ook steeds beter zou gaan. Van onze trip naar Dallas heb ik in ieder 
geval zeer warme herinneringen overgehouden.  
 
Beste Rini, mijn dank is groot. Niet alleen voor de begeleidende rol die je hebt 
gespeeld gedurende mijn promotie, maar ook heel erg bedankt voor het er simpelweg 
zijn voor me. Af en toe stoom afblazen, uithuilen of een IKEA kastje in elkaar zetten 
met elkaar (altijd de schroef met het pijltje naar buiten draaien!), daar hebben AIOs 
soms behoefte aan. Ook van jouw grote kennis op het gebied van atherosclerose, 
goede communicatieve eigenschappen, enthousiasme en (bijna pathologische) 
netheid heb ik veel geprofiteerd en geleerd (ook al heb ik thuis mijn collectie 
proefschriften nog lang niet op alfabetische volgorde staan). Dankzij je gratis theetjes 
van onze collectieve koffiekaart kom ik graag naar het werk. Onze trip naar Dallas 
was zeker prijsloos.  
 
Mijn promotor professor van der Steen, en professor Grosveld, professor Poelman, en 
professor Simoons, hartelijk dank voor uw bereidheid om mijn thesis kritisch te 
beoordelen. Eveneens wil ik professor Grosveld bedanken voor zijn betrokkenheid 
bij dit onderzoek en de prettige werksfeer die ik ervaar op de afdeling celbiologie. 
Uw afdeling is erg groot, maar ondanks dat heeft het toch de sociale en behulpzame 
sfeer van een kleinere intieme groep. I never felt lost in this big city.   
 
Dr. Davies and Dr. Tedgui, thank you for travelling this far to attend the public 
defence of my thesis. Your contributions to the shear stress congress are also 
gratefully acknowledged. I also want to thank Dr. Davies for his tour around the 
Philadelphia University campus. I especially liked the squirrels the size of small cats. 
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Beste Dennie, alleen pipetteren is lang zo leuk nog niet als samen met jou. In mijn 
eentje op het lab kwam ik maar al te vaak handen te kort. Je bent de rots in de 
branding, wanneer ik weer eens dreig te verdrinken in het papierwerk. De afgelopen 
jaren waren een verademing en mede dankzij jou is er een boel afgekomen en kon het 
allemaal in dit boekje worden opgeschreven. Verder ben je mijn vaste lunchpartner, 
klaagpaal, benchcleaner (“Carolien, je maakt echt een tering zooi van mijn bench!”), 
meeting dummie (gedeelde smart is halve smart, voor mij dan wel te verstaan), en 
kaatsmuur (wetenschappelijk gezien dan, niet letterlijk). Kortom, je bent de beste 
collega die een AIO zich kan wensen. Maak je geen zorgen, je hebt niet alleen alle 
kwaliteiten van een uitmuntende analist, maar ook die van een goede AIO in je. Zet 
hem op! Over 4-5 jaartjes wil ik in je dankwoord staan! 
 
Beste Rien, hoe druk je het ook had, altijd was je bereid om hulp te bieden wanneer 
er weer eens wat mis dreigde te gaan op het lab. Het aantal keren dat je me goed 
advies hebt gegeven is net zo talrijk als het nageslacht van je guppen thuis (tis altijd 
raak). Ook al kon ik je in het begin niet altijd goed verstaan (mompel de mompel), je 
hebt me veel onmisbare praktische kennis bijgebracht die de basis vormen voor al het 
werk dat omschreven wordt in dit boekje. Verder: je eNOS GFP muizen zijn absoluut 
prachtig, zeker onder de confocal.  
 
Dan de rest van de mensen op het lab: Teus, bedankt voor het doen van de 
bestellingen en mijn mede AIO genoten Hanne en Matthijs, bedankt voor de 
gezelligheid en de hulp bij allerlei ditjes en datjes. Heel veel succes met jullie verdere 
promotie! Ik beloof in ieder geval weer vaker wat gezelliger te doen op het werk (en 
nieuwe planten te kopen en die beter te verzorgen) nadat de promotie achter de rug is.  
 
Dan de mensen van de afdeling cel biologie die ik gedurende al die tijd meerdere 
keer heb aangesproken met: “Sorry, mag ik u even storen en een vraag stellen?”: 
Rick, Sylvia, en Dubi (oud labgenoten), Pim (een van de aardigste collega’s die ik 
ken) en de heren van de computerclub, Melle en de dames van het bestelkamertje, de 
mensen op Robbert Rotier’s lab (hele ml’s antilichamen worden er door ons 
“geleend”), Ton de Wit (voor de muizen en het leuke commentaar), en iedereen die 
ik vergeten ben, allen heel erg bedankt! 
 
Gert, bedankt voor de hulp met bij confocal en Joop voor het maken van de castjes, 
zonder jullie waren er toch wel flinke gaten gevallen in het proefschrift.  
 
De heren van de 22ste verdieping: Frank, je kunt fysiologie zo uitleggen dat ik het 
zelfs snap. Bedankt voor je theoretische bijdrage. Luc, je was altijd hulpvaardig en 
vriendelijk wat een heel fijne collega van je maakte. Veel succes met je nieuwe 
loopbaan (niet dat je die nodig zult hebben) en erg bedankt, m.n. voor je MMP werk. 
Dolf, succes met de AIO jaren die je nog voor de boeg hebt. 
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De studenten die hard hebben meegewerkt aan de verschillende studies: Laurens, 
Martin, Arjen, Rianne, Angela, Tariqe, en Fadime, allemaal heel erg bedankt voor 
jullie bijdrage! Ieder van jullie wens ik het allerbeste toe met jullie loopbaan! 
 
De wetenschappers waarmee we goede samenwerkingen hebben: 
Jolanda en Frank van de haemodynamiek (ook voor het organiseren van het shear 
stress symposium), Pieter Leenen en John Laman van de afdeling immunologie, Dirk 
Jan Duncker en de rest van de afdeling experimentele cardiologie, Rob Poelman, 
Berend Hierck en Marco de Ruiter uit Leiden, en Domique de Kleijn en Gerard 
Paterkamp uit Utrecht, bedankt voor de praktische hulp en/of de zeer gewaardeerde 
wetenschappelijke input. 
 
Van de 23ste wil ik speciaal de volgende mensen een extra bedankje geven: 
 
Monique, heel erg bedankt voor je hulp bij de muizen, zeker in het begin. Ik wens je 
nog veel succes toe met je verdere promotie en volgend jaar in Chicago ben ik wel bij 
je praatje, zeker weten! 
 
Lieve Esther, het was echt een stuk gezelliger toen je nog beneden zat en ik mis je 
enorm. Zonder jou ben ik de enige die een tering zooi van zijn bench maakt en ga ik 
nog maar nauwelijks in de zomer even een ijsje halen in de baas zijn tijd. Gelukkig 
kun je mijn smart goed maken door je eens flink uit te sloven als mijn paranimf 
(wink wink). Zonder dollen: je was en bent echt een super fijne collega om “around” 
te hebben. Bedankt voor alles!  
 
Annemarietje, ook met jou het ik stoom afgeblazen, uitgehuild en een IKEA kastje 
naar zijn grootje geholpen. Een oprechter en liever cardioloogje dan jij is er domweg 
niet op deze roterende aardkloot. Met zo’n huis van een karma kan het alleen maar 
goed komen met je. Nog even doorbijten, en dan mag jij ook het dankwoord 
schrijven. 
 
Desire, onze lieve, ultra nette, uiterst vis vriendelijke (jammer genoeg) ex-collega. 
Bedankt voor je gezelligheid en je goede tips. Ik kom langs zodra je je 500L 
aquarium (met guppen vretende haai!) geïnstalleerd hebt in je nieuwe woning. 
 
Bedankt lieve mans en paps. Hoe druk ik het ook had met mijn werk, ik kon 
naderhand altijd bij jullie weer terecht als jullie kleine meid. Thuis in Eindhoven was 
het altijd warm en gezellig (en het eten (ge)weldadig veel). Bedankt Kawah en Wing, 
zonder jullie is een spelletje monopolie spelen toch wel erg saai. Lief (rijk) zusje van 
me, wil je ophouden mijn spullen te lenen zonder het terug te geven!  
 
Lieve David, zonder jou geen lieve Caroline. We hebben samen al heel veel leuke 
dingen gezien en meegemaakt (Slecht Vlaams eten(!) in Brugge, ultra snob doen in 
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Londen, Venetiaans rioleringswater, “doggie-bags” en eikeltjes in New Orleans, sub 
zero Toronto, Beter dan gij Franse bediening in Parijs, een deinende Star ferry in 
Hong Kong, met rauw billen door de donkere landweggetjes van Texas, en Kou 
Kleumen op Keulse Kerstmarkten). Het leukste van dit alles is dat ik iedere keer weer 
het dierbaarste van al die plekken weer mee naar Rotterdam mocht nemen, n.l. jou. Ik 
hou van je. Bedankt lief, bedankt voor alles.  
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Chapter 1, figure 1: 3D reconstruction of an atherosclerotic rabbit aorta with IVUS, 
allowing the projection of wall thickness on the 3D lumen reconstruction. Indicated 
is also the shear stress distribution obtained by CFD. Atherosclerosis was induced in 
New Zealand White rabbits by a combination of denudation (surgical removal of the 
endothelium) and high cholesterol diet for two months. CFD modeling was based 
upon a commercially available finite element package as described before. On the 
left and right sides are indicated the macrophage distribution and the smooth muscle 
cell distribution. Lines in the figure indicate the approximate location of the 
histological cross sections. The position of these cross sections was determined by 
measurement at sacrifice. Note that upstream, where the shear stress is high, the 
macrophages accumulate. Full colour image of this figure is available in the colour 
section.  
 
 
Chapter 1, figure 2: Relationship between metalloproteinase activity as determined 
by zymography, plaque location and shear stress distribution mapped upon the 3D 
reconstruction of the blood vessel. CFD was used as described in figure 1. Mapping 
of location was performed by selection on basis of shear stress distribution and 
correction for shrinkage after dissection. Note that the location of MMP9 activity is 
upstream of the plaque and associates with high shear stress values. MMP-2 is 
activated through the entire plaque region. A-E represent samples from the sections 
in different locations of the atherosclerotic vessel. R stands for the control sample. 
Full colour image of this figure is available in the colour section.    
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Chapter 4, figure 1: Intracellular localization of eNOS-GFP and Golgi complex in 
areas of the carotid artery experiencing different shear stress patterns after 2 days of 
cast placement. (a) In the upper panel: Golgi complex in corresponding vascular 
regions visualized by en face immunofluorescence staining. Indicated are: the low 
shear stress region  (low), the high shear stress region (high), the oscillatory shear 
stress region (oscillatory), and the control region (undisturbed).  Fluorescence was 
monitored by en face confocal microscopy in stacks of 500 µm x 500 x 40 µm each. 
In the middle panel: Fluorescence of eNOS-GFP in endothelial cells located in the 
three different shear stress regions and in the contra-lateral carotid artery. In the 
lower panel the upper and middle panels are merged, showing the co-localization 
signal in yellow. (b-d) Quantification of the localization of (b) the Golgi complex, (c) 
the eNOS-GFP and d) the co-localization signals in response to the different shear 
stress fields in percentages of the total area (b,c) or of the total eNOS-GFP signal (d). 
n = 4, * P<0.05 versus low shear stress. †  P<0.05 versus undisturbed shear stress. 
Full colour image of this figure is available in the colour section.  
 
 
Chapter 4, figure 2: Intracellular localization of eNOS-GFP and PECAM-1 in 
regions of the carotid artery experiencing different shear stress patterns after two 
days cast placement. (a) In the upper panel: PECAM-1 in corresponding vascular 
regions visualized by en face immunofluorescence staining. Indicated are: the low 
shear stress region  (low), the high shear stress region (high), the oscillatory shear 
stress region (oscillatory), and the control region (undisturbed).  Fluorescence was 
monitored by en face confocal microscopy in stacks of 500 µm x 500 x 40 µm each. 
In the middle panel: Fluorescence of eNOS-GFP in endothelial cells located in the 
three different shear stress regions and in the contra-lateral carotid artery. In the 
lower panel the upper and middle panels are merged, showing the co-localization 
signal in yellow. (b-d) Quantification of the localization of (b) the PECAM-1, (c) the 
eNOS-GFP and d) the co-localization signals in response to the different shear stress 
fields in percentages of the total area (b,c) or of the total eNOS-GFP signal (d). n = 5, 
†  P<0.05 versus undisturbed shear stress. # P<0.05 versus oscillatory shear stress. 
Full colour image of this figure is available in the colour section. 
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hapter 4, figure 4: Intracellular localization of eNOS-GFP and phospho-eNOS in 
reas of the carotid artery experiencing different shear stress patterns after two days 
f cast placement. (a) In the upper panel: Phospho-eNOS in corresponding vascular 
gions visualized by en face immunofluorescence staining. Indicated are; the low 
hear stress region  (low), the high shear stress region (high), the oscillatory shear 
tress region (oscillatory), and the control region (undisturbed). Fluorescence was 
onitored by en face confocal microscopy in stacks of 500 µm x 500 µm each. In 
e middle panel: Fluorescence of eNOS-GFP in endothelial cells located in the three 
ifferent shear stress regions and in the contra-lateral carotid artery. In the lower 
anel the upper and middle panels are merged, showing the co-localization signal in 
ellow. (b-d) Quantification of the localization of (b) thePhospho-eNOS, (c) the 
NOS-GFP and d) the co-localization signals in response to the different shear stress 
elds in percentages of the total area (b,c) or of the total eNOS-GFP signal (d). n = 
, * P<0.05 versus low shear stress. †  P<0.05 versus undisturbed shear stress. Full 
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colour image of this figure is available in the colour section.  
 
 
Chapter 6, figure 1: Low shear stress and oscillatory shear stress induce 
atherosclerosis in apoE  –/– mice fed an atherogenic Western diet. Whole mount 
aortic arches and carotid arteries were stained with Oil-red-O for atherosclerotic 
lesions. The white lines demarcate the previous position of the cast with the high 
shear stress region. Upstream from the cast is the low shear stress region, and 
downstream from the cast is the oscillatory shear stress region. Animals were 
instrumented with a cast after 2 weeks of the beginning of the diet and sacrificed after 
6 (A), 9 (B), or 12 (C-E) weeks of cast placement.  No lesions are detected in the 
carotid arteries of sham operated mice (D) or in the carotid arteries of animals 
instrumented with a non-constrictive cast (E). Representative images are shown from 
groups consisting of 6-8 animals. Colour version of this figure is available in the full 
colour section.  
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hapter 6, figure 2: Histological analyses of carotid arteries at 9 weeks after cast 
lacement in apoE–/– mice fed a Western diet. (A) Representative images are shown 
om the low, high, and oscillatory shear stress regions as well as from the contra-
non-treated carotid artery (undisturbed shear stress) (hematoxylin and eosin 
staining, original magnifications 100X). (B) Representative images showing 
PECAM-1 staining (red) of the intact endothelium in the four different shear stress 
regions. Auto-fluorescence of the elastic lamellae is in green and the cell nuclei 
stained with DAPI are in blue. Original magnifications: 100 X. Histological analyses 
were performed by quantification of the intima/media ratio (C), and of the relative 
cross-sectional area of the vessel wall (D), which was obtained by measuring the area 
confined by the external elastic lamina of the instrumented carotid artery and 
expressed as percentage of the cross-sectional area of the contra-lateral non-treated 
carotid artery. * P<0.05 versus low shear stress. † P<0.05 versus oscillatory 
shear stress. Colour version of this figure is available in the full colour section.  
 
 
Chapter 6, figure 5: Intra-plaque hemorrhages in the lesions located in the low shear 
stress region. ApoE–/– mice were fed a Western diet and instrumented with a cast 
around the carotid artery. (A,B) After nine weeks, intra-plaque hemorrhages were 
found in approximately 28% of the animals analyzed. Arrowheads point at 
accumulations of red blood cells near the internal elastic lamina (A) or in the necrotic 
core (B). (C-H) After 7 weeks of cast placement, the animals were treated with 
angiotensin II infusion (400ng/kg/min) via a subcutaneously implanted osmotic 
minipump (Alzet, model 2004, Durect Corp) and were sacrificed 2 weeks later. Intra-
plaque hemorrhages were frequently observed (in 6 out of the 8 animals): (C) 
overview of an atherosclerotic lesion with intra-plaque hemorrhages in the low shear 
stress region; (D) overview of an atherosclerotic lesion in the oscillatory shear stress 
region. No intra-plaque hemorrhages can be detected; (E) detail from intra-plaque 
hemorrhage in the low shear stress atherosclerotic lesions; (F) the same detail as in 
(E) stained for iron deposits (arrowheads) with the Prussian blue reaction; (G): 
overview of a carotid artery with a large false lumen (FL); (H) detail showing the 
depressed lumen (arrowheads). 7 µm cryosections were stained with eosin and 
hematoxylin. Representative pictures from 6 animals are shown. Original 
magnifications: 100 X (C, D, G); 400 X (A, B, F, G, H). Colour version of this figure 
is available in the full colour section.  
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hapter 6, figure 3: (A) Cross-sections of carotid arteries 9 weeks after cast 
lacement in apoE–/– mice on a Western diet (100X magnification) stained for 
acrophages 15, lipids (Oil red-O), vascular smooth muscle cells (anti α-actin), or 
ollagen (picrosirius red) in the low shear stress and the oscillatory shear stress 
gion. MMP activity was studied by DQ gelatinase assay. (B) Quantification of 
acrophages, lipids, vascular smooth muscle cells, and collagen in the intimal area of 
e low shear stress and the oscillatory shear stress region, and of MMP activity. Data 
re the average values of sections from 5 different animals.  * P<0.05 versus low 
hear stress. Colour version of this figure is available in the full colour section.  
hapter 7, figure 4: Validation of result of a selected group of chemokines by 
muno-histological analysis of the protein levels in carotid arteries at different time 
oints after cast placement in mice on western diet. Shown are representative cross-
ctions of murine carotid arteries stained for fractalkine after 9 weeks of cast placement 
pper panel), and MCP1 (middle panel) and IP10 (lower panel after 1 week of cast 
lacement, in the control, low and oscillatory shear stress regions (20X magnification) 
hemokine expression is specified by a red signal. Green auto-fluorescence designates 
e intimal and medial areas (a). The results of the immuno-histological quantification of 
e chemokine signals. The percentages of fractalkine at time point 9 weeks (upper 
raph), MCP1 at time point 1 week (middle graph), and IP10 at time point 1 week 
ower graph) in the vessel area of the low shear stress (LSS) and the oscillatory shear 
ress (OSS) regions are shown (b). N=5. *P<0.05 versus control. #P<0.05 versus low 
ear stress. Colour version of this figure is available in the fu l colour section. 
 
Chapter 7, figure 5: The effect of fractalkine expression on cell recruitment in the 
mature lesions. Shown are representative cross-sections of murine carotid arteries 
double stained for CX3CR1 (red signal) and nuclei (blue signal). In the upper panel, 
CX3CR1 positive cells in the low shear stress lesions (indicated by arrows) are 
shown. The lumen is indicated by an (*), and the intima contours are traced by a 
white line. In the upper panel, CX3CR1 positive cells in the oscillatory shear stress 
lesions are shown. The lumen is indicated by an (*), and the intima contours are 
traced by a white line (a). The results of the immuno-histological quantification of 
the chemokine signal. The percentages of CX3CR1 positive area at time point 9 
weeks in the intima in the low (LSS) and the oscillatory shear stress (OSS) region 
(b). N=5. #P<0.05 versus low shear stress. Colour version of this figure is available 
in the colour section.  
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hapter 7, figure 7: Fractalkine function was inhibited during cast-induced 
therogenesis in ApoE KO mice by administration of a neutralizing antibody from 
Chapter 7, figure 6: CX3CR1 expressing cells located in the advanced lesions are 
mainly monocytes and macrophages. Shown are representative cross-sections of 
murine carotid arteries double stained for CX3CR1 (middle column) and CD11b, 
CD68, and VSMC α-actin (left column, from upper to lower panels), respectively. In 
the third column, the (yellow) co-localization signal is shown. The lumen is indicated 
by a (*) and the intima contours are traced by a white line. Colour version of this 
figure is available in the full colour version.   
 
 
C
a
week 6 till week 9. In the left column, Representative cross-sections are shown. 
These are stained for: (2a) lesion morphology by H/E, (2b) macrophages, (2c) lipids, 
(2d) VSMCs, (2e) collagen, and (2f) fractalkine receptor (CX3CR1). The lumen is 
indicated by a (*) and the intima contours are traced by a white line. In the right 
column, the lesion area is shown in the first graph, followed by results of the 
(immuno-) histological quantification of the different plaque components. The 
percentages of positive area at time point 9 weeks in the intima in the low (LSS) and 
the oscillatory shear stress (OSS) region are indicated, comparing the control 
antibody group (A) with the a-fractalkine antibody group (B). N=8. *P<0.05 versus 
control antibody group. Colour version of this figure is available in the full colour 
section.   
  
 
190
Chapter 7,  figure 6 
 
Chapter 7,  figure 7 
 
  
 
191
 
 
 
 
 
 Chapter 7,  figure 7 
 
  
 192
 
 
  
 193
urriculum vitae 
Caroline (Ka Lai) Cheng was born on the 20th of January 1978 in Hong Kong 
(China). She moved to the Netherlands in 1981 and graduated from the VWO in 1996 
at the Christian Huygens College in Eindhoven. She studied Medical Biology at the 
Free University (Vrije Universiteit) in Amsterdam where she graduated in 2000. In 
September 2000, she started as a Ph.D. student in the Erasmus MC in Rotterdam 
under the guidance of Dr. Rob Krams (department of Cardiology) and Dr. Rini de 
Crom (department of Cell Biology and Genetics). Her main interests are the effects 
of shear stress on the vessel wall during atherosclerosis development. At this 
moment, she remains at the department of cardiology, working as a post-doc in close 
collaboration with the department of cell biology and genetics. 
 
 
 
 
Scientific Awards: 
 
Finalist poster awards American Heart Association Congress 2005 
 
Fellowship from the Dutch Atherosclerosis Society, at the Dutch Atherosclerosis 
Society Symposium 2005 
 
“Best presentation award” awarded by ICIN 2004 
 
Finalist poster awards European Heart Congress 2004 
 
“Best presentation award” at the Dutch Atherosclerosis Society Symposium 2003 
 
“Best presentation award”, at the 14th endothelium research symposium 2003
C
 
  
 194
s List of publication
 
 
Full papers: 
 
C. Cheng, R. van Haperen, M. de Waard, L.C.A. van Damme, D. Tempel, L. 
Hanemaaijer, G.W.A. van Cappellen, J. Bos, Cornelis J. Slager, D.J. Duncker, 
A.F.W. van der Steen, R. de Crom, and R. Krams. Shear stress affects the 
intracellular distribution of eNOS: direct demonstration by a novel in vivo model.  
Blood. 2005;1;106(12):3691-8 
C. Cheng, R. de Crom, R. van Haperen, F. Helderman, B.M. Gourabi, L.C.A. van 
amme, S.W. Kirschbaum, C.J. Slager, A.F.W. van der Steen, and R. Krams. The 
le of shear stress in atherosclerosis: action through gene expression and 
flammation? 
ys. 2004;41(2):279-94. 
M.J.A.P. 
 vulnerability are 
an, F. Gijsen, J. Wentzel, R. van 
n, R. de Crom, and R. Krams. 
echanism. 
s. 
Submitted 
 
R. van Haperen, C. Cheng, B.M. Mees, E. van Deel, M. de Waard, L.C.A. van 
Damme, T. van Gent, T. van Aken, R. Krams, D.J. Duncker, R. de Crom. Functional 
expression of endothelial nitric oxide synthase fused to green fluorescent protein in 
transgenic mice. 
Am J Pathol. 2003;163(4):1677-86. 
 
F. Helderman, C. Cheng, L.C.A. van Damme, D. Segers, B. Mousavi Gourabi, N. 
Stergiopulos, M.M. Kockx, M. W. M. Knaapen, P.W. Serruys and R. Krams. The 
role of shear stress and wall stress after balloon angioplasty and stent placement. 
Recent Res Development in Biomechanics, 2003;1:99-109.  
D
ro
in
Cell Biochem Bioph
 
C. Cheng, D. Tempel, R. van Haperen, A. van der Baan, F. Grosveld, 
Daemen, R. Krams, and R. de Crom. Atherosclerotic lesion size and
determined by patterns of fluid shear stress. 
Circulation, in review  
 
C. Cheng, D. Tempel, A. Oostlander, F. Helderm
Haperen, P.W. Serruys, A. F. W. van der Stee
Rapamycin affects eNOS expression through a shear stress dependent m
Submitted 
 
C. Cheng, D. Tempel, R. van Haperen, M. Huisman, R. de Crom, and R. Kram
Shear stress affects chemokine expression during atherogenesis: difference in pro-
inflammatory abilities between low and oscillatory shear stress. 
  
 195
, S.W.M. Kirschbaum, A.E. Oostlander, F. 
elderman, A. van Wamel, C.J. Slager, P.W. Serruys, A.F.W. van der Steen and R. 
yte Adhesion in Atherosclerosis: A Biomechanical Approach. 
ase Prevention. 2005; 2(3):227-235. 
 
. Segers, C. Cheng, R. de CromD
H
Krams. Monoc
ascular DiseV
 
R. Krams, D. Segers, B.M. Gourabi, W. Maat, C. Cheng, C. van pelt, L.C.A. van 
Damme, P. de Feyter, A. F. W. van der Steen, C.L. de Korte, P.W. Serruys. 
Inflammation and atherosclerosis: mechanisms underlying vulnerable plaque. 
(2):107-13. J Interv Cardiol. 2003 Apr;16
 
S.G. Calier, L.C.A. van Damme, C.P. Blommerde, J.J. Wentzel, G. van Langehove, 
S. Verheye, M.M. Kockx, M.W. Knaapen, C. Cheng, F. Gijsen, D.J. Duncker, N. 
Sterngiopulos, C.J. Slager, P.W. Serruys, R. Krams. Augmentation of wall stress 
inhibits neointimal hyperplasia after stent implantation: inhibition through reduction 
of inflammation? 
irculation. 2003 Jun 3;107(21):2741-6.  C
 
 
Abstracts and Presentations: 
 
. Cheng, D. Tempel, LC . van Damme, K van Gaalen, R. van Haperen, R. de Crom, 
t the American Heart Association Congress, Dallas 2005 
ciation Congress, Dallas 2005 
R. Krams. Angiotensin II induces severe intra-plaque hemorrhages in lesions with a 
vulnerable plaque phenotype in apoE KO mice.  
Circulation 2005; 112:II-165.  
t the American Heart Association Congress, Dallas 2005 Presented a
 
C. Cheng, D. Tempel, L. van Damme, R. van Haperen, R. Krams, R de 
Crom.Vunerable lesions induced by low shear stress are characterized by expression 
of specific inflammatory chemokines.  
 2005; 112:II-82.  Circulation
resented aP
 
C. Cheng, D. Tempel, L. van Damme, R. van Haperen, R. Krams, R de Crom. 
Patterns of fluid shear stress determine atherosclerotic lesion size and vulnerability.  
Circulation 2005; 112:II-292.  
Presented at the American Heart Asso
 
C. Cheng, D. Tempel, L.C.A. van Damme, R. van Haperen, R. Krams, R. de Crom. 
Patterns of fluid shear stress determine atherosclerotic lesion size and vulnerability.  
Vasculaire Geneeskunde 2005; 2:30.  
Presented at the Dutch Atherosclerosis Society Symposium, Ermelo 2005 
 
  
 196
. Cheng, R. van Haperen, M. de Waard, R. de Crom, R. Krams. In vivo induced 
04 
resented at the American Heart Association Congress, New Orleans 2004  
 108: IV-151.  
n Congress, Orlando 2003  
. Cheng, R. van Haperen, M. de Waard, R. de Crom, R. Krams. ENOS expression 
ss: direct demonstration in a novel mouse model.  
resented at the 14  endothelium research symposium, Amsterdam 2003    
stration in a novel mouse model.  
2:14.  
003 
C
changes in shear stress patterns affect the expression and the intracellular localization 
of endothelial nitric oxide synthase. 
Eur. Heart. J. 2004; 25:58.  
Presented at the European Heart Congress, München 20
 
C. Cheng, M. de Waard. R. van Haperen, D. Tempel, A. van der Baan, R. Krams, R. 
de Crom. In vivo induction of low shear stress and oscillatory shear stress causes 
atherosclerosis.  
Circulation 2004; 110:III-39.  
P
 
C. Cheng, R. van Haperen, M. de Waard, R. de Crom, R. Krams. ENOS expression 
responds to changes in shear stress: direct demonstration in a novel in vivo mouse 
model. 
Circulation 2003;
Presented at the American Heart Associatio
 
C
responds to changes in shear stre
thP
 
C. Cheng, R. van Haperen, M. de Waard, R. de Crom, R. Krams. ENOS expression 
responds to changes in shear stress: direct demon
Vasculaire Geneeskunde 2003; 
Presented at the Dutch Atherosclerosis Society Symposium, Ermelo 2
 
 
 
 
 
 
  
 197
  
 198
 
